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ABSTRACT 
 
 
            Chapter I introduced the background of phthalocyanines including its physical 
properties and various synthetic methods of free-base and metallo-phthalocyanines. The 
background of PDT and BNCT was introduced and the objective of ideal sensitizers was 
described.  
            Chapter II described the synthesis and characterization of a series of pyridiloxy-
substituted zinc phthalocyanines with different length of alkyl groups. Pyridiloxy-
substituted silica phthalocyanines bearing different associated axial ligands, were 
alkylated with methyl or PEG chains. Biological study was performed on these cationic 
pyridiloxy-substituted zinc phthalocyanines.  
            Chapter III introduced the synthesis and photophysical properties of A3B-type 
zinc phthalocyanines conjugated with one or two cobalta-carborane cages. They are 
highly soluble in polar solvents such as methanol, acetone, DMF and DMSO. Their 
absorption and emission properties are solvent-dependent, and had ~0.1 fluorescence 
quantum yields. These Pcs may have potential application as dual sensitizers in the PDT 
and BNCT treatment of tumors. 
            Chapter IV introduced the synthesis and characterization of octa, tetra and 
dihdroxy-substituted phthalocyanines using different synthetic strategies.  
            Chapter V introduced the synthesis and characterization of octaphosphonate-
substituted zinc phthalocyanine. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Overview of Phthalocyanines 
            Phthalocyanine (Pc), known as an azoporphyrin derivative, is a class of synthetic 
tetrapyrrolic compound which is closely related to the naturally occurring porphyrin.1, 2 
Structure difference between Pc and porphyrin is that Pc has four extended benzo 
subunits and four nitrogen atoms at the meso positions on the macrocycle (Figure 1.1). Pc 
consists of a symmetrical macrocycle containing four isoindole units with a central cavity 
of appropriate size to fit more than 70 metal ions. Pc is an aromatic ring system due to its 
planar conjugated array of 18 π-electrons.  
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Figure 1.1. (a) Metal-free phthalocyanine; (b) metal-free porphyrin. 
            Pc was firstly reported as a dark blue insoluble byproduct during the preparation 
of ortho-cyanobenzamide from phthalimide and acetic acid by Braun and Tcherniac in 
1907.1 Twenty years later, de Diesbach and von der Weid of Fribourg University 
observed an unexpected stable blue material in the reactions of ortho-dibromobenzene 
with copper cyanide in refluxing pyridine.1 The mystery of the new compound wasn’t 
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resolved until Linstead et al. succeeded in determining its structure using several methods 
in the early 1930s.3-9 Pc is finally elucidated as a symmetrical, aromatic macrocycle of 18 
π-electrons, which is composed of four identical isoindole units.  
            Monomeric metallo-Pcs have characteristic absorption spectra including a Soret 
band in the visible region at approximately 350 nm, and a major strong Q band at around 
670 nm with a molar extinction coefficient in the range of 105 M-1cm-1 (Figure 1.2).10 
           
 
 
 
 
 
 
 
 
Q-band 
Soret band 
Figure 1.2. Typical absorption spectrum of a metallo-Pc in DMSO. 
            Pc normally has high thermal and chemical stabilities. It is also well known that 
the largest disadvantage of this kind of material is its extreme insolubility in most 
solvents due to its intrinsic nature. The planarity of the aromatic core and its extreme 
hydrophobicity leads to a pronounced tendency for aggregation. Unsubstituted Pc is 
poorly soluble in most organic solvents and water. In order to increase the solubility, Pcs’ 
backbone can be modified by attaching various substituent at the macrocycle periphery or 
centrally chelated metal ions which typically have oxidation states of +2 or greater.   
 
 2
1.2 Synthetic Strategies for Phthalocyanines 
1.2.1    General Aspects of Phthalocyanine Synthesis   
            The precursors of Pcs include phthalic acid, phthalonitrile, phthalic anhydride, 
phthalimide, diiminoisoindoline, o-cyanobenzamide, cyclohex-1-ene-1,2- dicarboxylic 
OH
OH
O
O
N
N
O
O
O
NH
O
O
NH
NH
NH
CN
NH2
O
O
O
O
Phthalic acid Phthalonitrile Phthalic anhydride Phthalimide
Diiminoisoindoline o-Cyanobenzamide Cyclohex-1-ene -1,2-dicarboxylic anhydride  
Figure 1.3. Basic Pc precursors. 
anhydride (Figure 1.3). Among these, phthalonitrile is the most useful precursor in the 
synthesis of Pc. Phthalonitrile is generally used in a reaction involving heating with a 
metal template in a high boiling point solvent, such as chlorobenzene, quinoline or 1-
chloronaphthalene.         
            In the early 1980s,11, 12 Tomoda et. al. published a simple method to synthesize Pc 
by heating 1,2-dicyanobenzene with a catalytic amount of DBU or DBN in an alcoholic 
solvent. High yields of 70% for metal-free and 80% for metal-containing Pc were 
achieved. Since the organic bases DBU and DBN were first employed in Pc synthesis by 
Tomoda, this method and the related preparation of metal-containing Pcs are referred to 
as “Tomoda method”. Common organic bases used in the synthesis of Pc are DBU, DBN, 
piperidine and DMAE (Figure 1.4). Wohrle and Knothe found in 1991 that the presence 
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of an organic base such as DBU and DBN is important in the synthesis of Pc.13 These 
organic bases can generally lead to high yield in Pc formation and more purity when 
various substituted dinitriles are used as the precursors. It was also reported that the use 
of weaker bases such as TEA, pyridine and THP failed to promote Pc formation while 
stronger bases than DBU and DBN did not improve the reaction. 
N
N N
N
N
H
N
OH
 
DBU                               DBN                    Piperidine                 DMAE 
Figure 1.4. Structures of common organic bases used in the syntheses of Pcs. 
            The symmetry of the resulting Pc largely depends on the structure of the 
precursors used in the reaction. Unsubstituted or symmetrically substituted precursors can 
lead to symmetric Pcs. For example, 4,5 - or 3,6 - disubstituted phthalonitriles can only 
lead to symmetric octasubstituted Pcs. 
            Unsymmetrically substituted precursors may lead to complicated mixtures of Pcs 
containing several constitutional isomers. For example, a 4 - substituted phthalonitrile 
can lead to four constitutional isomers: C4h, C2v, Cs, D2h (Figure 1.5). The modification of 
the properties of the substituent on the phthalonitrile and optimization of the reaction 
condition can improve the formation of one or two major isomers. However, in most 
cases, the separation of constitutional isomers is troublesome and difficult. The yields of 
products are poor due to tedious chromatography purification procedures.  
1.2.2    Mechanisms of Phthalocyanines’ Formation  
            The formation of Pcs using phthalonitrile as precursor usually requires the 
presence of a high boiling point alcohol such as pentanol or butanol as the solvent and a             
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Figure 1.5. Structures and symmetries of different Pc constitutional isomers. 
strong base such as DBU or DBN. Tomada et. al.11 proposed the role of the strong base 
as being an electron acceptor (Scheme 1.1). As a result, alkoxide anion (RO-) is both the  
N
N
ROH N
N
RO
H  
Scheme 1.1. Mechanism of formation of RO- (Y-)11 in Pc synthesis. 
nuleophile and reducing agent that reacts with a cyano group of a phthalonitrile to form 
an alkoxyisoindolenine intermediate as shown in Scheme 1.2.14 The dimeric intermediate 
reacts further with two molecules of the precursor to get the metal complex. 
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Scheme 1.2. Mechanisms of formation of a metallo-Pc.14
1.2.3 Synthesis of Symmetrical Phthalocyanine 
            The strategies to synthesize metal-free symmetrical Pcs are summarized in 
Scheme 1.3.15 Phthalonitrile 1 and diiminoisoindoline 2 can both be used as precursors to 
obtain metal-free Pc. Lithium alkoxide formed in situ by the addition of lithium to a 
primary alcohol is normally used, when phthalonitrile is the precursor. The lithium ion 
can be easily removed by acidic or aqueous work-up after the macrocyclization. Metallo-
free Pc (H2Pc) can also be synthesized by using a suitable organic reducing agent such as 
a hydroquinone. The “Tomoda method”11 involves heating of a phthalonitrile with a base 
(e.g. DBU, DBN) in a high boiling point solvent (e.g. n-pentanol) or in a basic solvent 
such as DMAE to afford H2Pc in high yields (70%). 
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CN
CN
NH
NH
NH
a, b or c
d
H
NN N
N
NN
H
N
N
1
2                       
Scheme 1.3 (a) Lithium, pentanol, followed by aqueous hydrolysis; (b) fusion with              
hydroquinone; (c) heat with a base (e.g. DBU, DBN); (d) refluxing in a high boiling point 
alcohol (e.g. n-pentanol).15
  
            Metallo-Pc can be prepared in several ways.1 They can be formed from 
phthalonitrile or diiminoisoindoline in the presence of the metal ion as a template for the 
cyclotetramerization. The direct metallation of H2Pc is another clean and high-yielding 
synthetic approach. Phthalic anhydride and phthalimide can also be used as the 
precursors in the presence of metal salts to produce metallo-Pc in good yields.  
            The high stability of unsubstituted Pc allows its purification by sublimation at 600 
ºC in vacuo.16-18 This method is useful to obtain ultra-pure materials. Another method of 
purification that relies on the stability of Pc is recrystallization from concentrated sulfuric 
acid and water. This method is particularly suitable to copper (II)-Pc which has no 
solubility in any organic solvent and is stable in sulfuric acid solution.5 Traditional 
purification methods such as column chromatography on alumina and silica gel, 
recrystallization and extraction can be applied to soluble Pcs. However, Pcs’ strong 
tendency for aggregation in solution may hinder its clean separation using these 
techniques.          
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1.2.4 Synthesis of Non-Centrosymmetric Phthalocyanine 
            Non-centrosymmetric Pc can be obtained by mixed condensation of two different 
phthalonitriles. It can lead to asymmetric Pc when unsymmetrically substituted 
precursors are used. In this case, different constitutional isomers are obtained as a 
mixture. Because of Pc’s low solubility and tendency for aggregation, it is difficult to 
separate and characterize the different isomers.19 Only a few examples in the literature 
show the successful separation of isomers by Hanack and co-workers, using an especially 
designed HPLC column.20, 21 The selective synthesis of unsymmetrically substituted Pcs 
is a big challenge for Pc chemists. In the past years, several approaches have been 
investigated for the synthesis of unsymmetrically substituted A3B-type Pcs (subunits: A 
and B). The synthetic methods to A3B-type Pcs can be summarized as: 1) statistical 
condensation; 2) ring expansion; and 3) polymer support synthesis (see below). 
1.2.4.1 Statistical Condensation  
            Statistical condensation method is the traditional method to synthesize the A3B-
type Pc containing three identical and one different isoindole subunits. It is based on the 
reaction of two differently substituted phthalonitrile or diiminoisoindoline A and B.   The 
reaction affords a mixture of six constitutional isomers (Scheme 1.4). The drawback of 
this method is the difficult purification procedure. Chromatography is generally used to 
do the tedious separation of the mixed products. The yield is normally low and 
contamination of the different isomers may occur.  
            One of the solutions is to modify one of the phthalonitriles with bulky or rigid 
substituents which can provide different solubility features to the macrocycles, and as a 
result, makes the separation easier. Especially when a phthalonitrile with rigid groups at 
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the 3 and 6 positions reacts with another phthalonitrile, fewer isomers are obtained.22, 23  
Varying the stoichiometry is another way to control the ratio of isomers  produced  in  the           
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Scheme 1.4. Statistical condensation of two phthalonitriles A and B. 
statistical condensation. Cook and et. al. reported that condensation of a phthalonitrile 
bearing long chain groups at the 3,6-positions and another differently substituted 
phthalonitrile in a 9:1 ratio can lead to simpler mixtures and separations in the 
purification step.24-28 In summary, the electronic properties, the position of the 
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substituents on the phthalonitrile precursors and their ratio can be the factors that 
determine the ratio of the Pc isomers produced. 
1.2.4.2 Ring Expansion  
            In the late 1980s, Kobayashi and his coworkers developed a new method to 
synthesize A3B-type Pc.29 This method involves the ring expansion reaction of a 
subphthalocyanine in the presence of succinimide or diiminoisoindoline derivatives as the 
reactants (Scheme 1.5). 
NH
NH
NH
N
N N
NN
N
B
Cl
R1
R2 NN N
N
NNN
N M
MX2
R1
R2
 
Scheme 1.5. Selective synthesis of A3B-type Pc.29 
            The selectivity of this ring expansion reaction is highly dependent on the 
reactants’ properties and the reaction conditions. It was reported that the best yield of the 
unsymmetrically substituted Pc could be achieved by using a metal template and by 
selectively choosing the substituents on the two reactants.30 The best yields were 
achieved in the case of reactions between subphthalocyanines bearing either no 
substituents or electron-withdrawing groups, and diiminoisoindoline derivatives bearing 
electron-donating groups.30 Van Lier and Sharman reported the synthesis of A3B-type 
fluorinated Pcs by the ring expansion method in 2005.31 Dodecafluorinated 
subphthalocyanine and diiminoisoindoline in 1:5 ratio reacted in DMSO at room 
temperature. The yield to obtain the dodecafluorinated Pc was up to 60%. Although in 
some cases the subphthalocyanine approach can be an efficient method to synthesize 
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unsymmetrically substituted Pcs, in many cases it may lead to a mixture of statistical Pc 
products. This may be caused by the partial or total fragmentation of the 
subphthalocyanine ring followed by statistical ring closure of the fragmentation products, 
and as a result leading to a mixture of all possible Pcs.32, 33 
1.2.4.3 Polymer Support 
            The method of using a polymeric support to synthesize A3B-type Pcs was 
developed by Leznoff and coworkers in 1982.34-36 It requires that a mono-functionalized 
phthlaonitrile or diiminoisoindoline can be bounded to the solid phase. The insoluble 
polymer bounded precursor (B) can react with another free precursor (A) to afford the 
A3B-type polymer bounded Pc (Scheme 1.6). The A3B-type Pc can be purified by  
NH
NH
NH
R
HN
HN
HN
O(CH2)nOTr P
NN N
N
NNN
N MR
R
R
O(CH2)nOTr P
 
Scheme 1.6. Synthesis of A3B-type Pc on a polymer support.34-36   
washing away the soluble A4-type byproduct and the resulting desired Pc can be cleaved 
from the solid-phase under mild conditions. Recently, Dr. Hammer Robert reported the 
solid-phase synthesis of A3B-type Pc using a PEG-based support with Wang linker.99 
However, it requires the easy-on and off properties of the precursors to the solid-phase, 
which limits its application in the universal method of synthesis of A3B-type Pcs. 
1.3     Applications of Phthalocyanine 
            Pcs have been widely used as colorants or dyes,37-39 photoconducting materials,40 
chemical sensors,41-43 semiconductors,44, 45 industrial catalysts46-48 and non-linear optical 
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materials.49, 50 The Pcs’ potential applications in various areas are due to their intense 
blue-green color, high photostability, high degree of aromaticity and unique electronic 
spectra. Pcs as near-IR dyes can also be used as fluorescent probes for application in the 
area of bioconjugations and labeling of biomolecules. La Jolla Blue (Figure 1.6) is the 
first commercially available Pc dye bearing two water-soluble axial polyethylene glycol 
moieties and two free carboxylic acid groups available for bioconjugation. Different  
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Figure 1.6.  Structure of La Jolla Blue dye™.51 
types of biomolecules such as nucleobases,52 oligonucleotides,51, 53-55 peptides,56 and 
proteins57-59 have been reported to bind with Pc dyes. These bioconjugates have potential 
applications in bioimaging and bioanalytical areas.  
1.3.1    Applications in Photodynamic Therapy (PDT) of Cancer 
            Pc, as a second-generation photosensitizer, has been widely used in PDT.10, 60 
Photodynamic action was first reported by Raab in 1900.1 He observed that Paramecia 
(unicellular organisms) were killed when exposed to light in the presence of acridine and 
eosin dyes.61 Since then, photodynamic therapy (PDT) was developed as a promising 
modality utilizing a photosensitizer, visible or near-infrared radiation and O2 to destroy 
unwanted cells. This technique has been accepted in the clinic as a curative or palliative 
therapy for cancer. In 1995, the FDA approved the first photosensitizing agent called 
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Photofrin® (a purified form of HpD, haematoporphyrin derivative) which has full 
approval in several countries for clinical use. However, Photofrin® has some drawbacks 
such as difficult reproducibility in synthesis, long half-life in patients, far from optimal 
spectral properties and low selectivity for tumors at 2 mg/kg.62, 63 As a consequence, 
benzoporphyrin derivatives, chlorines, purpurins, phthalocyanines have emerged as 
second-generation photosensitizers. 
            Among these, Pcs have promising applications in the PDT treatment of cancer.64, 
65  Since Pcs contain four iminoisoindoline units, they have more extended π-conjugates 
than porphyrins and stronger absorptions in the far-red region of the optical spectrum. 
They typically have a major Q absorption band around 670 nm with high molar 
extinction coefficient, in the range of 105 M-1cm-1, while the longest λ absorbing band of 
Photofrin® has only 3000 M-1cm-1 at 630 nm.66 In general, Pcs allow deeper penetration 
of light through tissue since longer wavelengths of light penetrate tissue more efficiently 
than shorter ones. Furthermore, cheaper diode lasers can be used in the near-IR range.  
            Several Pc derivatives such as ZnPc (CGP55847), AlPcS4 (Photosense®) and Pc 4 
have been in clinical trials to evaluate their photoefficiency in PDT.63, 67, 68 Pc 4 bearing 
one siloxy axial ligand and one hydroxyl group has been in Phase І trial for cancer 
treatment (Figure 1.7).69, 70 
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Figure 1.7.  Structure of Pcs currently under clinical investigation for PDT.63, 67, 68       
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1.3.1.1 Mechanisms of PDT  
            Figure 1.8 shows the basic steps involved in the treatment of cancer patients with 
PDT. In the PDT treatment, a photosensitive drug is injected into the cancer patient. After  
               
Figure 1.8. Treatment of a cancer patient with PDT.71 
 
selective localization in the malignant cells, the drug is activated by appropriate 
wavelength of light to produce reactive cytotoxic oxygen species that induce tumor death, 
while normal cells remain intact.72  
sensitizer hv sensitizer1 *
sensitizer1 * sensitizer3 *ISC
+
+
(a)
sensitizer* sensitizer* sensitizer
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+
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sensitizer + O2 sensitizer +
+
+
O2
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(b)
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3
3
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3
3 3
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1
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Scheme 1.7. PDT (a) Type I mechanism; (b) Type II mechanism.72 
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            During the application of PDT, the photosensitizer being activated by light will 
undergo two different processes to produce cytotoxic species. Scheme 1.7 shows the 
Type I and Type II mechanisms of these processes. The photosensitizer is first excited 
from the ground state (S0) to its first excited singlet state (S1). It is then converted to the 
triplet state (T1) through an intersystem crossing (ISC). In Type I mechanism, the exited 
state of the photosensitizer (T1) will react with a substrate to produce radical ions. These 
highly reactive species will interact with ground state molecular oxygen to yield 
superoxide and other anions which cause oxidative damage. In Type II mechanism, the 
exited state of photosensitizer (T1) reacts with molecular oxygen to yield highly toxic 
singlet oxygen species that induces oxidative damage. Both of these two types of 
processes can cause irreparable biological damage within the target tissues.72   
1.3.1.2 Ideal Photosensitizers for Application in PDT 
            An ideal photosensitizer for PDT should meet the following criteria:63, 64, 72, 73 1) it 
should be chemically pure and maintain a constant composition throughout treatment; 2) 
it should have minimal dark toxicity; 3) it should accumulate preferentially in tumor 
tissue; 4) it should target sensitive or vulnerable tumor cell sites; 5) it should have high 
photochemical reactivity; 6) it should have a large absorption coefficient within the 
wavelength range 600-800 nm; 7) it should be rapidly cleared from normal tissues after 
the treatment. Although it is difficult for a photosensitizer to fulfill all the above 
parameters, we make an effort to synthesize water-soluble Pcs as promising second-
generation photosensitizers. 
            A potential photosensitizing drug should be amphiphilic for crossing cellular 
membranes.60 Pc and porphyrin macrocycles are intrinsically hydrophobic. Various 
hydrophilic functional groups such as sulfonic acid,74-76 phosphonic acid,77-80 carboxylic 
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acid,81, 82 hydroxy83 and quaternary ammonium salts84, 85 have been used as peripheral 
substituents or axial ligands to make these macrocycles amphiphilic. Recently, our group 
has reported the synthesis and biological evaluation of cell targeted peptide conjugated 
zinc Pcs.56 These conjugates show high phototoxicity toward human carcinoma HEp2 
cells and preferentially localized in the lysosomes.  
            Wohrle and Durantini reported the synthesis of positively charged Zn (II)-
pyridiloxy-substituted Pcs.84, 85 However, they only beared four positive charges and 
consisted of a mixture of constitutional isomers. In Chapter ІІ, we report our design and 
synthesis of positively charged zinc and silicon pyridiloxy-substitute Pcs bearing eight 
positive charges and different side chains and associated axial ligands. Van Lier and 
Leznoff reported the synthesis of a series of hydroxy-substituted Zn-Pcs and their 
biological investigation.83 In Chapter IV, we report our design and synthesis of soluble 
octa-, tetra- and di-hydroxy-substituted Pcs. 
 1.3.2    Applications in Boron Neutron Capture Therapy (BNCT) of Cancer 
            Boron neutron capture therapy (BNCT) is a binary cancer treatment that involves 
the activation of a tumor-localized sensitizer containing boron-10 (10B) nuclei with low 
energy neutrons.86, 87 The resulting excited  and highly cytotoxic species  4He2+  and  7Li3+  
 
Figure 1.9. Schematic of boron-10 neutron interaction.88 
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are released and have short travel distances in tissues (up to 10 µm). The concept of            
BNCT is sketched in Figure 1.9. 
            Two compounds currently in clinical trials are disodium mercapto-closo-
dodecaborate Na2B12H11SH (BSH) and L-4-dihydroxyborylphenylalanine (BPA) (Figure 
1.10).89-93 However, these early-investigated BNCT agents do not show much selectivity 
B
COOHHO
HO
NH2
SH
Na2
 
           BPA                                                         BSH 
Figure 1.10. Structures of BPA and BSH. 
for tumor cells and no long retention times in tumors. For effective BNCT, the 10B-
containing agent has to fulfill the following requirements: 1) tumor concentration of 10B/g 
in the range 15–30 µg; 2) localize preferentially within or in close proximity to the tumor 
cell nuclei; 3) low persistence in blood and normal tissues; 4) selectivity of tumor/normal 
tissue greater than 5; 5) low toxicity; 6) persistence in tumor during all the irradiation 
treatment.94 Boronated-porphyrin has shown higher tumor-targeting selectivity and 
longer retention time in tumors.94, 95 Recently, our group has reported the synthesis and 
biological evaluation of a series of porphyrin conjugated with cobaltacarborane cages.96-
98 In Chapter II, we report our design and synthesis of a series of soluble A3B-type 
cobaltacarborane conjugated Pcs. 
1.4 References 
(1) Mckeown, N. B. Phthalocyanine Materials - Synthesis, Structure and Function 
1998, Cambridge University Press, United Kingdom. 
(2) Sharman, W. M.; Van Lier, J. E. The Porphyrin Handbook (Kadish, K.M., Smith, 
K. M. and Guilard, R., Eds.), Academic Press, Boston 2003, 15, 1-53. 
 17
(3) Byrne, G. T.; Linstead, R. P.; Lowe, A. R. J. Chem. Soc. 1934, 1017-1022. 
(4) Cook, A. H.; Linstead, R. P. J. Chem. Soc. 1934, 956-961. 
(5) Dent, C. E.; Linstead, R. P. J. Chem. Soc. 1934, 1027-1031. 
(6) Dent, C. E.; Linstead, R. P.; Lowe, A. R. J. Chem. Soc. 1934, 1033-1039. 
(7) Linstead, R. P. J. Chem. Soc. 1934, 1016-1017. 
(8) Linstead, R. P.; Lowe, A. R. J. Chem. Soc. 1934, 1031-1033. 
(9) Linstead, R. P.; Lowe, A. R. J. Chem. Soc. 1934, 1022-1027. 
(10) Ali, H.; van Lier, J. E. Chem. Rev. 1999, 99, 2379-2450. 
(11) Tomoda, H.; Saito, S.; Ogawa, S.; Shiraishi, S. Chem. Lett. 1980, 1277-1280. 
(12) Tomoda, H.; Saito, S.; Shiraishi, S. Chem. Lett. 1983, 313-316. 
(13) Wohrle, D.; Schnurpfeil, G.; Knothe, G. Dyes and Pigments 1992, 18, 91-102. 
(14) Christie, R. M.; Deans, D. D. J. Chem. Soc., Perkin Trans. 2 1989, 193-198. 
(15) Leznoff, C. C.; Lever, A. B. P. Phalocyanines: Properties and Applications. 
VCH: Weinheim. 1996, 4, 481-514. 
(16) Barrett, P. A.; Bradbrook, E. F.; Dent, C. E.; Linstead, R. P. J. Chem. Soc. 1939, 
1820-1828. 
(17) Barrett, P. A.; Dent, C. E.; Linstead, R. P. J. Chem. Soc. 1936, 1719-1736. 
(18) Barrett, P. A.; Frye, D. A.; Linstead, R. P. J. Chem. Soc.1938, 1157-1163. 
(19) de la Torre, G.; Claessens, C. G.; Torres, T. Eur. J. Org. Chem. 2000, 2821-2830. 
(20) Sommerauer, M.; Rager, C.; Hanack, M. J. Am. Chem. Soc. 1996, 118, 10085-
10093. 
(21) Hanack, M.; Meng, D. Y.; Beck, A.; Sommerauer, M.; Subramanian, L. R. J. 
Chem. Soc., Chem. Commun. 1993, 58-60. 
(22) RodriguezMorgade, S.; Hanack, M. Chem. Eur. J. 1997, 3, 1042-1051. 
(23) Linssen, T. G.; Hanack, M. Chem. Ber. 1994, 127, 2051-2057. 
(24) Bakboord, J. V.; Cook, M. J.; Hamuryudan, E. J. Porphyrins Phthalocyanines 
2000, 4, 510-517. 
 18
(25) Bryant, G. C.; Cook, M. J.; Haslam, S. D.; Richardson, R. M.; Ryan, T. G.; 
Thorne, A. J. J. Mater. Chem. 1994, 4, 209-216. 
(26) Chambrier, I.; Cook, M. J.; Cracknell, S. J.; McMurdo, J. J. Mater. Chem. 1993, 
3, 841-849. 
(27) McKeown, N. B.; Chambrier, I.; Cook, M. J. J. Chem. Soc., Perkin Trans. 1 1990, 
1169-1177. 
(28) Cook, M. J.; Daniel, M. F.; Harrison, K. J.; McKeown, N. B.; Thomson, A. J. J. 
Chem. Soc., Chem.  Commun. 1987, 1148-1150. 
(29) Kobayashi, N.; Kondo, R.; Nakajima, S.; Osa, T. J. Am. Chem. Soc. 1990, 112, 
9640-9641. 
(30) Weitemeyer, A.; Kliesch, H.; Wohrle, D. J. Org. Chem. 1995, 60, 4900-4904. 
(31) Sharman, W. M.; van Lier, J. E. Bioconjugate Chem. 2005, 16, 1166-1175. 
(32) Sastre, A.; delRey, B.; Torres, T. J. Org. Chem. 1996, 61, 8591-8597. 
(33) Sastre, A.; Torres, T.; Hanack, M. Tetrahedron Lett. 1995, 36, 8501-8504. 
(34) Leznoff, C. C. Can. J. Chem. 2000, 78, 167-183. 
(35) Hall, T. W.; Greenberg, S.; McArthur, C. R.; Khouw, B.; Leznoff, C. C. New J. 
Chem. 1982, 6, 653-658. 
(36) Leznoff, C. C.; Hall, T. W. Tetrahedron Lett. 1982, 23, 3023-3026. 
(37) Robertson, J. M. J. Chem. Soc. 1936, 1195-1209. 
(38) Robertson, J. M.; Woodward, I. J. Chem. Soc. 1937, 219-230. 
(39) Robertson, J. M.; Woodward, I. J. Chem. Soc. 1940, 36-48. 
(40) Law, K. Y. Chem. Rev. 1993, 93, 449-486. 
(41) Valli, L. Adv. Colloid Interface Sci. 2005, 116, 13-44. 
(42) Basova, T. V.; Tasaltin, C.; Gurek, A. G.; Ebeoglu, M. A.; Ozturk, Z. Z.; Ahsen, 
V. Sens. Actuators, B 2003, 96, 70-75. 
(43) Legin, A.; Makarychev-Mikhailov, S.; Goryacheva, O.; Kirsanov, D.; Vlasov, Y. 
Anal. Chim. Acta 2002, 457, 297-303. 
(44) Guillaud, G.; Simon, J.; Germain, J. P. Coordination Chem. Rev. 1998, 180, 
1433-1484. 
 19
(45) Zhou, R.; Josse, F.; Gopel, W.; Ozturk, Z. Z.; Bekaroglu, O. Appl. Organomet. 
Chem. 1996, 10, 557-577. 
(46) Basu, B.; Satapathy, S.; Bhatnagar, A. K. Cat. Rev. Sci. Eng. 1993, 35, 571-609. 
(47) Kaliya, O. L.; Lukyanets, E. A.; Vorozhtsov, G. N. J. Porphyrins 
Phthalocyanines 1999, 3, 592-610. 
(48) Navid, A.; Tyapochkin, E. M.; Archer, C. J.; Kozliak, E. I. J. Porphyrins 
Phthalocyanines 1999, 3, 654-666. 
(49) de la Torre, G.; Claessens, C. G.; Torres, T. Chem. Commun. 2007, 2000-2015. 
(50) de la Torre, G.; Vaquez, P.; Agullo-Lopez, F.; Torres, T. Chem. Rev. 2004, 104, 
3723-3750. 
(51) Devlin, R.; Studholme, R. M.; Dandliker, W. B.; Fahy, E.; Blumeyer, K.; Ghosh, 
S. S. Clin. Chem. 1993, 39, 1939-1943. 
(52) Li, X. Y.; Ng, D. K. P. Tetrahedron Lett. 2001, 42, 305-309. 
(53) Nesterova, I. V.; Verdree, V. T.; Pakhomov, S.; Strickler, K. L.; Allen, M. W.; 
Hammer, R. P.; Soper, S. A. Bioconjugate Chem. 2007, 18, 2159-2168. 
(54) Hammer, R. P.; Owens, C. V.; Hwang, S. H.; Sayes, C. M.; Soper, S. A. 
Bioconjugate Chem. 2002, 13, 1244-1252. 
(55) Walker, G. T.; Nadeau, J. G.; Linn, C. P.; Devlin, R. F.; Dandliker, W. B. Clin. 
Chem. 1996, 42, 9-13. 
(56) Sibrian-Vazquez, M.; Ortiz, J.; Nesterova, I. V.; Fernandez-Lazaro, F.; Sastre-
Santos, A.; Soper, S. A.; Vicente, M. G. H. Bioconjugate Chem. 2007, 18, 410-
420. 
(57) Verdree, V. T.; Pakhomov, S.; Su, G.; Allen, M. W.; Countryman, A. C.; 
Hammer, R. P.; Soper, S. A. J. Fluoresc. 2007, 17, 547-563. 
(58) Ogunsipe, A.; Nyokong, T. J. Porphyrins Phthalocyanines 2005, 9, 121-129. 
(59) Huang, J. D.; Wang, S. Q.; Lo, P. C.; Fong, W. P.; Ko, W. H.; Ng, D. K. P. New 
J. Chem. 2004, 28, 348-354. 
(60) Allen, C. M.; Sharman, W. M.; Van Lier, J. E. J. Porphyrins Phthalocyanines 
2001, 5, 161-169. 
(61) Raab, O. Z. Biol. 1900, 39, 524. 
(62) Berg, K.; Selbo, P. K.; Weyergang, A.; Dietze, A.; Prasmickaite, L.; Bonsted, A.; 
Engesaeter, B. O.; Angell-Petersen, E.; Warloe, T.; Frandsen, N.; Hogset, A. J. 
Microsc. 2005, 218, 133-147. 
 20
(63) Allison, R. R.; Downie, G. H.; Cuenca, R.; Hu, X. H.; Childs, C. J.; Sibata, C. H. 
Photodiag. Photodyn. Ther. 2004, 1, 27-42. 
(64) MacDonald, I. J.; Dougherty, T. J. J. Porphyrins Phthalocyanines 2001, 5, 105-
129. 
(65) Moore, J. V.; West, C. M. L.; Whitehurst, C. Phys. Med. Biol. 1997, 42, 913-935. 
(66) Henderson, B. W.; Fingar, V. H. Cancer Res. 1987, 47, 3110-3114. 
(67) Huang, Z. Tech. Canc. Res. Treat. 2005, 4, 283-293. 
(68) Detty, M. R.; Gibson, S. L.; Wagner, S. J. J. Med. Chem. 2004, 47, 3897-3915. 
(69) He, J.; Larkin, H. E.; Li, Y. S.; Rihter, B. D.; Zaidi, S. I. A.; Rodgers, M. A. J.; 
Mukhtar, H.; Kenney, M. E.; Oleinick, N. L. Photochem. Photobiol. 1997, 65, 
581-586. 
(70) Oleinick, N. L.; Antunez, A. R.; Clay, M. E.; Rihter, B. D.; Kenney, M. E. 
Photochem. Photobiol. 1993, 57, 242-247. 
(71) Kessel, D.; Luguya, R.; Vicente, M. G. H. Photochem. Photobiol. 2003, 78, 431-
435. 
(72) Sharman, W. M.; Allen, C. M.; van Lier, J. E. Drug Disc. Tod. 1999, 4, 507-517. 
(73) Wiedmann, M. W.; Caca, K. Curr. Pharm. Biotech. 2004, 5, 397-408. 
(74) Boyle, R. W.; Paquette, B.; Vanlier, J. E. Bri. J. Cancer 1992, 65, 813-817. 
(75) Paquette, B.; Boyle, R. W.; Ali, H.; Maclennan, A. H.; Truscott, T. G.; Vanlier, J. 
E. Photochem. Photobiol. 1991, 53, 323-327. 
(76) Ali, H.; Langlois, R.; Wagner, J. R.; Brasseur, N.; Paquette, B.; Vanlier, J. E. 
Photochem. Photobiol. 1988, 47, 713-717. 
(77) Boyle, R. W.; Vanlier, J. E. Synlett 1993, 351-352. 
(78) Boyle, R. W.; Vanlier, J. E. Synthesis 1995, 1079-1080. 
(79) Sharman, W. M.; Kudrevich, S. V.; vanLier, J. E. Tetrahedron Lett. 1996, 37, 
5831-5834. 
(80) Siegl, W. O.; Ferris, F. C.; Mucci, P. A. J. Org. Chem. 1977, 42, 3442-3443. 
(81) Liu, W.; Jensen, T. J.; Fronczek, F. R.; Hammer, R. P.; Smith, K. M.; Vicente, M. 
G. H. J. Med. Chem. 2005, 48, 1033-1041. 
(82) Li, X. Y.; He, X.; Ng, A. C. H.; Wu, C.; Ng, D. K. P. Macromol. 2000, 33, 2119-
2123. 
 21
(83) Hu, M.; Brasseur, N.; Yildiz, S. Z.; van Lier, J. E.; Leznoff, C. C. J. Med.  Chem. 
1998, 41, 1789-1802. 
(84) Scalise, N.; Durantini, E. N. Bioorg. Med. Chem. 2005, 13, 3037-3045. 
(85) Michelsen, U.; Kliesch, H.; Schnurpfeil, G.; Sobbi, A. K.; Wohrle, D. Photochem.  
Photobiol. 1996, 64, 694-701. 
(86) Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F. G.; Barth, R. F.; Codogni, I. 
M.; Wilson, J. G. Chem. Rev. 1998, 98, 1515-1562. 
(87) Barth, R. F.; Coderre, J. A.; Vicente, M. G. H.; Blue, T. E. Clin. Cancer Res. 
2005, 11, 3987-4002. 
(88) Hao, E. H.; Fronczek, F. R.; Vicente, M. G. H. J. Org. Chem. 2006, 71, 1233-
1236. 
(89) Coderre, J. A.; Morris, G. M. Radiat. Res. 1999, 151, 1-18. 
(90) Joel, D. D.; Coderre, J. A.; Micca, P. L.; Nawrocky, M. M. J. Neurooncol. 1999, 
41, 213-221. 
(91) Coderre, J. A.; Elowitz, E. H.; Chadha, M.; Bergland, R.; Capala, J.; Joel, D. D.; 
Liu, H. Y. B.; Slatkin, D. N.; Chanana, A. D. J. Neurooncol. 1997, 33, 141-152. 
(92) Nakagawa, Y.; Hatanaka, H. J. Neurooncol.  1997, 33, 105-115. 
(93) Kageji, T.; Nakagawa, Y.; Kitamura, K.; Matsumoto, K.; Hatanaka, H. J. 
Neurooncol.  1997, 33, 117-130. 
(94) Vicente, M. G. Curr Med Chem Anticancer Agents 2001, 1, 175-194. 
(95) Kahl, S. B.; Koo, M. S. J. Chem. Soc. Chem. Commun. 1990, 1769-1771. 
(96) Sibrian-Vazquez, M.; Hao, E. H.; Jensen, T. J.; Vincente, M. G. H. Bioconjugate 
Chem. 2006, 17, 928-934. 
(97) Hao, E. H.; Jensen, T. J.; Courtney, B. H.; Vicente, M. G. H. Bioconjugate Chem. 
2005, 16, 1495-1502. 
(98) Sibrian-Vazquez, M.; Jensen, T. J.; Fronczek, F. R.; Hammer, R. P.; Vicente, M. 
G. H. Bioconjugate Chem. 2005, 16, 852-863. 
 
(99) Erdem, S. S.; Nesterova, I. V.; Soper, S. A.; Hammer, R. P. J. Org. Chem. 2008, 
73, 5003-5007. 
 
 22
 23
CHAPTER 2 
 
 
SYNTHESES AND PROPERTIES OF CATIONIC OCTAPYRIDILOXY-
SUBSTITUTED PHTHALOCYANINES* 
 
 
2.1 Background  
Cationic photosensitizers are promising PDT drug candidates in the study of PDT 
since they were reported to potentially target highly vulnerable intracellular sites and lead 
to effective DNA photodamage.1-3 A series of positively charged pyridiloxy-substituted 
zinc Pcs have shown higher photodynamic activity than FDA-approved Photofrin® which 
is the first approved drug for PDT, and their biological efficacy can be adjusted by the 
introduction of alkyl groups of different length.4-6 In this Chapter, eight cationic 
pyridiloxy-substituted zinc or silicon Pcs were synthesized and their spectroscopic 
properties were evaluated. The biological properties of this series of Pc were also 
investigated and summarized later in this Chapter.    
            Silicon Pcs can be synthesized in two ways as summarized in Scheme 2.1. In 
1965, Lowery reported a simple synthesis of silicon-dichlorophthalocyanine.7 1,3-
Diiminoisoindoline was used as the starting material. It reacted with silicon tetrachloride 
in quinoline to give 71% yield of the Pc, while the reaction of o-cyanobenzamide with 
silicon tetrachloride only gave 35% yield of the Pc. Another method is by direct 
metallation of the metal-free Pc using trichlorosilane in the presence of tri-n-
butylamine.8,9 The second method is similar to the synthesis of silicon porphyrins. The 
dilithioporphyrin reacts with trichlorosilane to give nearly quantitative yield of the 
metallated silicon porphyrin.10 Rodgers et. al. reported that Si-octahexylphthalocyanine 
* Parts of this Chapter have appeared in the Journal of Medicinal Chemistry.11 
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 Scheme 2.1. Methods to synthesize silicon-Pcs.  
dichloride could be synthesized from the metal-free Pc and trichlorosilane in 47% yield.8 
Silicon-octahexylphthalocyanine dihydroxide was synthesized by reacting metal-free 
octahexylphthalocyanine and tri-n-butylamine with trichlorosilane in dichloromethane at 
room temperature.3 The reaction was complete in 4 hours and the subsequent 
hydroxylation with water and triethylamine afforded 84% overall yield of the silicon-Pc 
dihydroxide.3 
                  In this Chapter, a series of cationic silicon-Pcs were synthesized from a 
diiminoisoindoline derivative and silicon tetrachloride. Efforts to make silicon-
octapyridiloxyphthalocyanine dihydroxide by the direct metallation reaction did not 
succeed because of the poor solubility of the metal-free precursor in most organic 
solvents. When the method of direct metallation was applied to the synthesis of the 
silicon Pc, attention must be taken to select appropriate substituents at the periphery of 
the macrocycle in order to solubilize the free-base Pc. In general, the first method, when 
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1,3-diiminoisoindoline is used as the precursor, can be widely applied to the synthesis of 
silicon-Pcs.   
2.2       Synthesis of Octapyridiloxy-Substituted Zinc Phthalocyanines         
            Octapyridiloxy-substituted zinc Pcs 2.3-2.6 were synthesized in two steps shown 
in Scheme 2.2. The synthesis of octapyridiloxy-substituted zinc Pc was accomplished via 
the direct and convenient method of cyclotetramerization catalyzed by DBU in n-
pentanol using phthalonitrile 2.1 as the starting material.  
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Scheme 2.2. Synthesis of zinc Pcs. 
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            According to the procedure of WÖhrle,12 2.1 was synthesized in 86% yield from 
commercially available 4,5-dichlorophthalonitrile and 3-hydroxypyridine. The 
nucleophilic aromatic displacement reaction was catalyzed by finely grained potassium 
carbonate as a mild base. The first trial toward the synthesis of 4,5-(4-
pyridiloxy)phthalonitrile was not successful, probably due to the lower nucleophilicity of 
the hydroxyl group at the 4-position of the pyridine ring. The X-ray crystal structure of 
the key intermediate 2.1 is shown in Figure 2.1. One of the pyridine rings is disordered 
by 2-fold rotation and the other one appears to be ordered. The two OPy groups are 
oriented differently with respect to the phthalonitrile, with tortion angles -59.8(2)º about 
C1-O1 and -7.0(2) º about C2-O2. The colorless crystal was grown from slow 
evaporation of dichloromethane.  
 
Figure 2.1. Single crystal X-ray structure of 2.1. 
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            The cyclotetramerization reaction used zinc acetate as the metal source. The 
reaction solution was refluxed in dry n-pentanol using a small amount of DBU as the 
catalyst. The crude product was washed successively and repeatedly (3 times) with 
dichloromethane, acetone and cold methanol. Pc 2.2 was obtained as a dark green solid in 
an improved yield of 88% compared with the lithium method.4 
            However, Pc 2.2 has limited solubility in most common organic solvents, 
including DCM, THF, ethyl acetate, methanol and DMSO. The addition of pyridine did 
not induce disaggregation in solution. Nevertheless this compound is very soluble in 
TFA, probably due to the protonation of the pyridine groups. In addition, TFA did not 
induce demetalation of Pc 2.2 in a short time period, as observed by MALDI-TOF mass  
 
 
Figure 2.2. 13C NMR spectrum of Pc 2.2 in d-TFA at 300 MHz. * solvent signals. 
spectrometry and UV-Vis spectrophotometry. Therefore it was possible to obtain 1H 
NMR and 13C NMR spectra of Pc 2.2 in deuterated TFA. Figure 2.2 shows the 13C NMR 
*                  * *   
*    * 
*   * 
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spectrum of Pc 2.2 in pure deuterated TFA. As expected for symmetrically substituted Pc 
2.2, nine peaks were observed in the downfield region of the 13C NMR spectrum. 
            Pc 2.2 was then alkylated with three alkyl iodides of different length (methyl, 
propyl and hexyl) as shown in Scheme 2.2. The appropriate alkyl iodide was used not 
only as the reagent but also as the solvent. After heating the reaction at 40 ºC for one 
day, methyl iodide can be removed by evaporation under reduced pressure to obtain pure 
Pc 2.3. Since propyl and hexyl iodides have high boiling points, the blue solids were 
filtered under vacuum after the reaction and washed with acetone repeatedly. The 
alkylated zwitterionic salts 2.3-2.5 were obtained in quantitative yield. The cationic 
alkylated Pcs 2.3-2.5 have better solubility in organic solvents than neutral Pc 2.2, due to 
the presence of the alkyl groups and positive charges that induce disaggregation. Pc 2.3 
alkylated with methyl groups has better solubility in water than Pcs 2.4 and 2.5 with 
propyl and hexyl groups respectively, because of the shorter aliphatic and less 
hydrophobic alkyl chains. All three cationic Pcs 2.3-2.5 have high solubility in DMSO  
 
Figure 2.3. Absorption spectra of Pcs 2.3 (blue), 2.4 (red), 2.5 (green) in DMSO at 5 µM. 
and have a major Q absorption band at 677 nm. In particular, Pc 2.3 shows the largest 
extinction coefficient for the Q band of these cationic Pcs, as shown in Figure 2.3. 
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Furthermore the extinction coefficient decreased with the increasing length of the alkyl 
chain. 
 
Figure 2.4. Absorption spectra of Pc 2.3 in DMSO (red) and water (black) at 5 µM. 
            The absorption spectra of Pc 2.3 in DMSO and in water are shown in Figure 2.4. 
It was observed that the Q band of Pc 2.3 had a 5 nm red shift from water to DMSO and 
was less intense in water compared with that in DMSO due to its higher tendency for 
aggregation in water.    
            From the fluorescence spectra (Figure 2.5), Pc 2.3 also has higher fluorescence 
intensity in DMSO than in water. This is due to its better solubility and less aggregation 
in DMSO (see also Table 2.1 below). 
 
 
Figure 2.5. Emission spectra of Pc 2.3 in DMSO (black) and water (red) at 400-600 nM, 
excitation at 610 nm.    
 30
NC
NC
O
O
N
N
H
NN N
N
NN
H
N
N
OO
O
O
O O
O
O
N N
N
N
NN
N
N
1. Li, CH3(CH2)3CH2OH
2. AcOH, 60%
pentanol, DBU
53%
or
 
           2.1                                                                                             2.7                     
Scheme 2.3. Synthesis of metal-free Pc 2.7. 
            The free-base pyridiloxy-substituted Pc was synthesized through the lithium 
method in pentanol, followed by quenching using acetic acid (Scheme 2.3). The overall 
yield to achieve the free-base Pc is 60%. The synthesis of 2.7 was also accomplished by 
heating 2.1 in pentanol in the presence of a small amount of DBU as the catalyst. Pc 2.7 
as a dark blue solid was obtained in 53% yield after washing with different solvents.          
            Pegylated zinc and free-base Pcs 2.6 and 2.8 are shown in Figure 2.6. Conjugation 
of Pcs 2.2 and 2.7 with triethylene glycol iodide was accomplished by heating in a sealed 
tube at 70 ºC for 6 days. ZnPc 2.6 was isolated from the reaction solution by 
centrifugation and washed with acetone and dichloromethane. The crude product was 
purified on a Sephadex LH-20 column using methanol for elution. The free-base Pc 2.8 
was purified using a similar procedure to Pc 2.6. The two pegylated Pcs were obtained as 
dark green solids in 90% yield. We are collaborating with Dr. Jayne Garno of the LSU 
Chemistry Department to study the different aggregation behavior of these two pegylated 
Pcs in aqueous solution. The main observations of this study show that the Zn-Pc 2.6 
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aggregates to a higher extent than the free-base Pc 2.8. Pc 2.6 forms leaves-like large 
aggregates. On the other hand, Pc 2.8 forms microcrystals of smaller sizes. 
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Figure 2.6. Target zinc and free-base Pcs. 
2.3       Synthesis of Octapyridiloxy-Substituted Silicon Phthalocyanines 
         Pcs are notorious for their strong tendancy to aggregate in solution,13, 14 which 
can significantly decrease their photosensitizing ability through self-quenching.15  In 
order to decrease Pc aggregation and to increase their photodynamic activity, various 
hydrophilic and amphiphilic groups (e.g. carboxylates, sulfonates, phosphonates, 
PEGs)16-21 and bulky axial ligands [e.g. OSiMe2(CH2)3NMe2 and OCH(CH2NMe2)2]18, 22-
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25 have been introduced at the macrocycle periphery and the center metal with III or 
higher oxidation state (e.g. Si, Al, Ge and Sn), respectively. In our study, we found that 
the pyridinium moieties at the periphery of Pc can not prevent its serious aggregation in 
solution. Even long aliphatic chains up to six carbons were found not to efficiently 
prevent the Pc’s aggregation in solution. Therefore, we hypothesized that bulky and 
hydrophobic axial ligands attached to the center silicon could more effectively prevent 
Pcs’ aggregation and improve its solubility in solution. Recently, two glucosylated 
Si(IV)-Pcs were shown to have high phototoxicity toward human carcinoma HT29 and 
HepG2 cells,26 and a Si(IV)-Pc bearing two solketal axial substituents was found to be 
highly phototoxic to both 14C and B16F10 cell lines.27 Since ZnPcs show limited 
solubility in water, in our investigation of new water-soluble and effective PDT 
sensitizers, we decided to combine, in a single macrocycle, peripheral cationic pyridyloxy 
groups and two bulky axial ligands on centrally chelated Si(IV) ions. Therefore, we 
synthesized a series of cationic pyridiloxy-substituted Pcs (Figure 2.7) bearing either a 
methyl or a short PEG chain on the pyridyl groups and Si(IV) coordinating metals, with 
two large axial ligands on the silicon complexes. The properties of this series of water-
soluble Pcs are compared and discussed in later in this Chapter.  
            Pyridiloxy-substituted phthalonitrile 2.1 was converted to the corresponding 
diiminoisoindoline 2.9 by heating the reaction solution with ammonia gas in the presence 
of sodium methoxide in methanol for five hours. The diiminoisoindoline 2.9 was 
obtained in 91% yield. As shown in Scheme 2.4, the cyclotetramerization reaction takes 
place with the mixture of 2.9 and silicon tetrachloride in freshly distilled quinoline under 
the protection of argon. After silicon tetrachloride was added dropwise to the reaction 
solution, the mixture was heated up to 220 ºC. The solution was cooled down after 1 
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hour. The solid was filtered and washed repeatedly (3 times) with water, methanol and 
acetone giving dark blue Si(IV)-Pc dichloride 2.10 in 98% yield. The 1H NMR spectrum  
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Figure 2.7. Target silicon Pcs. 
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Scheme 2.4. Synthesis of silicon Pcs. 
can be interpreted clearly with one peak from the Pc core and four peaks from the 
peripheral pyridinium moieties in the upfield region. The dihydroxylation of Pc 2.10 was 
accomplished with sodium methoxide in ethanol/water. The presence of the OH groups in 
Pc 2.11 was confirmed by FT-IR, which shows a broad peak at 3382.3 cm-1 (O-H) and a 
sharp peak at 844.6 cm-1 (Si-O). Pc 2.11 was obtained in 81% yield. The MALDI-TOF 
spectra of Pc 2.10 and Pc 2.11 show the same pattern of ion cleavage of one axial ligand, 
as it is often observed for this type of compound.e.g.28 
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            Pcs 2.15-2.18 were obtained by reacting Pc 2.11 with a large excess of the 
corresponding alkylchlorosilane in dry pyridine, at 115 °C under argon atmosphere. The 
excess silane reagent was washed out with pentane and Pcs 2.12-2.14 were purified by 
column chromatography on silica gel, using THF for elution. The 1H NMR spectra of 
2.12-2.14 in either deuterated THF or DMF characteristically shows the Pc macrocycle 
protons in the downfield  region  at  >  9 ppm, the pyridyl protons between 8-9 ppm, the 
aliphatic protons on the axial ligands significantly upfield shifted below 0 ppm, and the 
axial ligand aromatic protons below 7 ppm. The MALDI-TOF MS spectra of Pcs 2.12-
2.14 all show the base peak corresponding to the cleavage of one axial ligand. They show 
high solubility in polar organic solvents, such as chloroform, DMF, THF and DMSO, and 
slight solubility in acetone and hexane.  
         Alkylation of Si(IV)-Pcs 2.12-2.14 gave the corresponding octa-cationic 
derivatives 2.15-2.17 in yields higher than 90% by reaction with the corresponding 
methyl iodide at 40 ºC. The spectrum of 1H NMR in deuterated THF or DMF testify the 
exact structure of the desired compounds according to the integration and chemical shifts 
of the Pc core and peripheral pyridinium parts. The Pc core proton was in the downfield 
region at above 9 ppm, and all of the pyridinium peaks show in the upfield in the region 
at 8-9 ppm. The aliphatic protons of the axial ligands have significantly upfield shift to 
below 0 ppm, and the aromatic protons in the axial ligands shifted to below 7 ppm. The 
sharp peaks in the 1H NMR show the monomeric states for these Pcs existing in the 
solvents. The MALDI-TOF spectra of the target cationic methylated compounds are more 
complicated than those for their corresponding neutral Pc precursors, since seven or eight 
alkylated groups can be cleaved, in combination with the loss of one axial ligand. The 
ESI spectra show the loss of several iodines and one of the axial ligands. All cationic 
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Si(IV)-Pcs were also characterized by NMR, MS, UV-vis and fluorescence spectroscopy, 
and are highly soluble in protic solvents such as methanol and water. 
            Cationic Pc 2.18 with eight triethoxy ligands was synthesized using a similar 
method, with PEGI in place of CH3I. PEGI was synthesized in 98% yield from the 
corresponding tosylate PEGTs, which was prepared according to Schultz’s procedure42 in 
88% yield. The pegylation reaction proceeded for 6 days to get the pure octapegylated 
Pcs. The reaction was followed by 1H NMR. The products were purified by washing with 
dichloromethane and acetone followed by chromatography in a gel permeation column 
LH-20 in methanol.  
2.4  Photophysical Studies of Octapyridiloxy-Substituted Zinc and Silicon              
Phthalocyanines 
             
            The spectral properties of zinc Pcs 2.3, 2.6, 2.15-2.18 in DMSO, methanol, DMF, 
acetonitrile and water different pH values are summarized in Table 2.1. The absorption 
and emission properties of this series of Pcs depend significantly on the solvent used and 
the solution pH. Both the nature of the N-pyridyl group (methyl vs. triethylene glycol) 
and the centrally chelated metal and associated axial ligands affect the photophysical 
properties of the Pc macrocycles. The Si(IV)-Pcs bearing two bulky axial ligands show 
significantly higher fluorescent quantum yields than the Zn(II)-Pcs, in all solvents 
studied. Among the Si(IV)-Pcs, Pc 2.15 bearing two flexible tri(n-propyl)siloxy axial 
groups has the highest fluorescence quantum yield in aqueous media at all pH values 
investigated (5.0. 6.0, 7.0, 7.4 and 8.0), whereas Pc 2.16 bearing two tri(isopropyl)siloxy 
axial groups, the most hydrophobic of the Si(IV)-Pcs synthesized, has the highest 
quantum yield in organic solvents (DMSO and methanol).  
            The neutral Si(IV)-Pcs 2.12-2.14 also showed high  fluorescence  quantum  yields 
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Table 2.1. Spectral properties of Pcs 2.3, 2.6, 2.15-2.18 in different media*. 
media ( pH ) 2.3 2.6 2.15 2.16 2.17 2.18 
DMSO       
abs. 360, 611, 677 356, 611, 677 360, 608, 676 360, 610, 678 359, 612, 681 359, 612, 680 
em. 682 682 679 681 684 683 
S.S. 5 5 3 3 3 3 
Q.Y. 0.0614 0.0692 0.0518 0.0763 0.0361 0.0670 
DMF       
abs. 358, 610, 676 354, 610, 676 360, 607, 675 360, 609, 677 358, 611, 679 357, 611, 679 
em.  679 680 678 679 682 681 
S.S.  3 4 3 2 3 2 
Q.Y.  0.0685 0.0759 0.0434 0.0921 0.0557 0.0973 
Acetonitrile       
abs.  351, 671 350, 608, 672 358, 604, 671 358, 606, 673 356, 608, 676 357, 608, 676 
em.  675 674 672 675 678 678 
S.S. 4 2 1 2 2 2 
Q.Y. 0.0328 0.0455 0.0343 0.0572 0.0688 0.0664 
MeOH       
abs. 349, 670 351, 607, 671 359, 603, 670 358, 606, 672 355, 607, 675 356, 608, 675 
em. 674 675 671 674 677 677 
S.S. 4 4 1 2 2 2 
Q.Y. 0.0394 0.0546 0.0958 0.1146 0.0748 0.0987 
Aqueous(5.0)       
abs.  346, 631, 674 352, 675 357, 608, 675 357, 606, 673 352, 612, 680 353, 611, 678 
em.  681 679 677 680 683 681 
S.S.  7 4 2 7 3 3 
Q.Y.  0.0041 0.0388 0.1136 0.0645 0.0658 0.0615 
Aqueous(6.0)       
abs. 346, 632, 667 351, 675 357, 608, 674 356, 610, 677 353, 612, 680 353, 611, 678 
em. 678 680 677 680 683 681 
S.S. 11 5 3 3 3 3 
Q.Y. 0.0032 0.0368 0.0839 0.0495 0.0449 0.0495 
Aqueous(7.0)       
abs. 346, 632, 667 350, 676 357, 608, 674 356, 610, 677 353, 612, 680 353, 611, 678 
em. 679 680 677 680 682 681 
S.S. 12 4 3 3 2 3 
Q.Y. 0.0038 0.0350 0.0732 0.0455 0.0566 0.0594 
Aqueous(7.4)       
abs.  347, 632, 668 351, 676 356, 608, 674 357, 610, 677 352, 612, 680 352, 611, 678 
em.  679 680 677 679 682 681 
S.S.  11 4 3 2 2 3 
Q.Y.  0.0034 0.0384 0.0740 0.0445 0.0613 0.0519 
Aqueous(8.0)       
abs. 347, 632, 668 352, 676 357, 608, 674 357, 610, 677 352, 612, 680 353, 611, 678 
em. 679 680 677 680 682 681 
S.S. 11 4 3 3 2 3 
Q.Y. 0.0033 0.0309 0.0756 0.0452 0.0604 0.0469 
*abs: absorption maxima (nm); em: emission maxima (nm); S.S.: Stokes shift (nm); Q.Y.: quantum yield. 
 
 
in organic solutions (see Table 2.2). The fluorescent quantum yields of Pcs 2.3, 2.6, 2.15- 
2.18 in aqueous media were found to generally decrease with the pH, being the largest at 
pH 5.0 as previously observed.29 The cationic Pcs bearing triethylene glycol chains on the 
pyridyloxy groups showed higher fluorescence quantum yields in organic solvents than 
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the corresponding methylated Pcs, although in aqueous media similar values were 
observed (Table 2.1).  
            In DMSO all Pcs show strong absorption and emission bands at ~ 677 and 681 
nm, respectively, and Stokes shifts of 3 and 5 nm for the Si(IV) and Zn(II) complexes, 
respectively, as it is typical for this type of compound (Figure 2.8).29-32 Although  the 
Zn(II)-Pcs show aggregation in protic solvents (methanol and water), as evidenced by the 
splitting and/or broadening of their Q absorption bands, and significant decrease in the 
intensity of their emission bands and quantum yields, the Si(IV)-Pcs show intense and 
sharp Q bands and the highest fluorescence quantum yields in methanol solution.   
 
Table 2.2. Spectral properties of Pcs 2.12-2.14 in organic solventsa. 
 
   
 
 
 
 
 
 
    
a: abs: absorption maxima (nm); em: emission maxima (nm); S.S.: Stokes Shift 
(nm); Q.Y.: quantum yield (nm). *: apparently, N.A.: not available 
 
    
 
media 2.12 2.13 2.14 
DMSO    
abs. 361, 611, 679 361, 612, 680 364, 614, 683 
em. 681 682 685 
S.S. 2 2 2 
Q.Y. 0.1861 0.1194 0.1677 
DMF    
abs. 360, 608, 676 360, 610, 678 363, 612, 681 
em. 678 680 683 
S.S. 2 2 2 
Q.Y. 0.1786 0.1819 0.1709 
MeOH    
abs. 359, 606, 672 358, 607, 674 361, 609, 677 
em. 675 676 679 
S.S. 3 2 2 
Q.Y. 0.1668 0.1433 0.1318 
Acetonitrile    
abs. 359, 609, 674 359, 676 363, 615, 679 
em. 676* 677* 681 
S.S. 2 1 2 
Q.Y. 0.0983* 0.0342* 0.0610* 
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Figure 2.8. (a-f) Absorption spectra of Pcs 2.3, 2.6, 2.15-2.18 at 5 µM in DMSO (solid 
line) and in phosphate buffer (100 mM, pH 7.4) (dashed line); (g-l) Emission spectra of 
Pcs 2.3, 2.6, 2.15-2.18 at 80 nM in DMSO (solid line) and in phosphate buffer (100 mM, 
pH 7.4) (dashed line).  
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            Pc aggregation in solution often results in broadening of the Q band absorptions, 
and bathochromic and hypsochromic shifts.33, 34 Whereas only a few examples of J-type 
aggregates have been documented, for example protonation of a tetrasulfonated Zn(II)-Pc 
in aqueous acetonitrile caused a bathochromic shift of the Q band,35 most of the 
aggregates are believed to be H-type, causing blue shifts and fluorescence quenching.34, 
36-38 Although the octa-cationic Zn(II)-Pcs 2.3 and 2.6 exist in their monomeric forms in 
DMSO,  showing  sharp  Q  absorption  bands  at  677  nm (Figure 2.8.a,b)  and  emission  
bands at 682 nm (Figure 2.8.g,h), in aqueous media they both form H-type aggregates as 
seen by the broadening and pronounced reduction in the intensity of their absorption and 
emission bands, along with reduction of their fluorescence quantum yields. Among all the 
Pcs evaluated in this study, Zn(II)-Pc 2.3 has the strongest tendency for aggregation in 
aqueous media and as a result it shows fluorescence quantum yields in water about one 
order of magnitude lower than all other cationic Pcs 2.6, 2.15-2.18.  
            The presence of the eight tri(ethylene glycol) chains on Zn(II)-Pc 2.6 significantly 
decreases its tendency for aggregation in aqueous media compared with Zn(II)-Pc 2.3 
bearing eight methyl groups, and as a result Pc’s 2.6 Q absorption band follows the 
Lambert Beer’s law (see Figure 2.9. (a)). However, the most efficient structural feature 
for minimizing aggregation of these cationic macrocycles is the presence of a centrally 
chelated silicon ion and associated bulky axial ligands. All Si(IV)-Pcs 2.15-2.18 were 
found to exist mainly as monomers in both DMSO and aqueous solutions, showing 
similar intense and sharp Q band absorptions (Figure 2.8. c-f) that strictly follow the 
Lambert Beer’s law (see Figure 2.9. (b)-(e)) and similarly intense emission bands (Figure 
2.8.i-l) in both media. 
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Figure 2.9. (a) Absorption spectra of Pc 2.6 in 10 mM phosphate buffer pH 7.4 at 16.4 
µM (black), 10.9 µM (red), 6.2 µM (green), 3.5 µM (blue), and 2.5 µM (light blue) 
concentrations; (b) absorption spectra of Pc 2.15 in 10 mM phosphate buffer pH 7.4 at 
7.9 µM (black), 5.1 µM (red), 2.8 µM (green), 1.4 µM (blue), and 0.2 µM (light blue) 
concentrations; (c) absorption spectra of Pc 2.16 in 10 mM phosphate buffer pH 7.4 at 
10.5 µM (black), 5.3 µM (red), 2.7 µM (green), 1.6 µM (blue), and 0.9 µM (light blue) 
concentrations; (d) absorption spectra of Pc 2.17 in 10 mM phosphate buffer pH 7.4 at 
7.1 µM (black), 4.7 µM (red), 2.9 µM (green), 1.5 µM (blue), and 0.5 µM (light blue) 
concentrations; (e) absorption spectra of Pc 2.18 in 10 mM phosphate buffer pH 7.4 at 6.9 
µM (black), 4.9 µM (red), 2.1 µM (green), 0.8 µM (blue), and 0.3 µM (light blue) 
concentrations. 
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            The singlet oxygen quantum yields for Pcs 2.6, 2.15-2.18 were determined in 
DMSO as previously reported,39 and were found to be in the range 0.09-0.15, as shown in 
Table 2.3. These values are characteristic for this type of Pc;26, 39 Si(IV)-Pc 2.16 was 
found to have the highest singlet oxygen quantum yield whereas Si(IV)-Pc 2.18 bearing 
eight short PEG chains had the lowest. It is possible that the singlet oxygen is inactivated 
by the PEG chains, as it has been previously observed.40, 41 Pc 2.16, the most hydrophobic 
of all the Si(IV)-Pcs synthesized, shows the highest quantum yield in DMSO. 
 Table 2.3. Singlet-oxygen quantum yields in DMSO.  
 
 
 
 
 
 
 
 
2.5       Summary of Biological Evaluation 
            The experiments using human carcinoma HEp2 cells of this series of cationic 
silicon and zinc Pcs were conducted in our laboratory by Mr. Timothy J. Jensen. The 
details of these investigations can be found in our published paper.11 As a brief summary, 
the study shows that all water-soluble Pcs were readily taken up by human HEp2 cells 
and the extent of their accumulation within cells depends on their hydrophobic character 
and increased in the order 2.18 < 2.15 < 2.17 < 2.16 < 2.6. Intracellularly, all Pcs 
localized preferentially within the cell lysosomes. The dark-toxicity of Pcs 2.6, 2.15-2.18 
was evaluated in human HEp2 cells exposed to increasing concentrations of each Pc up to 
100 µM. Only Zn(II)-Pc 2.6, the most accumulated within cells, showed measurable dark 
toxicity with an estimated IC50 ~ 85 µM. All Si(IV)-Pcs were found to be non-toxic to 
HEp2 cells in the dark up to 100 µM concentrations. Upon exposure to a low light dose 
Pc Φ∆ 
Pc 2.6 0.115 
Pc 2.15 0.134 
Pc 2.16 0.150 
Pc 2.17 0.110 
Pc 2.18 0.094 
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(1 J/cm2) all Pcs were highly toxic to HEp2 cells. The Zn(II)-Pc 2.6 and Si(IV)-Pcs 2.15 
and 2.17 were the most phototoxic (IC50 = 2.2 µM at 1 J/cm2 light dose), probably as a 
result of their ability to generate singlet oxygen and low tendency for aggregation. We 
are collaborating with Dr. Kwang-Poo Chang of the Chicago Medical School to study the 
effects of this series of zinc- and silicon-Pcs 2.6, 2.15-2.18 on Leishmania-infected and 
non-infected J774 cells of murine tumor macrophages. The preliminary study indicates 
that Pc 2.18 appears to be most promising to have selective activity against 
phogolysosomal Leishmania, leaving macrophages unharmed as the host cells. 
2.6      Conclusion 
            In this Chapter, a series of new cationic pyrilydoxyPcs (2.6, 2.15-2.18) bearing 
either Zn(II) or Si(IV) coordinated metal ions and methyl, propyl, hexyl or short PEG 
groups on the pyridyls, was successfully synthesized. The Si(IV)-Pcs bearing two bulky 
axial ligands exist mainly as monomers in both organic and aqueous solutions, and show 
higher fluorescence quantum yields in solution than the Zn(II)-Pcs. The only water-
soluble Zn(II)-Pc is Pc 2.6. Both these Pcs form aggregates in aqueous media, in 
particular Pc 2.3 bearing eight N-methyl groups; the presence of eight short PEGs 
increases the solubility of the Pc macrocycle in protic solvents but a centrally chelated 
silicon ion and associated bulky axial ligands is more efficient in minimizing Pc 
aggregation. This series of water-soluble Pcs exhibited singlet oxygen quantum yields in 
DMSO in the range 0.09-0.15 and their in vitro properties depended on both their 
tendency for aggregation and hydrophobic character. The most hydrophobic Pc 2.6 tested 
accumulated the most within HEp2 cells and was highly phototoxic (IC50 = 2.2 µM at 1 
J/cm2 light dose). Among the Si(IV)-Pcs, those with the lowest tendency for aggregation 
in aqueous media (2.15 and 2.17) and high ability for producing ROS were also highly 
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phototoxic (IC50 = 2.2 µM at 1 J/cm2 light dose). All Pcs localized subcellularly 
preferentially within the lysosomes. Of all this series of water-soluble Pcs, Si(IV)-Pc 2.18 
appears to be most promising to have selective activity against phogolysosomal 
Leishmania, leaving macrophages unharmed as the host cells. 
2.7       Experimental 
2.7.1    Synthesis 
            All air and moisture sensitive reactions were performed under an argon 
atmosphere. All solvents and reagents were purchased from commercial sources, unless 
otherwise stated. Dry solvents excluding methanol were purified using a Braun solvent 
purification system. Dry methanol was obtained by re-distillation after refluxing over 
calcium hydride for 5 h. Silica gel 60 (230×400 mesh, Sorbent Technologies) was used 
for column chromatography. Analytical thin-layer chromatography (TLC) was carried out 
using polyester backed TLC plates 254 (precoated, 200 µm) from Sorbent Technologies. 
NMR spectra were recorded on a DPX-250 or ARX-300 Bruker, or a Varian Inova-500 
spectrometers (250 MHz, 300 MHz or 500 MHz for 1H, 63 MHz, 75 MHz or 125 MHz 
for 13C). The chemical shifts are reported in δ ppm using the following deuterated 
solvents as internal references: CD2Cl2 5.32 ppm (1H), 53.8 ppm (13C); d-TFA 11.5 ppm 
(1H), 164.2 ppm (13C); d-DMSO 2.49 ppm (1H), 39.5 ppm (13C); d-THF 3.58 ppm (1H), 
1.73 ppm (13C); d-CH3OH 4.78 ppm (1H), 49.0 ppm (13C); d-DMF 8.01 ppm (1H), 162.7 
ppm (13C); CD3CN 1.93 ppm (1H), 118.2 ppm (13C); D2O 4.63 ppm (1H). Electronic 
absorption spectra were measured on a Perkin-Elmer Lambda 35 UV-vis spectrometer. 
IR spectra were recorded with a Bruker Tensor 27 spectrophotometer. Mass spectra were 
obtained on either a Bruker ProFlex III MALDI-TOF mass spectrometer using α-cyano-
4-hydroxycinnamic acid or dithranol as the matrix, or an Applied Biosystems QSTAR 
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XL quadrupole TOF MS for ESI. Elemental analyses were performed on a Thermo 
Finnigan Flash 1112 CHN elemental analyzer. Melting points were measured on a 
Fisher-Johns apparatus. 
            Phthalonitrile 2.1. 4, 5-Dichlorophthalonitrile (1.0 g, 5.0 mmol) and 3-
hydroxypyridine (2.2 g, 23.1 mmol) were dissolved in 15 mL of dry DMF at 80 °C under 
argon. Potassium carbonate (4.5 g, 32.6 mmol) was added to the reaction solution in 8 
portions every 5 min. The reaction solution was heated for 3 h, then cooled to room 
temperature and poured into 100 mL of ice water. After filtration under vacuum, the 
crude product was purified by column chromatography on neutral alumina using 
methanol/dichloromethane 1:50 for elution. The title compound (1.37 g) was obtained as 
a pale white solid in 86% yield. 1H NMR (CD2Cl2): δ 8.53 – 8.51 (m, 2H, Py-H), 8.42 (s, 
2H, Py-H), 7.42 – 7.41 (m, 4H, Py-H), 7.31 (s, 2H, Ar-H). 13C NMR (CD2Cl2): δ 151.53, 
147.46, 142.19, 127.18, 125.24, 123.67 (Ar-C, Py-C), 115.21 (CN), 112.19 (Ar-C). FTIR 
(solid): 2236.8 (CN), 1211.3 (C-O) cm-1. MS (MALDI-TOF) m/z 315.31 [M+H] +, calcd. 
for C18H11N4O2  315.09. Anal. calcd. for C18H10N4O2: C 68.79, H 3.21, N 17.83; Found: 
C 68.58, H 3.33, N 17.78. 
            Crystal data for 2.1: Colorless, C18H10N4O2, Mr=314.3, monoclinic space group 
C2/c, a=24.573(3), b= 9.417(2), c= 16.076(3) Å, β=128.21(2)˚, V=2923.0(12) Å3, Z=8, 
ρcalcd=1.428 gcm-3, MoKα radiation (λ=0.71073 Å; µ=0.098 mm-1), T=110K, 32427 data 
by Nonius KappaCCD, R=0.057 (3531 with F2>2σ), Rw=0.149  (all F2) for 5539 unique 
data having θ<33.1˚ and 217 refined parameters, CCDC 652076. Crystals were grown by 
slow evaporation of dichloromethane. 
            Triethylene glycol iodide. Compound CH3(OCH2CH2)3I was synthesized from 
the corresponding tosylate CH3(OCH2CH2)3Ts, which was prepared according to 
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Schultz’s procedure42 in 88% yield. For triethylene glycol tosylate CH3(OCH2CH2)3Ts: 
1H NMR (CD2Cl2): δ 7.78 (d, J = 8.3 Hz, 2H, Ar-H), 7.37 (d, J = 8.3 Hz, 2H, Ar-H), 4.12 
(t, J = 4.5 Hz, 2H, OCH2), 3.64 (t, J = 4.5 Hz, 2H, OCH2), 3.53 (s, 6H, OCH2), 3.49 (t, J = 
1.6 Hz, 2H, OCH2), 3.32 (s, 3H, OCH3), 2.44 (s, 3H, Ar-CH3). 13C NMR (CD2Cl2): δ 
145.44, 133.24, 130.22, 128.21 (Ar-C), 72.22 (OCH2), 71.01, 70.77, 70.72, 69.84, 68.92 
(OCH2), 58.95 (OCH3), 21.72 (Ar-CH3). MS (ESI) m/z  319.12 [M+H]+, 320.13 
[M+2H]+, 336.15 [M+H2O]+, 341.10 [M+Na]+, calcd. for C14H23O6S 319.12, C14H24O6S 
320.13, C14H24O7S 336.12, C14H22NaO6S 341.10. To a solution of this compound (10 g, 
0.031 mol) in 80 mL of dry acetone was added NaI (9.9 g, 0.062 mol) and the reaction 
was refluxed for 20 h. After cooling to room temperature, the solution was filtered under 
vacuum and washed with acetone. The filtrate was collected and concentrated. The 
residue was dissolved in 100 mL of dichloromethane, washed successively with 1 N 
sodium thiosulfate solution and brine, and dried over anhydrous sodium sulfate. The 
solvent was removed under vacuum and the product was obtained as light yellow liquid 
(8.5 g) in 98% yield. 1H NMR (CD2Cl2): δ 3.73 (t, J = 6.8 Hz, 2H, OCH2), 3.64 – 3.56 
(m, 6H, OCH2), 3.52 – 3.48 (m, 2H, OCH2), 3.33 (s, 3H, OCH3), 3.27 (t, J = 6.8 Hz, 2H, 
OCH2). 13C NMR (CDCl3): δ 77.42, 77.00, 76.58, 71.77, 70.42, 70.03 (OCH2), 58.85 
(OCH3). MS (ESI) m/z  275.01 [M+H]+, 292.04 [M+H2O]+, calcd. for  C7H16IO3 275.01, 
C7H17IO4 292.02.     
            ZnPc 2.2. Phthalonitrile 2.1 (0.4 g, 1.27 mmol) and zinc acetate dihydrate (0.1 g, 
0.45 mmol) were mixed and heated at 80 °C in 15 mL of dry pentanol. After adding a few 
drops of DBU, the temperature was raised to 140 °C. The mixture was heated overnight 
and then concentrated under reduced pressure. The crude product was washed three times 
successively with dichloromethane, acetone and cold methanol. The title product was 
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obtained as a dark blue solid (0.37 g) in 88% yield; mp > 250 °C. UV-vis (DMSO): λmax 
(log ε) 678 (4.08) nm. 1H NMR (d-TFA): δ 9.60 (s, 8H, Ar-H), 9.00 (s, 8H, Py-H), 8.81 
(br, 8H, Py-H), 8.62 (br, 8H, Py-H), 8.29 (br, 8H, Py-H). 13C NMR (d-TFA): δ 159.07, 
156.10, 151.27, 139.77, 137.94, 137.23, 134.47, 131.88, 121.24 (Ar-C, Py-C). MS 
(MALDI-TOF) m/z 1320.78 [M+], calcd. for  C72H40N16O8Zn 1320.25. 
      ZnPc 2.3. Pc 2.2 (0.2 g, 0.15 mmol) and 25 mL of CH3I were stirred at 40 °C and 
the reaction was followed by 1H NMR. After 1 day, methyl iodide was removed under 
reduced pressure. The crude product was washed with acetone to yield the title compound 
as a dark greenish blue solid (0.35 g) in 96% yield; mp > 250 °C. UV-vis (DMSO): λmax 
(log ε) 677 (4.84), 611 (4.21), 359 (4.48) nm. 1H NMR (D2O): δ 9.16 (s, 8H, Ar-H), 9.00 
(s, 8H, Py-H), 8.56 (d, J = 6.1 Hz, 8H, Py-H), 8.48 (d, J = 8.4 Hz, 8H, Py-H), 8.00 – 8.04 
(m, 1H, Py-H), 4.32 (s, 24H, CH3). 13C NMR (D2O): δ 157.24, 151.70, 147.57, 142.07, 
137.20, 136.06, 134.66, 130.380, 117.26 (Ar-C, Py-C), 50.00 (CH3). MS (MALDI-TOF) 
m/z 1320.48 [M-8I-8CH3]+, 1335.43 [M-8I-7CH3]+, calcd. for C72H40N16O8Zn 1320.25, 
C73H43N16O8Zn 1335.27. 
            ZnPc 2.4. Pc 2.2 (0.2 g, 0.15 mmol) and 25 ml iodopropane was stirred at 40 ºC 
for 2 days. The crude product can be filtered under vacuum and washed by acetone to get 
dark blue solid quantitatively. MS (MALDI-TOF) m/z 1320.588 (PyPcZn, M-8I-8C3H7), 
1364.566 (PyPcZn+C3H7, M-8I-7C3H7)  (calculated for  C72H40N16O8Zn 1320.251, 
C75H47N16O8Zn 1364.314); UV-vis (DMSO): λmax (log ε): 612.49 (4.106), 677.29 (4.450) 
nm.  
            ZnPc 2.5. Pc 2.2 (0.2 g, 0.15 mmol) and 25 ml iodohexane was stirred at 65 ºC 
for 2 days. The crude product can be filtered under vacuum and washed by acetone to get 
dark blue solid quantitatively. MS (MALDI-TOF) m/z 1320.397 (PyPcZn, M-8I-8C6H13), 
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1405.616 (PyPcZn+C6H13, M-8I-7C6H13)  (calculated for  C72H40N16O8Zn 1320.251, 
C78H53N16O8Zn 1405.353); UV-vis (DMSO):λmax (log ε): 677.52 (4.323) nm.  
      ZnPc 2.6. Pc 2.2 (0.02 g, 0.015mmol) and CH3(OCH2CH2)3I (1.5g, 5.5 mmol) 
were heated to 70 °C in a sealed 10 mL thick-wall tube for 6 days. The product was 
isolated from the reaction solution by centrifugation and washed twice with acetone and 
twice with dichloromethane. The crude product was purified on a Sephadex LH-20 
column using methanol for elution. The product was vacuum dried at 30 °C for 2 days to 
afford the title compound as a dark blue solid (56 mg) in 92% yield; mp 173 – 175 °C. 
UV-vis (DMF): λmax (log ε) 675 (4.74), 609 (4.10), 354 (4.36) nm. UV-vis (H2O):λmax 
(log ε) 674 (4.56), 611 (3.94), 351 (4.27). 1H NMR (d-DMF): δ 9.69 (s, 8H, Ar-H), 9.60 
(s, 8H, Py-H), 9.21 (d, J = 5.3 Hz, 8H, Py-H), 8.88 (d, J = 7.6 Hz, 8H, Py-H), 8.48 – 8.42 
(m, 8H, Py-H), 5.12 (br, 16H, OCH2), 4.16 (br, 16H, OCH2), 3.72 (br, 16H, OCH2), 3.57 
– 3.44 (m, 48H, OCH2), 3.26 (s, 24H, OCH3). 13C NMR (d-DMF): δ 157.24, 153.86, 
147.70, 142.12, 137.98, 136.65, 134.73, 129.97, 117.57 (Ar-C, Py-C), 72.34, 70.81, 
70.66, 69.63, 62.21, 58.70 (OCH2), 21.41 (OCH3). MS (MALDI-TOF) m/z  1320.60 [M-
8PEG]+, 1467.04 [M-7PEG]+, 1613.94 [M-6PEG]+, 1762.01 [M-5PEG]+, calcd. for 
C72H40N16O8Zn 1320.25, C79H55N16O11Zn 1467.35, C86H70N16O14Zn 1614.46, 
C93H85N16O17Zn 1761.56. HRMS-ESI m/z 549.9806 [M-6I-H]5+, 575.5675 [M-5I]5+, 
751.9363 [M-4I]4+, 1044.5473 [M-3I]3+, calcd. for [C128H159I2N16O32Zn]5+ 549.9737, 
[C128H160I3N16O32Zn]5+ 575.5562, [C128H160I4N16O32Zn]4+ 751.9437, 
[C128H160I5N16O32Zn]3+ 1043.8633. 
            H2Pc 2.7. Method A. Phthalonitrile 2.1 (2 g, 6.4 mmol) was put in 100 three-neck 
round bottom flask, the flask was evacuated and refill with argon for three times. 
Pentanol (40 mL) was added through syringe and the reaction was heated to 90 °C. Small 
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pieces of lithium (0.2 g, 28.57 mmol) were added to the reaction solution with cautious. 
The temperature was increased to 135 °C and remained for 24 hour. After reaction, the 
solution was cooled down to room temperature. Acetic acid (glacial, 9 ml) was added. 
The reaction was stirred for 15 min under room temperature. The reaction solution was 
poured to a mixture of 450 mL ice water and 50 mL methanol and green solid 
precipitated out. The solid was filtered and washed with water, ethyl acetate, 
dichloromethane and methanol to get dark green solid (1.2 g) in 60% yield. Method B. 
Phthalonitrile 2.1 (0.75 g, 2.39 mmol) was heated at 80 °C in 20 mL of dry pentanol. 
After adding DBU (0.36 mL, 2.39 mmol), the temperature was raised to 140 ºC. The 
mixture was heated for 24 hours and then concentrated under reduced pressure. The crude 
product was washed three times successively with water, dichloromethane, acetone and 
cold methanol. The title product was obtained as a dark blue solid (0.4 g) in 53% yield; 
mp > 250 °C. 1H NMR (d-TFA, 400 MHz): δ 8.89 (s, 8H, Ar-H), 8.69 (d, 8H, J = 5.4 Hz, 
Py-H), 8.52 (d, 8H, J = 5.4 Hz, Py-H), 8.19 – 8.15 (m, 8H, Py-H). 13C NMR (d-TFA, 100 
MHz): δ 159.51, 151.39, 139.87, 138.22, 134.53, 132.07 (Ar-C, Py-C). MS (MALDI-
TOF) m/z 1258.94 [M]+, calcd. for  C72H42N16O8 1258.34. 
              H2Pc 2.8. Pc 2.7 (59 mg, 0.045 mmol) and CH3(OCH2CH2)3I (3 g, 11 mmol) were 
heated at 70 ºC in a sealed 10 mL thick-wall tube for 6 days. The product was isolated 
from the reaction solution by centrifugation and washed twice with acetone and twice 
with mixed solvents of hexane/acetone (1/1). The crude product was purified on a 
Sephadex LH-20 column using methanol for elution. The product was vacuum dried at 30 
ºC for 2 days to afford the title compound as a dark blue solid (110 mg) in 72% yield; 
UV-vis (DMF): λmax (log ε) nm. UV-vis (H2O): λmax (log ε). 1HNMR (d-DMF): δ 9.71 
(br, 16H, Ar-H, Py-H), 9.19 (br, 16H, Py-H), 8.44 (br, 8H, Py-H), 5.13 (br, 16H, 
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OCH2CH2O), 4.18 (br, 16H, OCH2CH2O), 3.73 (br, 16H, OCH2CH2O), 3.51 – 3.43 (m, 
48H, OCH2CH2O), 3.24 (s, 24H, CH3O). ). 13C NMR (d-DMF): δ 157.09, 156.90, 
148.87, 142.24, 137.09, 135.48, 134.78, 130.02, 118.04 (Ar-C, Py-C), 72.23, 70.71, 
70.55, 69.35, 62.05 (OCH2), 58.69 (OCH3). ESI m/z 512.7199 [M-7I-2H]5+, 538.3411 
[M-6I-H]5+, 563.9609 [M-5I]5+, 736.7974 [M-4I]4+, 1024.8740 [M-3I]3+, calcd. for 
[C128H160IN16O32]5+ 512.0086, [C128H161I2N16O32]5+ 537.4158, [C128H162I3N16O32]5+ 
563.1735, [C128H162I4N16O32]4+ 735.6930, [C128H163I5N16O32]3+ 1023.2255. 
            Bis(pyridine-3-yloxy)diiminoisoindoline 2.9. Phthalonitrile 2.1 (2 g, 6.4 mmol) 
and sodium methoxide (0.5 g, 9.3 mmol) were dissolved in 100 mL of freshly distilled 
methanol. Ammonia gas was bubbled into the solution for 50 min at room temperature. 
The solution was then heated to 65 °C and refluxed under a slow stream of ammonia gas 
for 5 h. The solvent was removed under reduced pressure. Water (150 mL) was added to 
the concentrated residue to precipitate the product. The product was filtered and washed 
thoroughly with water to afford light green crystals of the title compound (1.9 g) in 91% 
yield; mp 122 – 124 °C. 1H NMR (d-DMSO): δ 8.52 (br, 1H), 8.39 – 8.34 (m, 6H), 7.62 
(br, 2H), 7.51 – 7.47 (m, 2H), 7.42 – 7.38 (m, 2H). 13C NMR (d-DMSO): δ 152.97, 
148.32, 144.85, 140.13, 124.95, 124.71, 113.63 (Ar-C, Py-C). FTIR (solid): 3036.73, 
2963.08, 1667.2 (CN), 1213.2 (CO) cm-1. MS (MALDI-TOF) m/z 332.20 [M+H]+, 
354.14 [M+Na]+, calcd. for  C18H14N5O2 332.11, C18H13N5O2Na 354.10. 
      SiPc 2.10. Dry diiminoisoindoline 2.9 (0.5 g, 1.5 mmol) was added to 5 mL of 
freshly redistilled quinoline. The reaction solution was stirred under argon for 10 min and 
then silicon tetrachloride (0.5 mL, 2.2 mmol) was added dropwise to the solution. The 
temperature was raised to 220 °C and maintained for 1 h. The solution was cooled to 
room temperature. The solid was filtered under vacuum and washed successively with 
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water, methanol and acetone. The title compound was obtained as a dark blue solid (0.5 
g) in 98% yield; mp > 250 °C. UV-vis (DMSO): λmax (log ε) 677 (3.83) nm. 1H NMR (d-
TFA): δ 9.66 (br, 8H, Ar-H), 8.98 (br, 8H, Py-H), 8.73 (br, 8H, Py-H), 8.58 (br, 8H, Py-
H), 8.21 (br, 8H, Py-H). 13C NMR (d-TFA): δ 158.95, 152.09, 151.43, 139.324, 137.64, 
136.40, 134.08, 131.48, 120.53 (Ar-C, Py-C). MS (MALDI-TOF) m/z 1319.82 [M-Cl]+, 
calcd. for  C72H40ClN16O8Si 1319.27. 
      SiPc 2.11. A mixture of Pc 2.10 (0.45 g, 0.33 mmol) and sodium methoxide (1.5 
g, 27 mmol) in 60 mL of water/ethanol (5:1) was heated to reflux for 5 h. The solvent 
was removed under reduced pressure and the product was isolated by precipitation upon 
addition of 10 mL of water. The slurry solid was filtered and washed thoroughly with 
water. The final product was dried under vacuum at 40 °C for 2 days to afford the title 
compound as a dark blue solid (0.35 g) in 81% yield; mp > 250 °C. UV-vis (DMSO): λmax 
(log ε) 677 (4.11), 609 (3.64), 364 (3.94) nm. 1H NMR (d-TFA): δ 9.72 (br, 8H, Ar-H), 
9.03 (br, 8H, Py-H), 9.81 (br, 8H, Py-H), 8.65 (br, 8H, Py-H), 8.63 (br, 8H, Py-H), 8.29 
(br, 8H, Py-H). 13C NMR (d-TFA): δ 159.11, 152.24, 151.58, 139.46, 137.78, 136.55, 
134.20, 131.61, 120.67 (Ar-C, Py-C). FTIR (solid): 3382.3 (O-H), 1209.5 (C-O), 844.6 
(Si-O) cm-1. MS (MALDI-TOF) m/z 1301.81 [M-OH]+, 1318.63 [M]+, calcd. for 
C72H41N16O9Si 1301.30, C72H42N16O10Si 1318.30.  
      SiPc 2.12. Pc 2.11 (0.17 g, 0.125 mmol) was dissolved in 10 mL of dry pyridine 
at 115 °C under an argon atmosphere. Chlorotripropylsilane (0.7 mL, 3.2 mmol) was 
added to the reaction solution dropwise via syringe. After 8 h another portion of 
chlorotripropylsilane (0.5 mL, 2.2 mmol) was added. The reaction solution was refluxed 
for another 9 h. The solvent was evaporated to dryness, and 10 mL of pentane were 
added. After sonication for 5 min, the crude product was obtained by centrifugation. The 
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solid was further purified using a short silica column and THF for elution. The title 
compound was dried under vacuum at 40 °C and obtained as a dark greenish blue solid 
(0.11 g, 52%); mp > 250  °C. UV-vis (CH2Cl2): λmax (log ε) 674 (5.34), 644 (4.54), 607 
(4.60), 360 (4.92) nm. 1H NMR (d-THF): δ 9.30 (s, 8H, Ar-H), 8.58 (d, J = 2.7 Hz, 8H, 
Py-H), 8.46 (dd, J = 1.0, 4.5 Hz, 8H, Py-H), 7.63 – 7.59 (m, 8H, Py-H), 7.45 – 7.41 (q, 
8H, Py-H), -0.15 (t, J = 7.2 Hz, 18H, CH3), -0.99 – -1.07 (m, 12H, CH2), -2.29 – -2.34 
(m, 12H, CH2). 13C NMR (d-THF): δ 154.75, 151.75, 149.04, 146.15, 141.46, 133.91, 
125.48, 125.09, 116.40 (Ar-C, Py-C), 17.84, 16.42, 15.87 (CH2CH2CH3). MS (MALDI-
TOF) m/z 1457.88 [M-OSi(C3H7)3]+, calcd. for C81H61N16O9Si2 1457.44). 
      SiPc 2.13. Pc 2.11 (0.12 g, 0.088 mmol) and chlorotriisopropylsilane (0.4 mL, 1.8 
mmol) reacted as described above for Pc 2.12 and the title compound was obtained as a 
dark greenish blue solid (94 mg, 64%); mp > 250 °C. UV-vis (CH2Cl2): λmax (log ε) 677 
(5.13), 646 (4.21), 609 (4.28), 359 (4.63) nm. 1H NMR (d-DMF): δ 9.43 (s, 8H, Ar-H), 
8.68 (s, 8H, Py-H), 8.57 (d, J = 4.4 Hz, 8H, Py-H), 7.84 (d, J = 8.4 Hz, 8H, Py-H), 7.64 – 
7.59 (m, 8H, Py-H), -1.06 (d, J = 8.0 Hz, 36H, CH3), -1.94 – -2.01 (m, 6H, CH). 13C 
NMR (d-DMF): δ 154.36, 151.52, 148.90, 146.18, 141.22, 133.22, 126.15, 125.68, 
116.01(Ar-C, Py-C), 16.11, 11.42 (CH(CH3)2). MS (MALDI-TOF) m/z  1631.23 
[M+H]+, 1457.42 [M-OSi(C3H7)3]+, calcd. for C90H83N16O10Si3 1631.58, C81H61N16O9Si2 
1457.43.    
      SiPc 2.14. Pc 2.11 (0.2 g, 0.15 mmol) and tert-butyldiphenylchlorosilane (0.8 mL, 
3.0 mmol) reacted as described above for Pc 2.12 and the title compound was obtained as 
a dark greenish blue solid (99 mg, 37%); mp 185-187 °C. UV-vis (DMF): λmax (log ε) 680 
(5.09), 650 (4.29), 612 (4.36), 363 (4.59) nm. 1H NMR (d-DMF): δ 9.19 (s, 8H, Ar-H), 
8.75 (d, J = 2.6 Hz, 8H, Py-H), 8.60 (d, J = 4.5 Hz, 8H, Py-H), 8.01 (s, 8H, Py-H), 7.92 – 
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7.90 (m, 8H, Py-H), 7.70 – 7.66 (m, 8H, Py-H), 6.99 (t, J = 7.3 Hz, 4H, Ar-H), 6.57 (t, J 
= 7.4 Hz, 8H, Ar-H), 4.91 (d, J = 7.1 Hz, 8H, Ar-H), -1.22 (s, 18H, C(CH3)3). 13C NMR 
(d-DMF): δ 154.44, 151.27, 148.62, 146.13, 141.19, 133.79, 133.30, 133.21, 128.94, 
126.94, 126.39, 125.78, 115.95 (Ar-C, Py-C), 24.99, 17.00 (C(CH3)3). MS (MALDI-
TOF) m/z  1794.37 M+, 1539.26 [M-(OSiPh2tBu)]+, calcd for C104H78N16O10Si3 1794.54, 
C88H59N16O9Si2 1539.42.  
      SiPc 2.15. Pc 2.12 (20 mg, 0.01 mmol) and CH3I (7 mL) reacted as described 
above for Pc 2.3 and the title compound was obtained as a greenish blue solid (27 mg, 
95%); mp > 250 °C. UV-vis (H2O): λmax (log ε) 674 (5.03), 644 (4.31), 607 (4.35), 356 
(4.68) nm. 1H NMR (d-CH3OH): δ 9.95 (s, 8H, Ar-H), 9.21 (s, 8H, Py-H), 8.77 (d, J = 
6.0 Hz, 8H, Py-H), 8.48 (d, J = 9.0, 8H, Py-H), 8.17 – 8.11 (q, 8H, Py-H), 4.48 (s, 24H, 
N-CH3), -0.20 (t, J = 7.2 Hz, 18H, CH3), -1.07 – -1.16 (m, 12H, CH2), -2.41 – -2.48 (m, 
12H, CH2). MS (MALDI-TOF) m/z 1644.87 [M-7CH3-8I]+, 1456.46 [M-OSi(C3H7)3-
8CH3-8I]+, calcd. for C91H85N16O10Si3 1645.59, C81H61N16O9Si2 1457.44. HRMS-ESI m/z 
795.1072 [M-3I]3+, 564.8538 [M-4I]4+, 532.6256 [M-5I-H]4+, 525.8209 [M-5I-
(CH3)2+H]4+, calcd. for [C98H106I5N16O10Si3]3+ 795.0936, [C98H106I4N16O10Si3]4+ 
564.9740, [C98H105I3N16O10Si3]3+ 532.6161, [C96H101I3N16O10Si3]3+ 525.9824.    
      SiPc 2.16. Pc 2.13 (35 mg, 0.02 mmol) and CH3I (8 mL) reacted as described 
above for Pc 2.3 and the title compound was obtained as a greenish blue solid (28 mg, 
96%); mp > 250 °C. UV-vis (H2O): λmax (log ε) 677 (4.84), 648 (4.05), 610 (4.07), 356 
(4.45) nm. 1H NMR (d-DMF): δ 9.97 (s, 8H, Ar-H), 9.67 (s, 8H, Py-H), 9.21 (d, J = 5.8 
Hz, 8H, Py-H), 8.86 (d, J = 8.8 Hz, 8H, Py-H), 8.46 – 8.45 (m, 8H, Py-H), 4.72 (s, 24H, 
N-CH3), -1.08 (d, J = 7.5 Hz, 36H, CH3), -1.98 – -2.10 (m, 6H, CH). MS (MALDI-TOF) 
m/z 1457.69 [M-8MeI-OSi(C3H7)3]+, 1472.70 [M-7MeI-OSi(C3H7)3]+, 1630.80 [M-
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8MeI]+, 1645.82 [M-7MeI]+, calcd. for C81H61N16O9Si2 1457.44, C82H64N16O9Si2 
1472.46, C90H82N16O10Si3 1630.57, C91H85N16O10Si3 1645.59. HRMS-ESI m/z 795.4410 
[M-3I]3+, 752.8038 [M-4I-H]3+, 564.6037 [M-4I]4+, 532.6259 [M-5I-H]4+, calcd. for 
[C98H106I5N16O10Si3]3+ 795.6001, [C98H105I4N16O10Si3]3+ 752.8038, 
[C98H106I4N16O10Si3]3+ 564.5941, [C98H105I3N16O10Si3]3+ 532.6161.    
      SiPc 2.17. Pc 2.14 (20 mg, 0.01 mmol) and CH3I (4 mL) reacted as described 
above for Pc 2.3 and the title compound was obtained as a greenish blue solid (29 mg, 
91%); mp 217-219 °C. UV-vis (H2O): λmax (log ε) 679 (4.81), 649 (3.96), 612 (4.01), 352 
(4.29) nm. 1H NMR (d-DMF): δ 9.79 (s, 8H, Ar-H), 9.71 (s, 8H, Py-H), 9.25 (d, J = 5.3 
Hz, 8H, Py-H), 8.88 (d, J = 7.8 Hz, 8H, Py-H), 8.57 – 8.54 (m, 8H, Py-H), 7.04 (t, J = 7.3 
Hz, 4H, Ar-H), 6.68 (t, J = 7.4 Hz, 8H, Ar-H), 4.89 (d, J = 7.0 Hz, 8H, Ar-H), 4.76 (s, 
24H, N-CH3), -1.24 (s, 18H, C(CH3)3). 13C NMR (d-DMF): δ 156.47, 149.87, 148.76, 
143.06, 138.95, 135.06, 134.24, 133.70, 133.05, 130.17, 129.32, 127.36, 117.61 (Ar-C, 
Py-C), 49.61 (N-CH3), 25.24, 17.04 (C(CH3)3). MS (MALDI-TOF) m/z 1810.95 [M-
7MeI-I+H]+, calcd. for C105H82N16O10Si3 1810.57. HRMS-ESI m/z 850.0984 [M-
(OSiPh2tBu)-I+2H]3+, 606.0964 [M-(OSiPh2tBu)-2I+2H]4+, 573.6194 [M-(OSiPh2tBu)-
3I+H]4+, 541.6409 [M-(OSiPh2tBu)-4I]4+, calcd. for [C96H85I7N16O9Si2]3+ 849.9846, 
[C98H85I6N16O9Si2]3+ 606.1078, [C96H84I5N16O9Si2]4+ 573.7842, [C96H83I4N16O9Si2]3+ 
541.8062).     
            SiPc 2.18. Pc 2.14 (45 mg, 0.025mmol) and CH3(OCH2CH2)3I (2.2 g, 8.2 mmol) 
reacted as described above for Pc 2.6 and the title compound was obtained as a dark blue 
solid (94 mg, 94%); mp 82-84 °C. UV-vis (H2O): λmax (log ε) 678 (4.76), 649 (3.90), 610 
(3.96), 353 (4.25) nm. 1H NMR (CD3CN): δ 9.58 (s, 8H, Ar-H), 9.43 (s, 8H, Py-H), 8.97 
(d, J = 5.3 Hz, 8H, Py-H), 8.63 (d, J = 7.7 Hz, 8H, Py-H), 8.29 (t, J = 7.6 Hz, 8H, Py-H), 
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6.98 (t, J = 7.3 Hz, 4H, Ar-H), 6.57 (t, J = 7.3 Hz, 8H, Ar-H), 5.02 (br, 16H, OCH2), 4.84 
(d, J = 7.1 Hz, 8H, Ar-H), 4.14 (br, 16H, OCH2), 3.70 (br, 16H, OCH2), 3.55 – 3.47 (m, 
48H, OCH2), 3.28 (s, 24H, OCH3), -1.26 (s, 18H, C(CH3)3). 13C NMR (CD3CN): δ 
156.50, 149.97, 148.87, 142.63, 138.42, 136.02, 134.40, 133.96, 133.15, 130.39, 129.55, 
127.50, 117.49 (Ar-C, Py-C), 72.48, 71.16, 70.88, 70.79, 69.38, 62.73, 59.01 (OCH2), 
25.37 (OCH3), 17.20, 4.81 (C(CH3)3). MS (MALDI-TOF) m/z  3985.42 [M-H]+, 3603.91 
[M-OSiPh2tBu-I-H]+, 3476.98 [M-OSiPh2tBu-2I-H]+, 3348.09 [M-OSiPh2tBu-3I-2H]+, 
3221.20 [M-OSiPh2tBu-4I-2H]+, calcd. for C160H197I8N16O34Si3 3985.58, 
C144H178I7N16O33Si2 3603.56, C144H178I6N16O33Si2 3476.66, C144H177I5N16O33Si2 3348.74, 
C144H177I4N16O33Si2 3221.84). HRMS-ESI m/z 1202.3092 [M-(OSiPh2tBu)-I+2H]3+, 
870.0024 [M-(OSiPh2tBu)-2I+2H]4+, 670.6225 [M-(OSiPh2tBu)-3I+2H]5+, 645.2429 [M-
(OSiPh2tBu)-4I+H]5+, calcd. for [C144H181I7N16O33Si2]3+ 1202.1943, 
[C144H181I6N16O33Si2]4+ 869.9196, [C141H181I5N16O33Si2]4+ 670.5548, 
[C144H180I4N16O33Si2]3+ 645.3780.      
2.7.2    Photophysical Study 
            All absorption spectra were measured on a Perkin-Elmer Lambda 35 UV-vis 
spectrometer with 10 mm path length quartz cuvettes. Emission spectra were obtained on 
a Fluorolog 3 spectrofluorimeter. Pure solvents were used as reference solutions. All 
solvents were either ACS spectrophotometric or HPLC grade. Sodium phosphate dibasic 
was purchased from EMD. Milli-Q water (resistance 18 MΩ) was prepared in-house. The 
phosphate buffer solutions were prepared by dissolving 1.43 g anhydrous sodium 
phosphate dibasic in 100 ml water followed by pH adjustment with concentrated 
hydrochloride or sodium hydroxide solution using a Thermo Orion Model 410 pH meter. 
Stock solutions (10 mM DMSO) of all Pcs were prepared. All dilutions were prepared by 
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spiking 0.2-2 µL of the corresponding DMSO stock solutions into 1 mL of each solvent. 
The optical densities of the solutions used for the emission studies were between 0.04-
0.05 at the excitation wavelength (610 nm) to eliminate inner filter effects. All the 
measurements were performed within 3 h of solution preparation.      
            Fluorescent quantum yields were calculated using a secondary standard method.43 
Methylene blue, a dye with excitation/emission wavelengths similar to Pcs, was used as 
the reference. The equation (
2
R
2
R
R
R
n
n
OD
OD
I
IQQ = ) was applied to calculate the quantum 
yield of the Pcs. In this equation, the fluorescence intensities of the analyte (I) and 
standard (IR), optical densities of the analyte (OD) and standard (ODR), and the refractive 
indexes of the analyte solvent (n) and standard solvent (nR) are incorporated, in addition 
to QR, the quantum yield of the reference standard (0.03 for methylene blue).44, 45  
            Singlet oxygen quantum yields were obtained in DMSO at room temperature, 
using ZnPc (Φ∆ = 0.67) as reference and 1,3-diphenylisobenzofuran (DPBF) as 
scavenger, according to the procedure previously described.39 The DPBF absorption 
decay was followed at 417 nm. The singlet oxygen quantum yields were determined with 
an accuracy of about 10%.  
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CHAPTER 3 
   
 
SYNTHESES AND PROPERTIES OF CARBORANYL CONJUGATED 
PHTHALOCYANINES* 
  
 
3.1       Background 
            Boron-containing Pcs have potential applications in the boron neutron capture 
therapy (BNCT) and photodynamic therapy (PDT) of cancer. BNCT and PDT are both 
bimodal techniques for cancer treatment. BNCT agents rich in boron-10 nuclides and 
with selective localization in malignant cells, have the ability of capturing low energy 
neutrons by boron-10 nuclei to produce high linear energy transfer (high-LET) α-particles 
and recoiling lithium-7 nuclei while releasing about 2.4 MeV of kinetic energy.1-3 The 
highly toxic LET particles have limited pathlengths in tissue (< 10 µm).1-3 Two 
clinically-approved boron containing compounds, mercapto-closo-dodecaborate (BSH) 
and 4-hydroxyborylphenylalanine (BPA), are currently used in the clinical trials in the 
USA, Japan and Europe.1 PDT is a binary modality using a photosensitizer (PS) and 
visible light to produce reactive oxygen species which can selectively destroy malignant 
cells.4 Pc has an advantage as a PDT photosensitizers, because it generally has a strong 
absorption within the “therapeutic window” (600-800 nm) for optimal light penetration 
deep through tissue, and high singlet oxygen quantum yields which are crucial for PDT 
treatment.5, 6 Various boronated porphyrins and derivatives have been synthesized and 
evaluated in vitro or in vivo studies as BNCT anti-cancer agents.7 Recently, our group 
has reported the syntheses of a series of porphyrin-cobaltacarborane conjugates and their 
biological evaluations.8-11 The dual applications of carboranylchlorin and 
tetrabenzoporphyrin for the PDT and BNCT have also been reported by our group.12-14  
* Parts of this Chapter have appeared in the Tetrahedron Letters.35 
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            Pcs’ well-known disadvantage is their high tendency to aggregate in most organic 
solvents and aqueous media due to the hydrophobic and planar nature of the Pc 
macrocycle. For these reasons Pcs’ applications in the both areas of PDT and BNCT have 
been retarded. Only a few examples of Pc-boron conjugates have been reported to date.15-
18 In this Chapter, we report the syntheses and photophysical study of a series of A3B-
type zinc Pcs containing one or two cobaltacarborane clusters (Figure 3.1). Pcs 3.7-3.10 
are conjugated to one or two cobaltacarborane clusters via one short polyethylene glycol 
chain. PEG-conjugated anti-cancer drugs are known to increase the serum lifetime, to 
reduce the uptake from the reticulo-endothelialsystem (RES) and to enhance the 
phototoxicity and vascular permeability in tumor tissues.19-23 
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Figure 3.1. Structures of target Pc conjugates. 
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3.2 Synthesis of Carboranyl Conjugated Phthalocyanines 
CH
BH
B
NN N
N
NNN
N Zn
RO O
O
O
Co
K
NC CN
HO OH
b
NC CN
RO OH
NC CN
RO O
O
O
Co
K
c
3.1: R = Me
3.4, 3.8: R = Me
3.2: R = (CH2CH2O)3Me
3.5, 3.9: R = (CH2CH2O)3Me
3.3, 3.7: R = H
3.6, 3.10: R = O Co K
O
a b
3.3-3.6
3.7-3.10
 
Scheme 3.1. Synthesis of ZnPc-Cobaltacarborane conjugates 3.7-3.10. Reagent and 
conditions: (a) RI, K2CO3, DMF, 24 h (16-50%); (b) 3, 3′-Co(8-C4H8O2-1,2-
C2B9H10)(1′,2′-C2B9H10), K2CO3, 60 °C, 24 h (>92%); (c) phthalonitrile, Zn(OAc)2, 
quinoline, 220 °C, 1 h (8 - 17%). 
 
         The synthetic routes to conjugates 3.7-3.10 are shown in Scheme 3.1. Zinc Pcs 
3.7-3.10 were synthesized from the corresponding conjugated phthalonitrile and excess 
unsubstituted phthalonitrile using zinc as the template in 8–17% yields. Zwitterionic 3, 
3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10) was synthesized from Cs[3,3′-Co(1,2-
C2B9H10)2] in dry dioxane in 93% yield, according to the literature.24, 25 I was able to 
obtain an improved result of X-ray structure analysis, which is shown in Figure 3.2.25 2,6-
Dihydroxyphthalonitrile reacted with 3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10) 
after activation with anhydrous potassium carbonate in acetone. Conjugated phthalonitrile 
3.6 containing two cobaltacarborane clusters was obtained in 96% yield. 2,6-
Dihydroxyphthalonitrile was monosubstituted using one equivalent of methyl iodide or 
triethylene glycol iodide26 to produce the monohydroxy-containing phthlaonitriles 3.1 
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and 3.2 in 50% and 16% yields, respectively. The crystal structure of 3.1 is shown in 
Figure 3.3. 
 
Figure 3.2. Single crystal X-ray structure of 3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-
C2B9H10). 
 
 
 
Figure 3.3. Single crystal X-ray structure of phthalonitrile 3.1. 
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           After activation with anhydrous potassium carbonate in acetone or 
acetone/chloroform mixed solvents, monohydroxy-containing phthalonitriles 3.1 or  
3.2 reacted with 3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10) to produce 
conjugated phthalonitriles 3.4 or 3.5, each containing one cobaltacarborane cluster. 
An excess amount of reagent 2,6-dihydroxyphthalonitrile reacted with 3,3′-Co(8-
C4H8O2-1,2-C2B9H10) (1′,2′-C2B9H10) to produce the mono-cobaltacarborane 
conjugated phthalonitrile 3.3. All the dioxane ring-opening reactions afforded the 
phthalonitrile conjugates in yields above 92%. The presence of the dicarbollide cages 
and the attached ethylene glycol chains makes phthalonitrile conjugates 3.3–3.6 very 
soluble in polar organic solvents, such as acetone, methanol and acetonitrile.  
            A3B-type Pcs are generally synthesized by three methods: 1) statistical 
condensation, 2) ring expansion, and 3) polymer support.27 We applied the traditional 
method of statistical condensation to synthesize the zinc Pcs 3.7-3.10 in 8-17% yields. 
The macrocyclization reactions took place by heating in quinoline at 220 °C for one hour 
in the presence of zinc acetate. Cobaltacarborane cages were found to survive these 
reaction conditions of quinoline at high temperature. Some bases such as Li and DBU 
generally used in the Pc formation reactions didn’t produce any expected product, which 
may be due to the incompatability of the carborane moiety with these bases. Solid state 
synthesis is widely used in the synthesis of borane conjugated Pcs.15, 18 Unfortunately, it 
also did not succeed in this case.  
            We found that using excess amount of reagent phthalonitrile (A) over carborane-
conjugated phthalonitrile (B) (molar ratio 30:1) produced only one A3B-type Pc, besides 
the A4-type Pc. The production of only one type of Pc except for the A4-type Pc is due to 
the large molar ratio of the two phthalonitrile precursors and the steric hindrance of the 
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cobaltacarborane cages linked via diethylene glycol chains at the 1,4-positions on the Pc 
periphery. By taking advantage of the large difference in solubility of the two resulting 
Pcs, the purification was simplified. After the reaction, the A4-type Pc was easily 
removed from the desired product by filtration since the A4-type Pc is not soluble in most 
solvents. The crude product containing the A3B-type Pc was further purified by Sephadex 
LH-20 column in acetone, followed by HPLC on a C18 column using multiple gradient 
methods with elution of mixed solvents of water and acetonitrile (see Experimental 
section). Dark bluish green solids of the target Pcs 3.7-3.10 were obtained in 8–17% 
yields. These low yields may be due to the impurities produced during the high 
temperature reactions, and/or the purification methods such as HPLC which may have 
removed some aggregates formed in the solvents used.  
            The idea of attaching cobaltacarborane cages to the Pc’s periphery in the last step, 
in order to increase the product yield, was not realistic, because the limited solubility of 
the Pc precursor prevents its further modification. A trial to synthesize free base Pc 
conjugated with cobaltacarborane moiety was not successful. The zinc acetate used as the 
template in this reaction was found to play an important role in this macrocyclisation 
step.  
            The dicobaltacarborane conjugated Pc 3.10 is very soluble in polar organic 
solvents such as acetone, methanol, DMSO, DMF and THF. Figure 3.4 shows the 
molecular structure of 3.10. The Zn-O bond indicated that the metal inside the 
macrocycle is in five coordination state and the axial ligand probably comes from the 
solvent (i.e. water). The DEPT spectrum of 3.10 in Figure 3.5 clearly shows that the 
dicarbollide CH carbons are characteristic at 54.15 and 47.24 ppm and the aliphatic CH2 
carbons in the range of 69-73 ppm in deuterated DMF. The 13C NMR spectrum of 3.10 
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has the expected six peaks in the upfield region at 72.98, 71.27, 70.49, 69.34, 54.15 and 
47.24 ppm. Pcs 3.7-3.10 have the same pattern of peaks in this region, and the OCH3 
carbon in Pc 3.8 appears at 57.49 ppm.   
 
 
Figure 3.4. Single crystal X-ray structure of Pc 3.10. 
 
 
 Figure 3.5. DEPT spectrum of Pc 3.10 in d-DMF (solvent: 34.9, 29.7 ppm). 
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            All target Pcs in d-DMF show the characteristic macrocycle protons of the three 
identical isoindole subunits in the range of 8–10 ppm. The two protons of the 
cobaltacarborane-substituted isoindole unit are in the range of 7–8 ppm and they have 
almost the same chemical shifts as the two aromatic protons of their corresponding 
phthalonitrile conjugates. The 1H NMR spectra show that the conjugated phthalonitriles 
in d-acetone have the dicarbollide CH protons overlapping as one sharp peak at 3.6 ppm 
and two sets of CH2 protons of the diethylene glycol chain overlapping as a broad peak at 
4.2 ppm. It is interesting to observe that the dicarbollide CH protons of the corresponding 
conjugated Pcs in d-DMF shifted downfield to about 4.3 ppm and split into two peaks 
resembling two kinds of protons contained in the cobaltacarborane cages, while the CH2 
protons of the diethylene glycol chain show four sets of  peaks in the range of 5.0–3.9 
ppm.  
            All Pcs investigated show similar MS (ESI) negative ion pattern as [M-K]-, except 
for Pc 3.10 containing two cobaltacarborane cages showing the pattern as [M-2K+H]- at 
1430.7214 m/z. The mononegative molecular ions of all Pcs (3.7 at 1019.3921; 3.8 at 
1033.4076; 3.9 at 1165.4859 and 3.10 at 1430.7214 m/z, Figure 3.6) show the same 
characteristic isotopic patterns which are due to the existence of large number of boron 
atoms.  
            Trace amount of demethylated byproduct in the high temperature 
macrocyclisation reaction of Pc 3.8 was observed in the ESI-MS spectrum at 1019 m/z. 
The separation of Pc 3.7 from Pc 3.8 is difficult by HPLC. Remethylation with excess 
methyl iodide was performed after the macrocyclisation reaction in order to convert all of 
Pc 3.7 to Pc 3.8. The reaction was followed by ESI-MS until the disappearance of the 
peak at 1019 m/z. The pure Pc 3.8 was obtained by reverse phase HPLC using water (A) 
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and acetonitrile (B) as the mobile phase with a multi-step gradient method from 70% B to 
100% B. 
(a)                                                                    (b)   
 
 
 
 
 
 
 
(c)                                                                    (d) 
        
 
 
 
 
 
 
 
 
Figure 3.6. HRMS-ESI spectra for Pcs (a) 3.7, (b) 3.8, (c) 3.9, (d) 3.10. 
  
3.3       Spectroscopic Properties of Cobaltacarboranyl-Phthalocyanines  
            Pcs 3.7-3.10 are soluble in polar organic solvents such as acetone, methanol, 
DMF and DMSO. Pc 3.8-3.10 were found to exist mainly as monomers in acetone 
showing strong and sharp Q band absorptions that strictly follow the Lambert Beer’s law 
(see Figure 3.7). It is observed that these A3B-type Pcs containing 1,4-substituents have  
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(a)                                                                       (b) 
 
 
 
 
 
 
 
Figure 3.7. (a) Absorption spectra of Pc 3.8 in acetone at 6.4 µM (black), 5.1 µM (red), 
3.4 µM (green), 1.7 µM (blue), and 0.7 µM (purple) concentrations; (b) Absorption 
spectra of Pc 3.10 in acetone at 8.7 µM (black), 6.8 µM (red), 4.8 µM (green), 2.3 µM 
(blue), and 0.3 µM (purple) concentrations. 
 
longer wavelength for the maximum absorption than those having 2,3-substituents due to 
their special geometry.26 Figure 3.8 (a) shows that Pc 3.10 has a maximum absorption 
wavelength at 684 nm in acetone, 695 nm in DMF and 696 nm in DMSO. Figure 3.8 (b) 
shows that Pc 3.10 has a maximum emission peak at 691 nm in acetone, and 6-11 nm red 
shift can be found in DMF and DMSO. Pcs 3.8 and 3.10 have the same patterns of  
 
 
 
 
 
 
 
Figure 3.8. (a) Absorption spectra of Pc 3.10 at 2.8 µM in acetone (solid line), DMF 
(dash line) and DMSO (dot line); (b) Emission spectra of Pc 3.10 at 300 nM in acetone 
(solid line), DMF (dash line) and DMSO (dot line), excited at 620 nm. 
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absorption and emission spectra in acetone, DMF and DMSO. Pc 3.8 has the maximum 
absorption wavelengths at 695 nm in DMSO and DMF and 9 nm of blue shift in acetone. 
Both Pcs 3.8 and 3.10 have relatively large Stokes shift of 6-8 nm in methanol, acetone 
and DMSO, while only 2 nm in DMF. Pc 3.9 bearing one triethylene glycol chain has the 
maximum absorption wavelength at 689 nm and relatively large Stokes shift of 7 nm in 
DMF. The phenomena of solvatochromism shift of these anionic carborane containing 
Pcs is consistent with those reported by Teixidor.28   
            All the zinc-Pc conjugates, except for Pc 3.7, are soluble in polar organic 
solvents. Pc 3.7 containing one free hydroxyl group may form aggregates through 
hydrogen bonding explaining its lower solubility in solution.29 The absorption and 
emission spectra of all Pcs in DMSO are shown in Figure 3.9. Pcs 3.9 and 3.10 have the 
same absorption peaks at 695 nm in DMSO, and Pc 3.8 containing one methoxy group 
has a red shift of 1 nm, at 696 nm. All Pcs 3.8–3.10 have the same emission peak at 702 
nm in DMSO. Pc 3.7 containing one hydroxyl group has a red shift of 13 nm compared  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. (a) Absorption spectra of Pc 3.7 (dash dotted line) at 4.2 µM, Pc 3.8 (dotted 
line) at 2.0 µM, Pc 3.9 (solid line) at 3.0 µM, Pc 3.10 (dashed line) at 3.3 µM in DMSO; 
(b) Emission spectra of Pc 3.7 (dash dotted line) at 0.42 µM, Pc 3.8 (dotted line) at 0.20 
µM, Pc 3.9 (solid line) at 0.30 µM, Pc 3.10 (dashed line) at 0.33 nM in DMSO, excited at 
620 nm.  
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with Pc 3.8. It has a hypsochromic shift shown as a shoulder in the absorption spectra, 
which is probably due to the formation of a dimer species. In the emission spectra, Pc 3.7 
has a significant decrease of the intensity, and the production of a minor peak at 676 nm, 
maybe due to the formation of dimer species.  
            The spectroscopic data observed for Pcs 3.7–3.10 in different organic solvents 
and aqueous solution (pH = 7.4) are summarized in Table 3.1.  Pc 3.9 containing one 
PEG chain and one cobaltacarborane cage has the highest fluorescent quantum yield 
among all Pcs in DMF, methanol and acetone. Pc 3.7 containing one hydroxyl group has 
the lowest fluorescent yields among all Pcs in all the solvents tested, which is probably 
due to its strong tendency for aggregation in the solvent. As a result, the aggregation in 
solution largely decreases its fluorescent and singlet oxygen quantum yields.30 These 
A3B- type Pcs have relatively large Stokes shift in the range of 5-10 nm. Nevertheless, Pc  
Table 3.1. Spectral properties of Pc 3.7-3.10 in different media*. 
 
Pc  DMSO DMF MeOH Acetone Bufferd 
3.7 abs 709b 705b 696b 700b 659c 
 em 715b, 676 712b, 673 706b, 670 707b, 669 680c 
 SS 6 7 10 7 NA 
 QY 0.0682 0.0671 0.0273 0.0554 NA 
3.8 abs 696, 627 695, 627 687, 620 684, 618 652c 
 em 702 697 694 691 683c 
 SS 6 2 7 7 NA 
 QY 0.1354 0.1445 0.1034 0.1035 NA 
3.9 abs 695, 626 689, 622 686, 621 685, 618 654c 
 em 702 696 694 690 683c 
 SS 7 7 8 5 NA 
 QY 0.1311 0.1550 0.1192 0.1532 NA 
3.10 abs 695, 626 695, 626 687, 620 686, 618 659c 
 em 702 697 695 692 681c 
  SS 7 2 8 6 NA 
  QY 0.1220 0.125 0.0897 0.1103 NA 
 
*abs: absorption maxima (nm); em: emission maxima (nm); S.S.: Stokes Shift (nm); Q.Y.: quantum yield (nm). b major 
peak. c broad.  d100 mM phosphate buffer , pH = 7.4. 
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3.8 and 3.10 have the lowest Stokes shift of 2 nm in DMF. All Pcs show the highest 
Stokes shift in methanol among all the solvents tested. The spectroscopic properties of 
these carboranyl-functionalized Pcs depend on both the carborane moieties and solvent 
environment.28  
3.4       Synthesis of Carboranyl Conjugated Phthalonitriles and Future Work 
            Zwitterionic 3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10) can undergo dioxane 
ring-opening reaction in the presence of various of nucleophilic reagents, such as halides 
(fluoride, chloride), hydroxide,31 cyanide, amines,32 phenolates33 and pyrrolyl ligands.34 
A series of carboranyl-substituted phthalonitriles were designed (Figure 3.10) and 
phthalonitriles 3.12, 3.13 and 3.16 have been synthesized in 85-94% yields (Schemes 3.2-
3.4). The carboranyl conjugated phthalonitriles 3.12, 3.13 and 3.16 were synthesized 
from the corresponding substituted phthalonitrile containing pyridyl or hydroxyl groups. 
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Figure 3.10. Target phthalonitrile conjugates. 
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Scheme 3.2. Syntheses of phthalonitrile conjugate 3.12. Reagents and conditions: (a). 3-
hydroxypyridine, K2CO3, 90 °C (74%); (b). 3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-
C2B9H10), 50 °C (94%). 
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Scheme 3.3. Syntheses of phthalonitrile conjugate 3.13. Reagents and conditions: (a). 
3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10), 50 °C (85%).  
O
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Scheme 3.4. Syntheses of phthalonitrile conjugate 3.16. Reagents and conditions: (a). 
hydroquinone, K2CO3, 50 °C to r.t. (22%); (b). 3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-
C2B9H10), K2CO3, 50 °C (94%); (c). 4-methoxyphenol, K2CO3, 90 °C (83%); (d). BBr3, -
80 °C (40%).  
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            I have also synthesized other mono and di-amino or hydroxyl-substituted 
phthalonitriles as shown in Scheme 3.5-3.8. Phthalonitrile 3.19 containing two free 
hydroxyl groups was synthesized in three different routes. 4,5-Dichlorophthalonitrile 
reacted with hydroquinone in the presence potassium carbonate to get phthalonitrile 3.19. 
Phthalonitrile 3.17 containing benzyloxy groups proceeded hydrogenation reaction with 
10% Pd/C to obtain the desired phthalonitrile 3.19 in 22% overall yield. Phthalontrile 
3.18 containing methoxyl groups reacted with boron tribromide to afford phthalonitrile  
NC CN
O OHO OH
NC CN
O OO O
NC CN
Cl Cl
3.18
3.19
e
b c
NC CN
O OO O
3.17a d
 
Scheme 3.5. Syntheses of phthalonitrile 3.19. Reagents and conditions: (a). 4-
benzyloxyphenol, K2CO3, 80 °C (48%); (b). 4-methoxyphenol, K2CO3, 80 °C (58%); (c). 
BBr3, -80 °C (29%); (d). Pd/C (10%), r.t., (46%). 
             
3.19 in 17% overall yield. Phthalonitrile 3.23 containing one free amino group was 
synthesized from 3-nitrophthalonitrile and 4-aminophenol in 75% yield. It was also 
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synthesized from phthalonitrile 3.22 containing Boc group by deprotection reaction with 
TFA at room temperature in 72% overall yield. Molecular structures of phthalonitriles 
3.11, 3.15, 3.17, 3.19, 3.21 and 3.24 are shown in Figure 3.11. Further modification of 
these phthalonitriles with 3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10) will lead to 
carboranyl-functionalized phthalonitriles. The statistical condensation method will be 
applied to these conjugated phthalonitriles to afford A3B-type Pcs. 
 
O
NC CN
3.20
OH
O
NC CNNC CN
NO2 NH2
O
NC CN
NHBoc
3.23
3.22
b
c d
a
 
 
Scheme 3.6. Syntheses of phthalonitriles 3.20 and 3.23. Reagents and conditions: (a). 4-
hydroxy-benzyl alcohol, K2CO3, r.t., (28%); (b). 4-aminophenol, K2CO3, 60 °C (75%); 
(c). N-Boc-4-aminophenol, K2CO3, 80 °C (80%); (d). TFA, DCM, r.t. (90%). 
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Scheme 3.7. Syntheses of phthalonitrile 3.21. Reagents and conditions: (a). 1-
(bromomethyl)-3-methoxybenzene, 60 °C (98%). 
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Scheme 3.8. Syntheses of phthalonitrile 3.24. Reagents and conditions: (a). 4-
aminophenol, K2CO3, 60 °C (66%). 
 
 
 
 
        
                                         
                                      (a)                                                                     (b) 
 
                    
                     
 
                                        (c)                                                                   (d) 
 
 
 
 
 
                                         (e)                                                                   (f) 
 
Figure 3.11. Single crystal X-ray structures of 3.11 (a), 3.15 (b), 3.17 (c), 3.19 (d), 3.21 
(e), 3.24 (f). 
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3.5       Conclusion 
            Four novel carboranyl-conjugated A3B-type Pcs were successfully synthesized in 
8-17% yields. These Pcs are highly soluble in polar solvents such as methanol, acetone, 
DMF and DMSO, their absorption and emission properties are solvent-dependent, and 
have ~0.1 fluorescence quantum yields. Several new phthalonitriles have been 
synthesized which can also be converted into A3B-type carboranyl-conjugated Pcs. The 
X-ray structures of several of these new compounds were obtained. These Pcs may have 
potential application as dual sensitizers in the PDT and BNCT treatment of tumors. 
3.6      Experimental 
            All chemicals were purchased from commercial sources and used directly without 
further purification. Silica gel 60 (230×400 mesh, Sorbent Technologies) and alumina gel 
(50 – 200 µm, neutral, standard activity І, Sorbent Technologies) were used for column 
chromatography. Analytical thin-layer chromatography (TLC) was carried out using 
polyester backed TLC plates 254 (precoated, 200 µm) from Sorbent Technologies. NMR 
spectra were recorded on a DPX-250 or AV-400 Bruker spectrometers (250 MHz or 400 
MHz for 1H, 63 MHz or 100 MHz for 13C). The chemical shifts are reported in δ ppm 
using the following deuterated solvents as internal references: CD3COCD3 2.04 ppm 
(1H), 29.92 ppm (13C); d-DMF 2.92 ppm (1H), 34.89 ppm (13C). Electronic absorption 
spectra were measured on a Perkin-Elmer Lambda 35 UV-vis spectrometer. High 
resolution ESI mass spectra were obtained on an Agilent Technologies 6210 Time-of-
Flight LC/MS. HPLC separation and analyses were carried out on a Dionex system 
equipped with a P680 pump and a UVD340U detector. Semi-preparative column was 
Luna C18 100 Å, 5 µm, 10 × 250 mm from Phenomenex, USA. Analytical HPLC was 
carried out on a Delta Pak C18 300 Å, 5 µm, 3.9 × 150 mm ( Waters, USA ) column; flow 
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rate 1.0 mL/min; injected volume 20 µL; wavelength detection 350 nm; solvent A H2O, 
solvent B acetonitrile. Multi-step gradient elution method was used. Condition a: time 0 
min, 70% B; 10 min, 80% B; 20 min, 90% B; 37 min, 100%; condition b: time 0 min, 
75% B; 10 min, 85% B; 20 min, 100% B; 37 min, 100%; condition c: time 0 min, 85% B; 
10 min, 95% B; 20 min, 100% B; 37 min, 100%  
            Zwitterionic [3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10)].24 0.5 g Cs[3,3′-
Co(1,2-C2B9H10)2] was dissolved in 50 mL anhydrous 1, 4-dioxane. Boron trifluoride 
diethyl etherate (1.1 mL, 8.8 mmol) was added dropwise to the solution. The reaction was 
refluxed under an atmosphere of argon for 5 h. After the solution was cooled down to 
room temperature, the solvent was evaporated. The crude product was obtained by 
chromatography on alumina gel using DCM : hexane (4:1) as the eluent to afford orange 
solid 0.56 g (93%).1H NMR (acetone-d6, 400 MHz): δ 4.69 (t, J = 4.1 Hz, 4H, OCH2), 
4.40 (s, 2H, CH), 4.05 (t, J = 4.1 Hz, 4H, OCH2), 4.02 (s, 2H, CH). 1H NMR (CDCl3, 300 
MHz): δ 4.54 (t, J = 4.2 Hz, 4H, OCH2), 4.03 (t, J = 4.2 Hz, 4H, OCH2), 3.77 (s, 2H, 
CH), 3.33 (s, 2H, CH).  13C NMR (acetone-d6, 400 MHz): δ 83.98, 66.24 (OCH2),  55.17, 
48.87 (CH).     
            Phthalonitrile 3.1. 2, 6-Dihydroxyphthalonitrile (1 g, 6.27 mmol) was dissolved 
in 90 mL DMF with argon flow. Potassium carbonate (0.85 g, 6.27 mmol) was added in 
three portions. After adding methyl iodide (0.38 mL, 6.27 mmol) dropwise into the 
solution in four portions, the solution was stirred at room temperature in the sealed 
system for 1 day. After the reaction, the solution was quenched with 90 mL 1 N HCl 
solution. The precipitate was filtered under vacuum. The crude product was purified by 
column chromatography on neutral alumina using methanol/dichloromethane 1:20 for 
elution. The title compound (0.4 g) was obtained as a white crystal in 50% yield. 1H 
 79
NMR (acetone-d6, 250 MHz): δ 7.47-7.36 (m, 2H, Ar-H), 3.96 (s, 3H, OCH3). 13C NMR 
(acetone-d6, 63 MHz): δ 156.31, 155.39, 123.68, 119.83, 114.30, 114.19, 103.56, 102.57 
(Ar-C, CN), 57.38 (OCH3). HRMS-ESI: m/z 173.0355 [M-H]-, calcd. for [C9H5N2O2]- 
173.0356.             
            Phthalonitrile 3.2. 2, 6-Dihydroxyphthalonitrile (1 g, 6.3 mmol) was dissolved in 
90 mL DMF with argon flow. Potassium carbonate (0.85 g, 6.3 mmol) was added in three 
portions. After adding triethylene glycol iodide (1.65 mL, 6.3 mmol) dropwise into the 
solution in four portions, the solution was stirred at room temperature in the sealed 
system for 1 day. After the solution was cooled down to room temperature, the precipitate 
was removed from the solution by filtration. The solution was concentrated and added 
with 10 mL acetone, the precipitate was filtered again. The solvent was evaporated to get 
viscous liquid. The crude product was purified with aluminum column with ethanol / 
dichloromethane 5 / 95 for elution to get pale white solid 0.3 g in 16% yield. 1H NMR 
(acetone-d6, 250 MHz): δ 7.49 (d, J = 9.4 Hz, 1H, Ar-H), 7.36 (d, J = 9.4 Hz, 1H, Ar-H), 
4.30 (t, J = 4.5 Hz, 2H, OCH2), 3.84 (t, J = 4.5 Hz, 2H, OCH2), 3.67 – 3.63 (m, 2H, 
OCH2), 3.59 – 3.54 (m, 4H, OCH2), 3.46 – 3.43 (m, 2H, OCH2), 3.26 (s, 3H, OCH3). 13C 
NMR (acetone-d6, 63 MHz): δ 155.80, 155.75, 123.66, 121.65, 114.37, 114.28, 104.30, 
102.42 (Ar-C, CN), 72.53, 71.46, 71.14, 70.96, 70.81, 70.07 (OCH2), 58.70 (OCH3). 
HRMS-ESI: m/z 305.1140 [M-H]-, 306.1169 [M]-, calcd. for [C15H17N2O5]- 305.1142, 
[C15H18N2O5]- 306.1216. 
            Phthalonitrile Conjugate 3.3. A mixture of 2, 6-Dihydroxyphthalonitrile (0.38 g, 
2.4 mmol) and potassium carbonate (0.066 g, 0.48 mmol) in acetone were refluxed at 60 
°C under argon. After 20 min, [3,3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10)] (0.20g, 
0.48 mmol)  was added to the reaction solution in 3 portions. The reaction solution was 
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heated for 24 h, then cooled to room temperature and evaporate the solvent out. The 
crude product was purified by silica gel chromatography using 
methanol/dichloromethane 5: 95 for elution to get the title compound (0.27 g) as an 
orange solid in 93% yield. 1H NMR (acetone-d6, 400 MHz): δ 7.52 (d, J = 9.4 Hz, 1H, 
Ar-H), 7.37 (d, J = 9.4 Hz, 1H, Ar-H), 4.31 – 4.29 (m, 2H, OCH2), 4.23 (br, 4H, OCH2), 
3.84 – 3.82 (m, 2H, OCH2), 3.57 (s, 4H, CH), 3.00 – 1.50 (br, 17H, BH). 13C NMR 
(acetone-d6, 100 MHz): δ 156.01, 155.62, 123.62, 121.95, 114.35, 114.26, 104.37, 102.40 
(Ar-C, CN), 73.05, 71.00, 70.14, 69.31 (OCH2), 55.09, 47.24 (CH). HRMS-ESI: m/z 
570.3495 [M-K]-, calcd. for [C16H32B18CoN2O4]- 570.3495. 
            Phthalonitrile Conjugate 3.4. A mixture of 3.1 (0.08 g, 0.46 mmol) and 
potassium carbonate (0.066 g, 0.48 mmol) in mixed solvents of acetone and chloroform 
(5:1) were refluxed at 60 °C under argon. After 20 min, [3, 3′-Co(8-C4H8O2-1,2-
C2B9H10)(1′,2′-C2B9H10)] (0.20g, 0.48 mmol)  was added to the reaction solution in 3 
portions. The reaction solution was heated for 16 h, then cooled to room temperature and 
evaporate the solvent out. It was dissolved in 50 mL ethyl acetate and washed with 10 
mL water for 3 times. The crude product in the organic layer was purified by silica gel 
chromatography using methanol/dichloromethane 1:10 for elution to get the title 
compound (0.95 g) as an orange solid in 92% yield. 1H NMR (acetone-d6, 250 MHz): δ 
7.68 (d, J = 9.5 Hz, 1H, Ar-H), 7.56 (d, J = 9.5 Hz, 1H, Ar-H), 4.34 (t, J = 4.7 Hz, 2H, 
OCH2), 4.24 (br, 4H, OCH2), 3.99 (s, 3H, OCH3), 3.84 (t, J =4.7 Hz, 2H, OCH2), 3.57 (s, 
4H, CH), 3.00 – 1.50 (br, 17H, BH). 13C NMR (acetone-d6, 63 MHz): δ 156.84, 156.34, 
121.69, 119.49, 114.03, 105.33, 104.40 (Ar-C, CN), 73.10, 71.06, 70.21, 69.35 (OCH2), 
57.45 (OCH3), 55.06, 47.26 (CH). HRMS-ESI: m/z 584.3677 [M-K]-, calcd. for 
[C17H34B18CoN2O4]- 584.3653. 
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            Phthalonitrile Conjugate 3.5. A mixture of 3.2 (0.15 g, 0.49 mmol) and 
potassium carbonate (0.066 g, 0.48 mmol) in acetone were refluxed at 60 °C under 
argon. After 20 min, [3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10)] (0.21g, 0.51 
mmol)  was added to the reaction solution in 3 portions. The reaction solution was heated 
for 24 h, then cooled to room temperature and evaporate to dry. The crude product was 
purified by silica gel chromatography using methanol/dichloromethane 5: 95 for elution 
to get the title compound (0.34 g) as an orange solid in 92% yield. 1H NMR (acetone-d6, 
250 MHz): δ 7.66–7.56 (m, 2H, Ar-H), 4.37 – 4.32 (m, 4H, OCH2), 4.21 (br, 4H, OCH2), 
3.90 – 3.83 (m, 4H, OCH2), 3.71 – 3.68 (m, 2H, OCH2), 3.62 – 3.57 (m, 8H, OCH2, CH), 
3.50 – 3.46 (m, 2H, OCH2), 3.28 (s, 3H, OCH3), 3.00 – 1.50 (br, 17H, BH). 13C NMR 
(acetone-d6, 63 MHz): δ 156.08, 155.79, 121.13, 120.77, 113.93, 113.78, 104.63, 104.56 
(Ar-C, CN), 72.76, 71.91, 70.94, 70.69, 70.42, 70.23, 69.78, 69.64, 69.08 (OCH2), 58.74 
(OCH3), 54.36, 47.00 (CH). HRMS-ESI: m/z 716.4434 [M-K]-, calcd. for 
[C23H46B18CoN2O7]- 716.4444. 
            Phthalonitrile Conjugate 3.6. A mixture of 2, 6-dihydroxyphthalonitrile (0.15 g, 
0.94 mmol) and [3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10)] (0.82g, 1.97 mmol) in 
40 mL acetone (phenol-free) were refluxed at 60 °C under argon. Potassium carbonate 
(0.27 g, 1.97 mmol) was added to the reaction solution in 3 portions every 5 min. The 
reaction solution was heated for 24 h, then cooled to room temperature and evaporate the 
solvent out. It was dissolved in 100 mL of ethyl acetate and washed with 20 mL of water 
for 3 times. The crude product in the organic layer was purified by silica gel 
chromatography using methanol/dichloromethane 1:40 for elution to get the title 
compound (0.95 g) as an orange solid in 96% yield. 1H NMR (acetone-d6, 250 MHz): δ 
7.62 (s, 2H, Ar-H), 4.34 (t, J = 5.0 Hz, 4H, OCH2), 4.22 (br, 8H, OCH2), 3.86 (t, J = 5.0 
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Hz, 4H, OCH2), 3.59 (s, 8H, CH), 3.00 – 1.50 (br, 34H, BH). 13C NMR (acetone-d6, 63 
MHz): δ 156.31, 121.20, 114.04, 105.00 (Ar-C, CN), 72.99, 70.84, 69.98, 69.27 (OCH2), 
54.91, 47.20 (CH). HRMS-ESI: m/z 489.8393 [M-2K]2-, calcd. for [C24H60B36Co2N2O6]2- 
489.8374. 
            Pc Conjugate 3.7. Phthalonitrile (1.52 g, 12.0 mmol), anhydrous zinc acetate 
(0.36 g, 2.0 mmol) and conjugated phthalonitrile 3.3 (60 mg, 0.1 mmol) were added into 
a 10 mL thick-wall Schlenk tube. The tube was dried by purge-and-refill with argon for 
three times. Then 1.0 mL of freshly distilled quinoline was added and the solution was 
heated to 220 °C. After 1 hour, the reaction residue was cooled down to room 
temperature. The solid in the solution was filtered and washed completely with acetone 
and methanol. The dark green filtrate was concentrated to dryness. The crude product 
was purified with a Sephadex LH-20 column using acetone for elution. The pure 
conjugated phthalocyanine 3.7 was obtained by reverse phase HPLC on a Luna C18 semi-
preparative column using water / acetonitrile as the mobile phase with a multi-step 
gradient method (condition c). The pure product was collected and vacuum dried at 30 °C 
for 2 days to afford a dark bluish green solid (8.0 mg) in 8% yield based on the amount of 
3.3 used. 1H NMR (d-DMF, 400 MHz): δ 9.37 – 9.03 (m, 8H, Ar-H), 8.34 – 8.12 (m, 6H, 
Ar-H), 4.52 – 4.37 (m, 8H, OCH2, CH), 4.11 – 4.05 (m, 2H, OCH2), 3.97 -3.96 (m, 2H, 
OCH2), 3.00 – 1.50 (br, 17H, BH). 13C NMR (d-DMF, 100 MHz): δ 153.36, 152.59, 
139.35, 138.80, 134.75, 134.50, 130.31, 130.15, 129.96, 129.76, 123.33, 122.96 (Ar-C), 
73.08, 71.17, 70.06, 69.44 (OCH2), 54.34, 47.28 (CH). HRMS-ESI: m/z 1019.3921 [M-
K]-, calcd. for [C40H44B18CoN8O4Zn]- 1019.3914. HPLC: tR = 5.873 min. UV-vis 
(DMSO): λmax (log ε) 706 (5.09). 
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            Pc Conjugate 3.8. Phthalonitrile (0.76 g, 6.0 mmol), anhydrous zinc acetate (90 
g, 0.5 mmol) and conjugated phthalonitrile 3.4 (30 mg, 0.05 mmol) were added into a 10 
mL thick-wall Schlenk tube. The tube was dried by purge-and-refill with argon for three 
times. Then 0.5 mL freshly distilled quinoline was added and the solution was heated to 
220 °C. After 1 hour, the reaction residue was cooled down to room temperature. The 
solid in the solution was filtered and washed completely with acetone and methanol. The 
dark green filtrate was concentrated to dryness. The crude product was purified with a 
Sephadex LH-20 column using acetone for elution. The crude product and potassium 
carbonate (22 mg, 0.16 mmol) was dissolved in 10 mL of acetone with argon flow. After 
10 min, methyl iodide (0.01 mL, 0.16 mmol) was added dropwise into the solution. The 
solution was stirred at room temperature in the sealed system. The reaction was followed 
by ESI-MS until the disappearance of the peak of the demethylation byproduct. One day 
later, the solvent was evaporated out and another Sephadex LH-20 column was applied to 
get the crude product with the elution of acetone. The pure conjugated Pc 3.8 was 
obtained by reverse phase HPLC on a Luna C18 semi-preparative column using water / 
acetonitrile as the mobile phase with a multi-step gradient method (condition a). The pure 
product was collected and vacuum dried at 30 °C for 2 days to afford a dark bluish green 
solid (6.5 mg) in 12% yield based on the amount of 3.4 used. 1H NMR (d-DMF, 400 
MHz): δ 9.35 (br, 6H, Ar-H), 8.23-8.22 (m, 6H, Ar-H), 7.61 (br, 2H, Ar-H), 4.96 (br, 2H, 
OCH2), 4.60 (s, 3H, OCH3), 4.49 (t, J = 4.7 Hz, 2H, OCH2), 4.41 (s, 2H, CH), 4.37 (s, 
2H, CH), 4.06 (t, J = 5.4 Hz, 2H, OCH2), 3.97 (t, J = 5.4 Hz, 2H, OCH2), 3.00 – 1.50 (br, 
17H, BH).  13C NMR (d-DMF, 100 MHz): δ 154.08, 153.78, 153.65, 152.26, 151.07, 
139.25, 139.05, 130.11, 129.90, 129.77, 123.37, 122.95, 117.09, 115.21 (Ar-C), 72.98, 
71.21, 70.42, 69.39 (OCH2), 57.49 (OCH3), 54.27, 47.27 (CH). HRMS-ESI: m/z 
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1033.4076 [M-K]-, calcd. for [C41H46B18CoN8O4Zn]- 1033.4071. HPLC: tR = 4.693 min. 
UV-vis (acetone): λmax (log ε) 684 (5.26), 618 (4.49); UV-vis (DMSO): λmax (log ε) 695 
(5.20), 627 (4.50). 
            Pc Conjugate 3.9. Phthalonitrile (0.76 g, 6.0 mmol), anhydrous zinc acetate (90 
mg, 0.5 mmol) and conjugated phthalonitrile 3.5 (38 mg, 0.05 mmol) were added into a 
10 mL thick-wall Schlenk tube. The tube was dried by purge-and-refill with argon for 
three times. Then 0.5 mL freshly distilled quinoline was added and the solution was 
heated to 220 °C. After 1 hour, the reaction residue was cooled down to room 
temperature. The solid in the solution was filtered and washed completely with acetone 
and methanol. The dark green filtrate was concentrated to dryness. The crude product 
was purified on a Sephadex LH-20 column using acetone for elution. The pure 
conjugated Pc 3.9 was obtained by reverse phase HPLC on a Luna C18 semi-preparative 
column using water / acetonitrile as the mobile phase with a multi-step gradient method 
(condition c). The pure product was collected and vacuum dried at 30 °C for 2 days to 
afford a dark bluish green solid (10.0 mg) in 17% yield based on the amount of 3.5 used. 
1H NMR (d-DMF, 400 MHz): δ 9.44 (br, 6H, Ar-H), 8.25 (br, 6H, Ar-H), 7.76 (br, 2H, 
Ar-H), 5.00 (br, 4H, OCH2), 4.51 – 4.47 (m, 4H, OCH2), 4.38 (s, 2H, CH), 4.35 (s, 2H, 
CH), 4.11 (t, J = 5.0 Hz, 2H, OCH2), 4.06 (t, J = 5.1 Hz, 2H, OCH2), 3.96 (t, J = 5.3 Hz, 
2H, OCH2), 3.82 (t, J = 4.9 Hz, 2H, OCH2), 3.65 (t, J = 4.8 Hz, 2H, OCH2), 3.57 (br, 2H, 
OCH2), 3.22 (s, 3H, OCH3), 3.00 – 1.50 (br, 17H, BH).  13C NMR (d-DMF, 100 MHz): δ 
154.32, 154.10, 153.95, 153.68, 153.65, 151.66, 151.55, 139.52, 139.14, 130.25, 129.98, 
129.90, 128.15, 127.91, 127.74, 123.54, 123.11, 123.01, 117.35 (Ar-C), 73.02, 72.40, 
71.54, 71.25, 71.20, 70.92, 70.86, 70.60, 69.40(OCH2), 58.58 (OCH3), 54.24, 47.26 
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(CH). HRMS-ESI: m/z 1165.4859 [M-K]-, calcd. for [C47H58B18CoN8O7Zn]- 1165.4862. 
HPLC: tR = 4.523 min. UV-vis (DMSO): λmax (log ε)  695 (5.19), 626 (4.47). 
            Pc Conjugate 3.10. Phthalonitrile (0.76 g, 6.0 mmol), anhydrous zinc acetate (90 
mg, 0.5 mmol) and conjugated phthalonitrile 3.6 (50 mg, 0.05 mmol) were added into a 
10 mL thick-wall Schlenk tube. The tube was dried by purge-and-refill with argon for 
three times. Then 0.5 mL freshly distilled quinoline was added and the solution was 
heated to 220 °C. After 1 hour, the reaction residue was cooled down to room 
temperature. The solid in the solution was filtered and washed completely with acetone 
and methanol. The dark green filtrate was concentrated to dryness. The crude product 
was purified on a Sephadex LH-20 column using acetone for elution. The pure 
conjugated phthalocyanine 3.10 was obtained by reverse phase HPLC on a Luna C18 
semi-preparative column using water / acetonitrile as the mobile phase with a multi-step 
gradient method (condition c). The pure product was collected and vacuum dried at 30 °C 
for 2 days to afford a dark bluish green solid (11.3 mg) in 15% yield based on the amount 
of 3.6 used. 1H NMR (d-DMF, 250 MHz): δ 9.55-9.45 (m, 6H, Ar-H), 8.34-8.26 (m, 6H, 
Ar-H), 7.81 (br, 2H, Ar-H), 5.03-4.99 (m, 4H, OCH2), 4.54-4.50 (m, 4H, OCH2), 4.39 (s, 
4H, CH), 4.36 (s, 4H, CH), 4.08 (t, J = 5.2 Hz, 4H, OCH2), 3.98 (t, J = 5.2 Hz, 4H, 
OCH2), 3.00 – 1.50 (br, 34H, BH). 13C NMR (d-DMF, 63 MHz): δ 154.26, 154.12, 
153.98, 153.77, 151.57, 139.67, 139.21, 130.13, 129.79, 123.46, 123.03, 122.93, 117.12 
(Ar-C), 72.98, 71.27, 70.49, 69.34 (OCH2), 54.15, 47.24 (CH). HRMS-ESI: m/z 
1430.7214 [M-2K+H]-, calcd. for [C48H73B36Co2N8O6Zn]- 1430.7214. HPLC: tR = 6.040 
min. UV-vis (acetone): λmax (log ε) 686 (5.36), 618 (4.62); UV-vis (DMSO): λmax (log ε) 
695 (5.12), 626 (4.41). 
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            Phthalonitrile 3.11. 3-Nitrophthalonitrile (1.5 g, 8.7 mmol) and 3-
hydroxypyridine (1.5 g, 15.8 mmol) were dissolved in dry DMF (30 mL). Potassium 
carbonate (20 g, 14.5 mmol) was added to the solution in five portions. The reaction was 
heated at 90 °C for 4 hours. After the reaction, the solution was cooled down to room 
temperature and poured to ice water (500 mL) to get precipitate. The crude product was 
further purified by alumina column with elution of methanol/DCM (5/95) to afford earth 
pink solid (1.4 g, 74%). 1H NMR (CD2Cl2, 250 MHz): δ 8.54 – 8.48 (m, 2H, Ar-H), 7.70 
– 7.44 (m, 4H, Ar-H), 7.15 – 7.12 (m, 1H, Ar-H). 13C NMR (CD2Cl2, 63 MHz): δ 160.16, 
151.10, 147.58, 142.71, 135.29, 128.30, 127.86, 125.10, 121.16, 117.67, 115.43, 112.91, 
106.84 (Ar-C, CN). MS (MALDI-TOF) m/z 221.946 M+, calcd. for C13H7N3O  221.059. 
            Phthalonitrile Conjugate 3.12. A mixture of phthalonitrile 3.11 (0.1 g, 0.45 
mmol) in acetone (50 mL) were refluxed at 50 °C under argon. [3, 3′-Co(8-C4H8O2-1,2-
C2B9H10)(1′,2′-C2B9H10)] (0.2 g, 0.48 mmol) was added to the reaction solution in 3 
portions. The reaction solution was heated for 1 day, then cooled to room temperature 
and evaporated to dry. The crude product was purified by silica gel chromatography 
using methanol/DCM 5: 95 for elution to get the title compound as a yellow solid (0.3 g, 
94%). 1H NMR (acetone-d6, 250 MHz): δ 9.34 – 9.28 (m, 2H, Ar-H), 8.69 – 8.66 (m, 1H, 
Ar-H), 8.35 – 8.29 (m, 1H, Ar-H), 8.05 – 7.96 (m, 2H, Ar-H), 7.83 – 7.79 (m, 1H, Ar-H), 
5.01 (t, J = 4.4 Hz, OCH2), 4.13 – 4.06 (m, 4H, OCH2), 3.94 (br, 2H, OCH2), 3.64 (s, 4H, 
CH), 3.00 – 1.50 (br, 17H, BH). 13C NMR (acetone-d6, 63 MHz): δ 158.15, 155.06, 
143.84, 138.80, 137.03, 131.24, 130.21, 124.39, 118.17, 115.76, 113.03, 108.84 (Ar-C, 
CN), 73.32, 69.75, 69.70, 63.08, 52.73, 47.35 (OCH2, CH). HRMS-ESI: m/z 631.3981 
[M-H]-, calcd. for [C21H36B18CoN3O3]- 631.3815. 
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            Phthalonitrile Conjugate 3.13. A mixture of 4,5-bis(pyridin-3-
yloxy)phthalonitrile 2.1 (0.1 g, 0.3 mmol) in acetone (50 mL) were refluxed at 50 °C 
under argon. [3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10)] (0.27g, 0.65 mmol)  was 
added to the reaction solution in 3 portions. The reaction solution was followed by TLC 
and heated for 3 days, then cooled to room temperature and evaporate to dry. The crude 
product was purified by silica gel chromatography using methanol/ethyl acetate 5: 95 for 
elution to get a yellow solid (0.3 g, 85%). 1H NMR (acetone-d6, 300 MHz): δ 9.38 (s, 2H, 
Ar-H), 9.27 (d, J = 4.8 Hz, 2H, Ar-H), 8.63 – 8.59 (m, 2H, Ar-H), 8.32 – 8.27 (m, 2H, 
Ar-H), 8.21 (s, 2H, Ar-H), 4.99 (br, 4H, OCH2), 4.10 (br, 4H, OCH2), 4.04 (br, 4H, 
OCH2), 3.92 (br, 4H, OCH2), 3.66 (s, 8H, CH), 3.00 – 1.50 (br, 34H, BH). 13C NMR 
(acetone-d6, 75 MHz): δ 154.80, 149.91, 143.54, 138.39, 136.36, 130.21, 127.07, 115.09, 
114.71 (Ar-C, CN), 73.35, 69.72, 69.63, 62.88, 52.51, 47.32 (OCH2, CH). HRMS-ESI: 
m/z 1134.7528 [M-2K+H]-, calcd. for 1134.7353 [C34H67B36Co2N4O6]-. 
            Phthalonitrile 3.14. 3-Nitrophthalonitrile (1.5 g, 8.7 mmol) and 4-
methoxyphenol (1.6 g, 12.9 mmol) were dissolved in dry DMF (30 mL). Potassium 
carbonate (20 g, 14.5 mmol) was added to the solution in five portions. The reaction was 
heated at 90 °C for 2 hours. After the reaction, the solution was cooled down to room 
temperature and poured to ice water (500 mL) to get precipitate. The crude product was 
further purified by alumina column with elution of DCM to afford white solid (1.8 g, 
83%). 1H NMR (CDCl3, 250 MHz): δ 7.54 (t, J = 8.2 Hz, 1H, Ar-H), 7.39 (d, J = 7.6 Hz 
1H, Ar-H), 7.02 – 6.90 (m, 5H, Ar-H), 3.80 (s, 3H, Ar-H). 13C NMR (CDCl3, 63 MHz): δ 
161.53, 157.51, 146.70, 134.43, 126.47, 121.60, 119.69, 116.86, 115.34, 115.13, 112.78, 
105.11 (Ar-C, CN), 55.59 (OCH3). MS (MALDI-TOF) m/z 250.934 M+, calcd. for 
C15H10N2O2  250.074. 
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            Phthalonitrile 3.15. Method A. Hydroquinone (1.0 g, 9 mmol) and potassium 
carbonate (1.6 g, 11.6 mmol) were dissolved in anhydrous DMF (30 mL) under argon 
flow. The solution was heated to 50 ºC. 3-Nitrophthalonitrile (1 g, 5.8 mmol) was 
dissolved in DMF (2 mL) and the solution was injected into the solution through syringe. 
The reaction solution was remained at 50 ºC for two hours and stirred at room 
temperature for two days. After the reaction the solvent was evaporated to dry. 1 N 
hydrochloride solution (30 mL) was added to the residue and the precipitate was filtered 
and washed with water. It was dissolved in acetone (50 mL) and dried over anhydrous 
sodium sulfate. The crude product was purified by chromatography on silica column with 
elution of DCM/methanol (95/5) to afford white solid (0.3 g, 22%). Method B. 
Procedure was silimar to that described as method B for 3.19, 40% yield was obtained. 
1H NMR (acetone-d6, 250 MHz): δ 8.75 (br, 1H, OH), 7.79 (t, J = 4.3 Hz, 1H, Ar-H), 
7.68 – 7.65 (m, 1H, Ar-H), 7.20 – 7.16 (m, 1H, Ar-H), 7.10 – 7.07 (m, 2H, Ar-H), 6.96 – 
6.92 (m, 2H, Ar-H). 13C NMR (acetone-d6, 63 MHz): δ 162.59, 156.44, 147.18, 136.16, 
127.83, 122.64, 121.14, 117.60, 117.38, 116.22, 113.87, 105.63 (Ar-C, CN). HRMS-ESI: 
m/z 237.0655 [M+H]+, calcd. for [C14H9N2O2]+ 237.0658. 
            Phthalonitrile Conjugate 3.16. A mixture of phthalonitrile 3.15 (0.1 g, 0.41 
mmol) and potassium carbonate (61.5 mg, 0.46 mmol) in acetone (50 mL) were refluxed 
at 50 °C under argon. After 20 min, [3, 3′-Co(8-C4H8O2-1,2-C2B9H10)(1′,2′-C2B9H10)] 
(0.18 g, 0.43 mmol)  was added to the reaction solution in 3 portions. The reaction 
solution was heated for 1 day, then cooled to room temperature and evaporated to dry. 
The crude product was purified by silica gel chromatography using methanol/DCM 5: 95 
for elution to get a yellow solid (0.24 g, 94%). 1H NMR (acetone-d6, 400 MHz): δ 7.81 – 
7.77 (m, 1H, Ar-H), 7.68 – 7.66 (m, 1H, Ar-H), 7.22 – 7.16 (m, 3H, Ar-H), 7.09 – 7.07 
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(m, 2H, Ar-H), 4.25 (br, 4H, OCH2), 4.16 (t, J = 4.8 Hz, 2H, OCH2), 3.82 (t, J = 4.8 Hz, 
2H, OCH2), 3.59 (s, 4H, CH), 3.00 – 1.50 (br, 34H, BH). 13C NMR (acetone-d6, 100 
MHz): δ 162.39, 157.97, 148.14, 136.21, 127.94, 122.49, 121.36, 117.34, 117.13, 116.20, 
113.83, 105.72 (Ar-C, CN), 72.85, 70.12, 69.27, 68.98 (OCH2), 55.15, 47.22 (CH). 
HRMS-ESI: m/z 646.3819 [M-K]-, calcd. for 646.3812 [C22H36B18CoN2O4]-. 
            Phthalonitrile 3.17. 3, 6-Dihydroxyphthalonitrile (0.5 g, 2.5 mmol) and 4-
benzyloxyphenol (1.1 g, 5.5 mmol) were dissolved in DMF (15 mL). Potassium 
carbonate (4.8 g, 34.8 mmol) was added into the solution in five portions and the reaction 
solution was heated to 80 °C. After 3 hours, the reaction solution was cooled to room 
temperature and the solution was poured into ice water and the solid was filtered. The 
crude product was purified with silica column eluted with DCM/hexane (4/1) to afford 
the white solid (0.65 g, 48%). 1H NMR (CD2Cl2, 250 MHz): δ 7.46 – 7.40 (m, 10H, Ar-
H), 7.13 (s, 2H, Ar-H), 7.08 (br, 8H, Ar-H), 5.11 (s, 4H, OCH2). 13C NMR (CD2Cl2, 63 
MHz): δ 157.14, 152.80, 147.81, 137.20, 128.97, 128.48, 127.97, 121.82, 121.17, 116.90, 
115.74, 110.17 (Ar-C, CN), 70.95 (OCH2). MS (MALDI-TOF) m/z 525.697 [M+H] +, 
calcd. for C34H25N2O4  525.181. 
            Phthalonitrile 3.18. 4,5–Dichlorophthalonitrile (1 g, 5.1 mmol) and 4-
methoxyphenol (2.5 g, 20.1 mmol) were dissolved in dry DMF (30 mL). The reaction 
solution was heated to 80 °C. Potassium carbonate (7.4 g, 53.6 mmol) was added into the 
solution in six portions every five minutes. After three hours, the reaction solution was 
cooled to room temperature and the solution was poured into ice water (500 mL) and the 
solid was filtered. The crude product was purified with alumina column eluted with 
DCM/hexane (3/1) to afford the white floppy solid (1.1 g, 58%). 1H NMR (CDCl3, 250 
MHz): δ 7.03 – 6.97 (m, 10H, Ar-H), 3.82 (s, 6H, OCH3). 13C NMR (CDCl3, 63 MHz): δ 
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157.99, 152.84, 147.50, 121.82, 120.96, 115.89, 115.75, 110.04 (Ar-C, CN), 56.07 
(OCH3). MS (MALDI-TOF) m/z  371.967 M+, calcd. for C22H16N2O4  372.110. 
            Phthalonitrile 3.19. Method A. Phthalonitrile 3.17 (0.2 g, 0.38 mmol) and 10% 
palladium on charcoal (0.02 g) was put in a 100 mL three-neck Schlenk flask and the 
flask was degassed for three times. DCM (25 mL) was injected into the flask and the 
hydrogen filled balloon was connected to the flask. The reaction solution was stirred at 
room temperature for 2 days. After the reaction, the solution was filtered through a celite 
cake under vacuum. The solution was evaporated to dry and purified by chromatography 
with silica gel eluted with DCM/methanol (95/5) to afford white solid (0.06 g, 46%). 
Method B. Phthalonitrile 3.18 (1.5 g, 4 mmol) was dissolved in freshly distilled DCM 
(50 mL). The reaction solution was stirred at -80 °C. Boron tribromide (0.8 mL, 8.5 
mmol) in DCM (20 mL) was added dropwise in 10 min through an additional funnel. The 
reaction solution was kept at -80 °C for one hour and continued to stir at room 
temperature for 24 hours. The reaction solution was poured into 200 mL ice water slowly. 
The precipitate was dissolved in 300 mL ethyl acetate and extracted with 100 mL 2N 
sodium hydroxide solution. It is neutralized with 1 N hydrochloride solution and 
extracted with 300 mL ether. The organic layer was dried over anhydrous sodium sulfate. 
The crude product was purified by chromatography on silica column with elution of 
methanol/DCM (10/90) to afford yellow solid (0.4 g, 29%). Method C. Procedure was 
silimar to that described as method A for 3.15, 15% yield was obtained.  1H NMR 
(acetone-d6, 250 MHz): δ 7.13 (s, 2H, Ar-H), 7.02 (d, J = 8.9 Hz, 4H, Ar-H), 6.91 (d, J = 
8.9 Hz, 4H, Ar-H). 13C NMR (acetone-d6, 63 MHz): δ 168.59, 155.50, 154.57, 148.69, 
128.37, 121.75, 117.34, 112.29 (Ar-C, CN).  
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            Phthalonitrile 3.20. 3 - Nitrophthalonitrile (1 g, 5.8 mmol) was dissolved in DMF 
(15 mL). 4-Hydroxy-benzyl alcohol (1.1 mg, 8.9 mmol) and potassium carbonate (5 g, 36 
mmol) were added into the solution. The reaction solution stirred at room temperature for 
15 hours. The reaction solution was concentrated. The residue was poured into mild 
acidic hydrochloric solution (pH = 5, 300 mL). The solid was filtered and washed with 
water. The crude product was purified with alumina column eluted with ethyl 
acetate/hexane (10/1) to afford the white floppy solid (0.4 g, 28%).1H NMR (d-acetone, 
400 MHz): δ 7.85 – 7.81 (m, 1H, Ar-H), 7.73 – 7.71 (m, 1H, Ar-H), 7.50 (d, 2H, J = 8.6 
Hz, Ar-H), 7.27 – 7.24 (m, 1H, Ar-H), 7.20 (d, 2H, J = 8.6 Hz, Ar-H), 4.67 (s, 2H, CH2), 
4.33 (br, 1H, OH). 13C NMR (d-acetone, 100 MHz): δ 161.67, 154.04, 141.33, 136.24, 
129.46, 128.47, 122.21, 120.80, 117.60, 116.17, 113.76, 106.61 (Ar-C, CN), 63.92 (CH2). 
HRMS-ESI: m/z 233.0708 [M-OH] +, 273.0634 [M+Na] +, calcd. for C15H9N2O  
233.0709, C15H10N2O 2Na 273.0634. 
            Phthalonitrile 3.21. 3, 6-Dihydroxyphthalonitrile (2 g, 12.5 mmol) and 1-
(bromomethyl)-3-methoxybenzene (5.2 mL, 36 mmol) were dissolved in DMF (60 mL). 
Potassium carbonate (7 g, 51 mmol) was added into the solution in five portions and the 
reaction solution was heated to 60 °C. After ten hours, the reaction solution was cooled to 
room temperature and the solution was poured into ice water and the solid was filtered. 
The crude product was purified with alumina column eluted with DCM/hexane (3/2) to 
afford the white floppy solid (4.78 g, 98%). 1H NMR (CD2Cl2, 300 MHz): δ 7.34 – 7.29 
(m, 1H, Ar-H), 7.19 (s, 1H, Ar-H), 7.01 – 6.98 (m, 2H, Ar-H), 6.90 – 6.87 (m, 1H, Ar-H), 
5.17 (s, 2H, OCH2), 3.81 (s, 3H, OCH3). 13C NMR (CD2Cl2, 75 MHz): δ 160.44, 155.25, 
137.11, 130.24, 119.65, 114.31, 113.49, 113.00, 106.03 (Ar-C, CN), 72.00 (OCH2), 55.62 
(OCH3). 
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            Phthalonitrile 3.22. 3-nitrophthalonitrile (2 g, 11.6 mmol) and N-Boc-4-
aminophenol (3.6 g, 17 mmol) were dissolved in DMF (30 mL). Potassium carbonate (25 
g, 0.18 mol) was added into the solution in five portions and the reaction solution was 
heated to 80 °C. After 2 hours, the reaction solution was cooled to room temperature and 
the solution was poured into ice water and the solid was filtered. The crude product was 
purified with alumina column eluted with DCM to afford the white solid (3.1 g, 80%).1H 
NMR (acetone-d6, 250 MHz): δ 8.58 (br, 1H, NH), 7.80 (t, J = 8.2 Hz, 1H, Ar-H), 7.70 -
7.66 (m, 3H, Ar-H), 7.25 – 7.14 (m, 3H, Ar-H), 1.48 (s, 9H, C(CH3)3). 13C NMR 
(acetone-d6, 63 MHz): δ 162.06, 153.67, 149.42, 138.63, 136.15, 128.07, 121.68, 121.52, 
120.68, 117.39, 116.15, 113.77, 105.94 (Ar-C, CN), 80.21, 28.42 (C(CH3)3). HRMS-ESI: 
m/z 336.1340 [M+H]+, calcd. for [C19H18N3O3]+ 336.1342; 353.1604 [M+H2O]+, calcd. 
for [C19H19N3O4]+ 353.1376; 358.1163 [M+Na]+, calcd. for [C19H17N3O3Na]+ 358.1168. 
            Phthalonitrile 3.23. Method A. Phthalonitrile 3.22 (2 g, 6.0 mmol) was 
dissolved in mixed solvents of DCM (50 mL) and TFA (10 mL). The reaction solution 
was stirred at room temperature for three hours. After the reaction the solvent was 
evaporated to dry. 1 N sodium hydroxide solution (30 mL) was added to the residue and 
white precipitate was out. The solid was filtered and dissolved in ethyl acetate (200 mL). 
The organic solution was washed with 1 N sodium hydroxide solution (20 mL, × 1) and 
brine (20 mL, × 2) and dried over anhydrous sodium sulfate. The crude product was 
purified by chromatography on alumina column with elution of DCM/methanol (98/2) to 
afford white solid (1.3 g, 90%). Method B. Procedure was silimar to that described as for 
3.24, 75% yield was obtained.  1H NMR (acetone-d6, 250 MHz): δ 7.78 (t, J = 8.2 Hz, 
1H, Ar-H), 7.63 (d, J = 7.6 Hz, 1H, Ar-H), 7.16 (d, J = 8.6 Hz, 1H, Ar-H), 6.94 (d, J = 8.8 
Hz, 2H, Ar-H), 6.76 (d, J = 8.8 Hz, 2H, Ar-H), 4.81 (br, 2H, NH2). 13C NMR (acetone-d6, 
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63 MHz): δ 163.08, 147.86, 145.09, 136.08, 127.50, 122.26, 120.90, 117.28, 116.28, 
116.20, 114.00, 105.26 (Ar-C, CN). HRMS-ESI: m/z 236.0813 [M+H]+, calcd. for 
[C14H10N3O]+ 236.0818. 
            Phthalonitrile 3.24. 4,5–Dichlorophthalonitrile (0.5 g, 2.5 mmol) and 4-
aminophenol (0.56 g, 5.1 mmol) were dissolved in anhydrous DMF (10 mL) and heated 
to 60 °C. Potassium carbonate (2.3 g, 16.7 mmol) was added into the solution in six 
portions every five minutes. After one day, the reaction solution was cooled to room 
temperature and the solution was poured into ice water (500 mL) and the solid was 
filtered. The crude product was purified with alumina column eluted with DCM/hexane 
(5/1) and methanol/DCM (2/98) to afford the yellow solid (0.57 g, 66%). 1H NMR 
(CD2Cl2, 250 MHz): δ 7.08 (s, 2H, Ar-H), 6.92 (d, J = 8.8 Hz, 4H, Ar-H), 6.74 (d, J = 8.8 
Hz, 4H, Ar-H), 3.83 (br, 4H, NH2). 13C NMR (CD2Cl2, 63 MHz): δ 153.19, 145.65, 
145.53, 121.91, 120.44, 116.62, 116.02, 109.58 (Ar-C, CN). HRMS-ESI: m/z 343.1189 
[M+H]+, calcd. for [C20H15N4O2]+ 343.1189. 
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CHAPTER 4 
 
 
SYNTHESES OF A SERIES OF HYDROXY-SUBSTITUTED ZINC 
PHTHALOCYANINES 
 
 
4.1       Background 
            Pcs are well-known of their high tendency for aggregation in organic solvents and 
aqueous solution. As a result, they can be modified by appropriate substituents1, 2 in order 
to diminish their tendency for aggregation in solution. Some hydrophilic groups such as 
sulfonic acid, carboxylic acid and hydroxyl groups3-7 have been introduced to the Pc 
macrocycles in order to increase the amphiphilicity of Pc and promote the permeability of 
cell membranes. Meso-tetrahydroxyphenyl chlorin (mTHPC) is a second-generation PDT 
photosensitizer which shows higher photosensitizing efficiency than Photofrin®, an FDA-
approved PDT photosensitizer. mTHPC has been applied in the treatment of early 
prostate cancer and is currently undergoing Phase II trials.2, 8-11 Leznoff and van Lier 
reported that hydroxyl-substituted Pcs were also potential PDT agents in 1998.12 In this 
Chapter, we report the syntheses and characterization of octa, tetra and dihydroxy-
substituted zinc Pcs. 
4.2       Synthesis of Octahydroxy-substituted Zinc Phthalocyanines             
            Octahydroxy-substituted zinc Pc can be synthesized using two strategies. The first 
synthetic strategy is shown in Scheme 4.1. 4,5-Di-(2,5-di-tert-butyl-4-methoxy)-
phthalonitrile 4.1 was synthesized using a previously published procedure13 involving 
heating 4,5-dichlorophthalonitrile and 2,5-di-tert-butyl-4-methoxyphenol in dry DMF in 
the presence of potassium carbonate, but using a longer reaction time 40 h instead of 3 h. 
The reaction was followed by 1H NMR until complete disappearance of the mono-
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substituted phthalonitrile which is indicated by the missing of its characteristic chemical 
shift at 7.899 ppm.             
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Scheme 4.1. Synthesis of octa(4-methoxyphenyl)-substituted Pcs. 
            Two different methods were investigated for the cyclotetramerization reaction of 
phthalonitrile 4.1 (Scheme 4.1). The method using NMP as a solvent was investigated 
first.13, 14 The precursor 4.1 was dissolved in dry NMP, excess of anhydrous zinc acetate 
was added and the reaction solution was heated to 150 ºC under argon for 1 day. The 
solid was filtered and purified by chromatography on silica gel column affording Pc 4.3 
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in 9% yield. In the second method, precursor 4.1 was treated with lithium in dry pentanol 
at 135 ºC. It was refluxed for 3 hours, then zinc acetate was added to the solution and it 
was refluxed for another 15 hours. The solid was washed with mixed solvents of 
methanol and water 3 times after the removal of pentanol. Then it was extracted with 
hexane and further purified by silica gel column chromatography, using hexane/DCM 
(2:1) for elution. The yield of this reaction was increased to 31% after purification. The 
free-base Pc 4.2 was isolated in 30% yield by work up with acetic acid after the 
cyclotetramerization with lithium in dry pentanol and the zinc complex 4.3 was obtained 
in quantitative yield upon metallation of Pc 4.2 using ZnBr2 in DMF.    
          
 
                               (a)                                                                  (b) 
Figure 4.1. (a) Top view of single crystal structure of Pc 4.3; (b) side view of single 
crystal structure of Pc 4.3. 
 
            The zinc complex 4.3 is very soluble in many organic solvents such as DCM, 
acetone, THF, hexane while slightly soluble in methanol. A suitable crystal for X-ray 
analysis was obtained by slow diffusion of methanol into chloroform. Figure 4.1 shows 
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the structure of Pc 4.3. From the top view, we can observe that the peripheral phenyl 
rings are perpendicular to the plane of the Pc macrocycle to minimize steric hindrance. 
From the side view, we can observe that the macrocycle core is planar with zinc metal 
occupying the inner core of the Pc. The zinc metal may coordinate with one water 
molecule, which may come from the solvents used for purification. The bulky tert-butyl 
groups might minimize the aggregation of this compound in solution which probably 
explains the large extinction coefficient of 3.0×105 (L.mol-1.cm-1) observed for this Pc at 
678.45 nm in acetone. 
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                          4.3                                                                                 4.5                                      
Scheme 4.2. Synthesis of octahydroxy-substituted zinc Pc. 
            Various methods including BBr3,15, 16 BBr3·SMe2,17 Py·HCl18 and TMSI19, 20 
were investigated for the demethylation reaction. Unfortunately, none of these methods 
led to the desired product, Pc 4.5, in reasonable yield. Boron tribromide as a Lewis acid 
was investigated for the deprotection of the methoxyl groups in dry DCM at -78 ºC in an 
argon atmosphere.15, 16 The butyl groups at the phenyl rings were found to be cleaved 
under these acidic conditions, as indicated by the MALDI-TOF mass spectrum. Although 
the product could be isolated by column chromatography followed by preparative TLC, 
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only about 1% yield was obtained. Boron tribromide dimethylsulfide complex17 was also 
tried under the same condition used with boron tribromide, but no desired product was 
observed, as indicated by MALDI-TOF mass spectrometry after 2 days. Other methods, 
using pyridine hydrochloride18 and iodotrimethylsilane19, 20 for the deprotection of the 
methoxyl groups didn’t work here either. Finally, sodium ethanethiolate was used to do 
the demethylation,21, 22 as shown in Scheme 4.2. A mixture of Pc 4.3 and excess sodium 
ethanethiolate was heated in dry DMF at 135 ºC for 1 day under an argon atmosphere. 
The reaction was followed by MALDI-TOF mass spectrometry. After the reaction, the 
solution was poured into water and extracted with ethyl acetate to obtain the crude Pc 4.5 
product. Pure Pc 4.5 was obtained after purification with Sephadex LH-20 and HPLC 
using methanol as the isocratic solvent system. However, the yield was only 25% and 
partial debenzylation as a side reaction was observed to occur under these conditions.  
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                                          4.4                                                                 4.5 
Scheme 4.3. Synthesis of octahydroxy-substituted zinc Pc.  
            Therefore, the first strategy to synthesize octahydroxy-substituted zinc Pc 
involved three steps and afforded the target product in 5% overall yield. In order to avoid 
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the troublesome demethylation step, I investigated another methodology, as shown in 
Scheme 4.3. The synthesis started with the reaction of 2,5-di-tert-butyl-hydroquinone and 
4, 5-dichlorophthalonitrile (Scheme 4.3). 4,5-Bis (2,5-di-tert-butyl-4-hydroxyphenoxy)-
phthalonitrile 4.4 was obtained in 27% yield. In this reaction, no side products of trimer 
or dimer were observed (Figure 4.2). It is probably due to the large steric hindrance of the 
two butyl groups at the hydroquinone moiety. The following macrocyclization reation 
using lithium metal afforded the target Pc 4.5 in 9% yield. This two-step synthesis has an 
overall yield of 2% which is similar to that of the first strategy investigated, but involves 
one less step and can be completed in a shorter time period. 
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                                        (a)                                                                     (b) 
Figure 4.2.  Possible side products of phthalonitrile 4.4: (a) trimer and (b) dimer. 
 
            The octahydroxy-substituted zinc Pc 4.5 is soluble in polar solvents such as 
acetone, methanol, acetonitrile, DMF and DMSO. It is also soluble in some nonpolar 
solvents such as DCM and THF because of the presence of sixteen hydrophobic tert-butyl 
groups at the Pc’s periphery. Figure 4.3 shows the 1H NMR of Pc 4.5 in d-acetone at 250 
MHz. The peak (singlet) at 8.8 ppm is due to the protons at the Pc’s backbone and the 
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peaks (doublet) at 7.06 ppm and 7.03 ppm are due to the protons on the phenyl rings at 
the periphery of the Pc.            
             
Figure 4.3. 1H NMR of Pc 4.5 in d-acetone at 250 MHz. 
            The broad peak at 8.1 ppm is due to the hydroxyl groups on the phenyl rings. The 
upfield peaks at 1.5 ppm and 1.3 ppm are due to two sets of butyl groups attached to the 
phenyl rings. Pc 4.5 has a strong Q absorption peak in its UV-vis spectrum with an 
extinction coefficient of 1.1×105 (L.mol-1.cm-1) at 678.7 nm in acetone (Figure 4.4).  
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Figure 4.4.  Absorption spectrum of Pc 4.5 in acetone at 2 µM. 
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4.3       Synthesis of Tetrahydroxy-Substituted Zinc Phthalocyanines             
            3-Substituted phthalonitrile 4.6 was synthesized from 3-nitrophthalonitrile and 
2,5-di-ertbutylhydroquinone in the presence of potassium carbonate in 38% yield 
(Scheme 4.7). The single crystal structure of phthalonitrile 4.6 is shown in Figure 4.7. 
The yield is unexpectedly low because of  a side reaction leading to the dimer species 4.7 
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Scheme 4.7. Synthesis of Pc 4.8. 
 (Figure 4.8) in 46% yield. Figure 4.9 shows the two independent molecules in the crystal 
structure. This dimeric side product is a good starting material to synthesize Pc-dimer 
species. 
 
 Figure 4.7. Single crystal X-ray structure of phthalonitrile 4.6.  
 104
NC CN
O O
NC CN
 
Figure 4.8. Molecular structure of dimer 4.7                                                                   
 
                                                                                                                             
Figure 4.9. Single crystal X-ray structure of dimer 4.7. 
 
            Macrocyclization of monosubstituted phthalonitrile can result in a mixture of four 
constitutional isomers with C4h, Cs, C2v, D2h molecular symmetry (Figure 4.10). The 
separation has been done by Hanack and his coworker using high pressure liquid 
chromatography.23, 24 They stated that the isomer distribution of tetra-α-substituted metal 
Pc depends on the nature of the substituent, reaction condition and metal center.25 The 
first trial using lithium in pentanol at 140 ºC leads to all possible isomers. However, only 
C4h as the major isomer can be collected after chromatography  purification.  The  method 
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Figure 4.10. Four possible constitutional isomers for tetrahydroxy-substituted Pc. 
 
to decrease the reaction temperature and increase the reaction time can favor the 
production of C4h isomer when the bulky substituent is at the α position.26 The second 
trial using lithium in octanol at 70 ºC for 24 hours led to cleaner products and less 
isomers. Two green bands were observed on the preparative alumina TLC plate, but only 
the more polar band as the major product was able to be collected and characterized.  
            From the spectrum of 1H NMR in deuterated DMF, Pc 4.8 with C4h symmetry has 
the same splitting pattern of the Pc core protons in the range of 7–9 ppm as what has been 
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reported for a different C4h Pc.2, 27 The broad peak downfield at 9.6 ppm is attributed to 
the hydroxyl group, which is consistent with the chemical shifts of the hydroxyl groups in 
Pc 4.13. The peak at 7.3 ppm is due to the aromatic protons on the substituted phenyl 
group.  
            Tetrasubstituted Pc 4.10 containing four MeO groups was synthesized using the 
same strategy (Scheme 4.8). The macrocyclization reaction took place at 140 ºC in 
pentanol producing mixed isomers. The isomer with C4h symmetry was isolated. The 
same pattern on the 1H NMR spectrum in the range of 7–9 ppm in deuterated DCM was 
observed, except that the disappearance of the OH peak at 9.6 ppm and the overlapping 
of one proton of the substituted phenyl ring and one proton on the macrocycle core at 
7.40 ppm.      
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Scheme 4.8. Synthesis of Pc 4.10. 
4.4 Synthesis of Dihydroxy-Substituted Zinc Phthalocyanines             
            The A3B-type (A phthalonitrile; B 4.1) free-base Pc 4.11 was synthesized by the 
method of statistical condensation using a small amount of DBU as the catalyst in dry n-
pentanol (Scheme 4.4). With the phthalonitrile ratio of 20:1 (A/B), the formation of A4,  
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Scheme 4.4. Synthesis of dihydroxy-substituted zinc Pc. 
                         
A3B and A2B2 Pcs (Figure 4.5) were observed after the reaction. No AB3 isomer was 
produced from the analysis of the MALDI-TOF mass spectrum of the reaction mixture. 
Since A4-type Pc is not soluble in any solvent, it can be easily removed by filtration after 
the reaction. The A3B-type Pc as the major product was isolated by chromatography on a 
short silica gel column. Figure 4.6 (a) shows that A3B (982) and A2B2 (1450) Pcs were 
both formed when the phthalonitrile ratio was 20:1 (A:B) in the cyclotetramerization 
reaction. When the phthalonitrile ratio was increased to 40:1 (A:B), the A2B2-type Pc was 
not produced, as indicated by MALDI-TOF mass spectrometry, as shown in Figure 4.6 
(b). Under these conditions, Pc 4.11 was isolated in 12% yield. 
            The free-base Pc 4.11 was soluble in CHCl3, CH2Cl2 and THF, while not soluble 
in polar solvents such as acetone. The following step of insertion of zinc metal into the Pc 
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Figure 4.5. Structures of A2B2- and A4- type Pcs. 
 
 
 
 
 
Figure 4.6. Mass spectra of the crude product 4.11 with different phthalonitrile ratios             
(a) A/B=20, (b) A/B=40.   
 
macrocycle using dry DMF as solvent was not successful probably due to the insolubility 
of the free base Pc in DMF. Changing the solvent to DCM made the reaction proceed in          
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quantitative yield. The deprotection of the methoxyl groups of Pc 4.12 with sodium 
ethanethiolate produced both free-base and zinc Pcs. Therefore, the demethylation 
reaction of free-base Pc 4.11 was accomplished first, before the metallation reaction. 
However, the yield was low and the target Pc 4.13 was synthesized by zinc insertion with 
zinc bromide in dry DMF.  
            We tried a second strategy to synthesize Pc 4.13. Phthalonitrile 4.4 and 4,5-
dichlorophthalonitrile was macrocyclized by heating at 140 ºC in dry pentanol and in the 
presence of a catalytic amount of DBU. The free-base Pc was identified by a peak at 
954.90 (m/z) by MALDI-TOF mass spectrometry. The following metallation reaction 
took place by heating the reaction solution in DMF at 40 ºC. The macrocyclization 
reaction has a yield of 6% using zinc template. Pc 4.13 containing two hydroxyl groups 
shows good solubility in DMF, however, it shows tendency for aggregation in DCM, 
acetone and methanol.   
 
            
Cl O O OH I O O OH
NaI
acetone, reflux, 90%  
                                                                                                                   4.14 
  
Scheme 4.5. Synthesis of PEG precursor. 
  
            In order to improve the solubility of the A3B-type zinc Pc, two short PEG chains 
containing two free hydroxyl groups were conjugated to the Pc. 2-[2-(2-
Iodoethoxy)ethoxy]ethanol28 was synthesized from 2-[2-(2-chloroethoxy)ethoxy]ethanol 
and sodium iodide in 90% yield (Scheme 4.5). 
 110
 
NN N
N
NNN
N
OO
Zn
O O
O
O
OH
O
O
HO
NC
OO
O O
O
O
OH
O
O
HO
CN
K2CO3, acetone, 59%
1. phthalonitrile, DBU,
pentanol, 120 ºC
2. Zn(OAc)2
15%
OO
HO OH
NC CN
I O O OH
 
 
 4.4                                                        4.15                                               4.16 
 
Scheme 4.6. Synthesis of PEG-conjugated Pc 4.16. 
            Scheme 4.6 shows the synthesis of Pc 4.16. Phthalonitrile 4.4 reacted with 2-[2-
(2-iodoethoxy)ethoxy]ethanol at 50 ºC for two days to produce phthalonitrile 4.15 
containing two short PEG chains in 59% yield. Using the method of statistical 
condensation, a large excess of phthalonitrile reacted with 4.15 in the presence of a small 
amount of DBU to give the A3B-type zinc Pc 4.16 in 15% yield. Because of the presence 
of the amphiphilic PEG chains and the hydrophobic tert-butyl groups, Pc 4.16 is highly 
soluble in various solvents such as acetone, methanol, DCM and DMF.              
4.5       Conclusion 
            In this Chapter, octa, tetra and dihydroxyl-substituted Pcs were synthesized in 
pure form using different synthetic strategies. All Pcs are highly soluble in polar organic 
solvents. Photophysical studies are being conducted and will be soon reported. 
4.6       Experimental 
            All chemicals were purchased from commercial sources and used directly without 
further purification. Silica gel 60 (230×400 mesh, Sorbent Technologies) and alumina gel 
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(50–200 µm, neutral, standard activity І, Sorbent Technologies) were used for column 
chromatography. Analytical thin-layer chromatography (TLC) was carried out using 
polyester backed TLC plates 254 (precoated, 200 µm) from Sorbent Technologies. Prep 
alumina and silica TLC plates were purchased from Sorbent Technologies Inc. (w / UV 
254, 1000 µm) NMR spectra were recorded on a DPX-250 or AV-400 Bruker 
spectrometers (250 MHz or 400 MHz for 1H, 63 MHz or 100 MHz for 13C). The chemical 
shifts are reported in δ ppm using the following deuterated solvents as internal 
references: CD3COCD3 2.04 ppm (1H), 29.92 ppm (13C); d-DMF 2.92 ppm (1H), 34.89 
ppm (13C). Electronic absorption spectra were measured on a Perkin-Elmer Lambda 35 
UV-vis spectrometer. High resolution ESI mass spectra were obtained on an Agilent 
Technologies 6210 Time-of-Flight LC/MS. HPLC separation and analyses were carried 
out on a Dionex system equipped with a P680 pump and a UVD340U detector. Semi-
preparative column was Luna C18 100 Å, 5 µm, 10 × 250 mm from Phenomenex, USA. 
Analytical HPLC was carried out on a Delta Pak C18 300 Å, 5 µm, 3.9 × 150 mm 
(Waters, USA) column; flow rate 1.0 mL/min; injected volume 20 µL; wavelength 
detection 350 nm. 
            Phthalonitrile 4.1. 4, 5-Dichlorophthalonitrile (1 g, 5 mmol) and 2, 5-di-tert-
butyl-4-methoxyphenol (4 g, 16.4 mmol) were dissolved in 30mL dry DMF at 95 ºC 
under argon’s flow. Potassium carbonate (4.5 g, 32.8 mmol) was added to the reaction 
solution in 8 portions every 5 min. After 1 day, another portion (2 g, 14.5 mmol) of 2, 5-
di-tert-butyl-4-methoxyphenol was added to the reaction solution. The reaction was 
followed by 1H NMR with the missing of mono-substituted phthalonitrile. After 24 hours 
the reaction solution was cooled to room temperature and poured into 250 mL ice water. 
After filtration under vacuum, the cruder product was purified through a silica column 
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with mixed elution hexane/DCM (4/1). The product was recrystallized with hexane to get 
pure white solid (2.3 g, 77%). 1H NMR (CD2Cl2, 300 MHz): δ 7.18 (s, 2H, Ar-H), 7.04 
(s, 2H, Ar-H), 6.95 (s, 2H, Ar-H), 3.95 (s, 6H, OCH3), 1.42 (s, 18H, C(CH3)3), 1.40 (s, 
18H, C(CH3)3). 13C NMR (CD2Cl2, 75 MHz): δ 156.27, 153.31, 145.56, 140.40, 138.61, 
120.88, 120.63, 116.00, 111.76, 109.68 (Ar-C, CN), 55.80 (OCH3), 35.06, 34.96, 30.62, 
29.85 (C(CH3)3). MS (MALDI-TOF) m/z 596.87 [M]+, calcd. for  [C38H48N2O4]+ 596.36. 
            H2Pc 4.2. Phthalonitrile 4.1 (0.5 g, 0.84 mmol) was put in a 25 mL three-neck 
flask and the flask was evacuated and refill with argon for three times. Pentanol (5 mL) 
was added in through syringe and the reaction solution was heated to 120 ºC. Lithium ( 
0.048 g, 6.8 mmol) was added in small pieces. The reaction was kept for 17 hours. The 
reaction solution was cooled down to room temperature. Acetic acid (15 mL) was added 
to the solution and it stirred for half an hour. The solution was poured to 200 mL solution 
of ice water/methanol (10/1). The mixed the solution was stirred vigorously for one hour. 
The product was filtered and then dissolved in 100 mL of hexane. The impurity was 
removed by filtration. The product solution was dried over anhydrous sodium sulfate 
overnight. The solvent was evaporated out and the residue was washed with methanol 
until the filtrate was colorless. The product was dried under vacuum at 70 ºC to get fresh 
green solid (0.15 g, 30%). 1H NMR (CD2Cl2, 300 MHz): δ 8.90 (s, 8H, Ar-H), 7.09 (s, 
8H, Ar-H), 7.07 (s, 8H, Ar-H), 3.97 (s, 24H, OCH3), 1.52 (s, 72H, C(CH3)3), 1.27 (s, 
72H, C(CH3)3), -0.35 (s, 2H, NH). 13C NMR (CD2Cl2, 75 MHz): δ 154.66, 152.21, 
149.30, 138.72, 137.55, 132.83, 118.29, 113.36, 111.91 (Ar-C), 56.01 (OCH3), 35.10, 
34.81, 30.39, 29.85 (C(CH3)3). MS (MALDI-TOF) m/z 2388.37 [M]+, calcd. for 
C152H194N8O16 2388.46. 
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            ZnPc 4.3. Phthalonitrile (0.38 g, 0.64 mmol) was dissolved in 3 mL dry pentanol 
at 135 ºC. With the protection of argon, metal lithium (0.1 g, 14 mmol) was added 
carefully to the reaction solution in small pieces. After two minutes, the reaction solution 
turns to green. It was heated for 3 hours. Then 400mg of anhydrous zinc acetate was 
added. It was refluxed for another 3 hours. The solvent was removed under reduced 
pressure. The dry residue was washed with methanol: H2O (1:1) for three times and 
extracted with 100 ml hexane. The crude product was purified by going through a silica 
column with the elution of hexane/DCM (2/1) to obtain pure green solid (0.12 g, 31%). 
1H NMR (CD2Cl2, 300 MHz): δ 8.89 (s, 8H, Ar-H), 7.06 (s, 8H, Ar-H), 7.05 (s, 8H, Ar-
H), 3.95 (s, 24H, OCH3), 1.50 (s, 72H, C(CH3)3), 1.25 (s, 72H, C(CH3)3). 13C NMR 
(CD2Cl2, 75 MHz): δ 154.50, 153.37, 151.57, 149.49, 138.57, 137.43, 134.39, 118.12, 
113.38, 111.87 (Ar-C), 56.00 (OCH3), 35.06, 34.76, 30.34, 29.81 (C(CH3)3). MS 
(MALDI-TOF) m/z 2451.80 [M]+, calcd. for C152H192N8O16Zn 2451.38. 
            Phthalonitrile 4.4. 2, 5-Di-tert-butyl-hydroquinone (2.3 g, 10.3 mmol) was 
dissolved in 30 mL of DMF. The reaction flask was charged with nitrogen and potassium 
carbonate (0.7 g, 5.1 mmol) was added into the reaction solution in five portions. The 
solution was heated to 50 ºC. 4, 5-dichlorophthalonitrile (0.5 g, 2.6 mmol) was dissolved 
in 10 mL of DMF as solution A and added to the reaction solution through additional 
funnel dropwise in 30 minutes. After addition of solution A, the temperature was raised 
to 100 ºC and heated for three days. After the solution was cooled down, it was 
concentrated to 10 mL and poured to 100 mL of ice water, the solution was neutralized 
by 1 N HCl solution until pH = 5. The precipitates were filtered and further purified by 
chromatography on silica gel with hexane/DCM (1/1) and MeOH/DCM (2/98) to get 
white solid (0.4 g, 27%). 1H NMR (CD2Cl2, 400 MHz): δ 7.09 (s, 2H, Ar-H), 6.84 (s, 2H, 
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Ar-H), 6.79 (s, 2H, Ar-H), 5.01 (s, 2H, OH), 1.37 (s, 18H, C(CH3)3), 1.31 (s, 18H, 
C(CH3)3). 1H NMR (d-acetone, 400 MHz): δ 8.66 (s, 2H, OH), 7.27 (s, 2H, Ar-H), 6.99 
(s, 2H, Ar-H), 6.85 (s, 2H, Ar-H), 1.34 (s, 18H, C(CH3)3), 1.31 (s, 18H, C(CH3)3). 13C 
NMR (CD2Cl2, 100 MHz): δ 153.03, 144.75, 139.71, 135.39, 120.80, 120.05, 115.54, 
115.41, 109.11 (Ar-C, CN), 34.18, 34.01, 29.88, 28.89 (C(CH3)3). HRMS-ESI: m/z 
567.3219 [M-H]-, 568.3245 [M]-, 1135.6526 [2M-H]-, calcd. for [C36H43N2O4]- 567.3228, 
[C36H44N2O4]- 568.3261, [C72H87N4O8]- 1135.6524. FTIR (solid): 3463.7 (br, OH), 
2236.0 (CN) cm-1. 
            ZnPc 4.5. Method A. ZnPc 4.3 (60 mg, 0.024 mmol) and sodium ethanethiolate 
(900 mg, 9.6 mmol) were dissolved in 35 ml dry DMF. The reaction was refluxing at 135 
ºC for 24 hours under argon protection. The reaction was followed by MALDI-TOF 
mass spectroscopy. After one day, the reaction solution was poured into 150 mL H2O. It 
was extracted with ethyl acetate (50 mL, ×3) and then dried over anhydrous sodium 
sulfate. The crude product was purified by Sephadex LH-20 with methanol. After 
chromatography with HPLC using methanol as the mobile phase, green solid was 
obtained (15 mg, 25%). Method B. Phthalonitrile 4.4 (0.08 g, 0.14 mmol) was dissolved 
in 3 mL of pentanol in 25 mL three neck flask. The solution was heated at 135 ºC. 
Lithium (30 mg, 4.3 mmol) was added into the solution in small portions and the reaction 
solution was heated for 10 hours. The solution was cool down to room temperature, and 
zinc acetate (0.1 g, 0.55 mmol) was added. The solution was refluxed at 135 ºC for two 
hours and then evaporated to dry and dissolved in 100 mL water. The suspension stayed 
in the refrigerator for three hours. The green precipitate was filtered under vacuum and 
washed with water. The crude product was purified by chromatography on alumina 
column with elution of methanol/DCM (2/98). The final product was purified by HPLC 
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with methanol as the mobile phase, green solid was obtained (7 mg, 9%). 1HNMR (d-
acetone, 250 MHz): δ 8.818 (s, 8H, Ar-H), 8.088 (br, 8H, OH), 7.061 (s, Ar-H, 8H), 
7.029 (s, Ar-H, 8H), 1.462 (s, 9H, C(CH3)3), 1.311 (s, 9H, C(CH3)3). 13CNMR (d-
methanol, 63 MHz): δ 154.542, 153.015, 152.833, 149.049, 139.927, 135.914, 134.645, 
119.631, 116.406, 113.237 (Ar-C), 35.373, 35.344, 31.002, 30.116 (C(CH3)3). MS 
(MALDI-TOF) m/z 2338.71 [M]+, calcd. for C144H176N8O16Zn 2339.25. HRMS-ESI: m/z 
1168.6159 [M-2H]2-, calcd. for [C144H174N8O16Zn]2- 1168.6194. tR = 11.23 min (MeOH). 
UV-vis (acetone): λmax (log ε) 678.66 (5.04) nm. 
            Phthalonitrile 4.6. 2, 5-Di-tert-butylhydroquinone (3.2 g, 14 mmol) was 
dissolved in 100 mL DMF. The reaction flask was charged with nitrogen and potassium 
carbonate (2 g, 14 mmol) was added into the reaction solution in five portions. The 
solution was heated to 50 ºC. 3-Nitrophthalonitrile (2 g, 11 mmol) was dissolved in 40 
mL of DMF as solution A and added to the reaction solution through additional funnel 
dropwise in 30 minutes. After addition of solution A, the temperature was raised to 100 
ºC and kept for 20 hours. After the solution was cooled down, it was concentrated to 20 
mL and poured to 100 mL water, the precipitates were filtered and recrystallized with 
acetone to get dimeric phthalonitrile 4.7 as white solid and the solution was evaporated to 
dry and further purified by chromatography on silica gel with MeOH/DCM (2/98) to get 
light yellow solid (1.5 g, 38%). 1H NMR (CD2Cl2, 400 MHz): δ 7.58 – 7.54 (m, 1H, Ar-
H), 7.43 – 7.41 (m, 1H, Ar-H), 7.04 – 7.02 (m, 1H, Ar-H), 6.84 (s, 1H, Ar-H), 6.77 (s, 
1H, Ar-H), 1.34 (s, 9H, C(CH3)3), 1.30 (s, 9H, C(CH3)3). 13C NMR (CD2Cl2, 100 MHz): 
δ 162.31, 152.55, 145.13, 140.86, 136.15, 134.89, 126.65, 120.88, 120.26, 117.44, 
116.41, 115.86, 113.65, 105.59 (Ar-C, CN), 34.68, 34.49, 30.45, 29.49 (C(CH3)3). 
HRMS-ESI: m/z 347.1766 [M-H]-, 348.1791 [M]-, 695.3580 [2M-H]-, calcd. for 
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[C22H23N2O2]- 347.1766, [C22H24N2O2]- 348.1838, [C44H47N4O4]- 695.3597. FTIR (solid): 
3440.9 (br, OH), 2243.0 (CN) cm-1. Dimer 4.7 (1.2 g, 46%). 1H NMR (CD2Cl2, 400 
MHz): δ 7.66 – 7.62 (m, 2H, Ar-H), 7.52 – 7.50 (m, 2H, Ar-H), 7.52 – 7.50 (m, 2H, Ar-
H), 7.13 – 7.11 (m, 2H, Ar-H), 7.00 (s, 2H, Ar-H), 1.30 (s, 18H, C(CH3)3). 13C NMR 
(CD2Cl2, 100 MHz): δ 160.73, 149.51, 141.97, 134.67, 127.04, 121.10, 120.34, 117.39, 
115.19, 112.87, 105.92 (Ar-C, CN), 34.50, 29.78 (C(CH3)3).  
            ZnPc 4.8. Method A. Phthalonitrile 4.6 (80 mg, 0.23 mmol) was dissolved in 3 
mL pentanol. The solution was protected by argon and heated to 130 ºC. Lithium (15 mg, 
2.2 mmol) was added into the solution in small pieces. After heating for 4 hours, zinc 
acetate (50 mg, 0.27 mmol) was added into the solution and continued to heat for 2 hours. 
The solvent was evaporated out and dissolved in mixed solvents of methanol/water (1/1). 
The green solid was filtered and washed with dichloromethane. The crude product was 
further purified by chromatography on alumina column with the elution of 
methanol/DCM (5/95) and followed by a preparative alumina TLC with the elution of 
methanol/DCM (2/98) to afford a green solid as the major product (7 mg, 8%). The crude 
product was further purified by HPLC. Method B. Lithium (0.033 g, 4.6 mmol) was 
dissolved in octanol (5 mL) and heated to 170 ºC for 1 hour to get a homogeneous 
solution. Then the solution was cooled down to room temperature and phthalonitrile 4.6 
(50 mg, 0.14 mmol) in DCM (1 mL) was added into the reaction solution through 
syringe. After four hours, anhydrous zinc acetate (40 g, 0.2 mmol) was added into the 
solution. The reaction solution was heated to 70 ºC for 24 hours. The solution was loaded 
to a silica column directly to get one fraction with elution of methanol/DCM (2/98). 
Ethanol (10 mL) was added to the solution and the solution was concentrated by 
azeotropic distillation. Hexane (5 mL) was added to the residue (1 mL) and the 
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suspension was centrifuged to get crude solid product. The crude product was eluted with 
acetone on a short Sephdex LH-20 column to remove any insoluble impurities. Then the 
product was loaded on silica preparative TLC plate and developed with hexane/DCM 
(1/4) and DCM/methanol (98/2). Two major green bands were collected. The two 
isomers were purified separately on alumina preparative TLC plate with developing 
solvents of hexane/DCM (1/4) and DCM/methanol (98/2). The crude product was 
obtained as dark green solid (8 mg, 15%). Further purification was done by HPLC. 1H 
NMR (d-DMF, 400 MHz): δ 9.60 (br, 4H, OH), 9.08 (d, J = 7.4 Hz, 4H, Ar-H), 8.10 (t, J 
= 7.5 Hz, 4H, Ar-H), 7.45 (d, J = 7.4 Hz, 4H, Ar-H), 7.30 (s, 8H, Ar-H), 1.71 (s, 36H, 
C(CH3)3), 1.41 (s, 36H, C(CH3)3). HRMS-ESI: m/z 1459.6721 [M+H]+, calcd. for 
[C88H97N8O8Zn]+ 1459.6730.  
            Phthalonitrile 4.9. 3-Nitrophthalonitrile (0.4 g, 2.3 mmol) and 2, 5-di-tert-butyl-
4-methoxyphenol (0.6 g, 2.8 mmol) were dissolved in 20 mL DMF and heated to 90 ºC. 
Potassium carbonate (4.2 g, 30.4 mmol) was added into the solution in five portions. The 
reaction solution was heated for 4 hours. After the solution was cooled down to room 
temperature, the solution was poured into 450 mL ice water and white solid precipitated 
out. The solid was filtered under vacuum. The solid was dissolved in 100 mL DCM and 
dried over sodium sulfate. The crude product was purified by chromatography on 
alumina gel with elution of DCM/hexane (4/1) to afford white solid (1.0 g, 83%). 1H 
NMR (CD2Cl2, 250 MHz): δ 7.58 – 7.52 (m, 1H, Ar-H), 7.44 – 7.40 (m, 1H, Ar-H), 7.02 
– 6.95 (m, 2H, Ar-H), 6.78 (s, 1H, Ar-H), 3.88 (s, 3H, OCH3), 1.34 (s, 9H, C(CH3)3), 
1.30 (s, 9H, C(CH3)3). 13C NMR (CD2Cl2, 63 MHz): δ 162.19, 156.34, 144.98, 140.47, 
138.40, 134.87, 126.62, 120.55, 120.19, 117.38, 115.87, 113.67, 111.60, 105.54 (Ar-C, 
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CN), 55.73 (OCH3), 34.88, 34.83, 30.44, 29.60 (C(CH3)3). MS (MALDI-TOF) m/z 
362.25 [M] +, calcd. for C23H26N2O2  362.20. 
            ZnPc 4.10. Phthalonitrile 4.9 (0.1 g, 0.28 mmol) and zinc acetate (0.05 g, 0.27 
mmol) were put in a 25 ml schlenk flask and it was evacuated and refilled with argon for 
three times. Pentanol (3 mL) was added into the flask and the solution was heated to 140 
ºC. Small amount of DBU (13 µL) was added through syringe. The reaction was followed 
by TLC until the disappearance of the starting material. After heating for 4 hours, the 
solution was cooled down to room temperature. The solvent was evaporated to dry and 
the crude product was purified by chromatography with silica gel eluted with ethyl 
acetate/hexane (1/10). A second silica column was applied with elution of ethyl 
acetate/DCM/hexane (3/10/1) to get the major fraction. The major fraction was further 
purified by preparative silica TLC with elution of DCM/hexane (5/1) to afford bluish 
green solid (11 mg, 10%). 1H NMR (CD2Cl2, 300 MHz): δ 9.07 (d, 4H, Ar-H), 7.93 (t, 
4H, Ar-H), 7.40 (t, 4H, Ar-H), 7.21 (s, 4H, Ar-H), 4.02 (s, 12H, OCH3), 1.75 (s, 36H, 
C(CH3)3), 1.40 (s, 36H, C(CH3)3). MS (MALDI-TOF) m/z 1514.54 [M] +, calcd. for 
C92H104N8O8Zn  1514.73. 
            H2Pc 4.11. Phthalonitrile 4.1 (0.3 g, 0.5 mmol) and phthalonitile (7.6 g, 59.3 
mmol) was mixed together in 50 mL dry pentanol at 140 ºC. With the protection of 
argon, 0.6 mL DBU was added dropwise to the reaction solution. After refluxing for 9 
hours, the reaction solution was cooled to room temperature. Pour the solution to 200 mL 
methanol and filter under vacuum. The insoluble solid was washed with methanol and 
DCM. The filtrate was concentrated and the residue was loaded on a short silica column 
using DCM as the elution. The product was dried under vacuum to get the blue solid 
(0.06 g, 12%). 1H NMR (CDCl3 with one drop of d-TFA, 300 MHz): δ 7.98 – 7.87 (m, 
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18H, Ar-H), 4.11 (s, 6H, OCH3), 1.72 (s, 18H, C(CH3)3), 1.46 (s, 18H, C(CH3)3). MS 
(MALDI-TOF) m/z 982.81 [M] +, calcd. for C62H62N8O4  982.49. 
            ZnPc 4.12. H2Pc 4.11 (0.07 g, 0.7 mmol) and zinc bromide (0.16 g, 0.7 mmol) 
was dissolved in 20 mL DCM and refluxed for 2 hours. After the reaction solution was 
cooled down to room temperature, it was filtered to remove excess amount of salt. The 
residue was purified by chromatography on silica column with the elution of DCM/THF 
(20/1) to yield the bluish green solid (0.067 g, 96%). 1H NMR (d-THF, 250 MHz): δ 9.32 
– 9.27 (m, 4H, Ar-H), 9.22 – 9.19 (m, 2H, Ar-H), 9.04 (s, 2H, Ar-H), 8.11 – 8.08 (m, 4H, 
Ar-H), 8.05 – 8.02 (m, 2H, Ar-H), 7.31 (s, 2H, Ar-H), 7.17 (s, 2H, Ar-H), 4.01 (m, 6H, 
Ar-H), 1.61 (s, 18H, C(CH3)3), 1.38 (s, 18H, C(CH3)3). MS (MALDI-TOF) m/z 1044.84 
[M] +, calcd. for C62H60N8O4Zn  1044.40. 
            ZnPc 4.13. Phthalonitrile 4.4 (0.1 g, 0.176 mmol) and phthalonitrile (1.9 g, 15 
mmol) were mixed together in 50 mL dry pentanol at 140 ºC. With the charging of argon, 
DBU (0.2 mL) was added into the solution. The reaction proceeded for 24 hours. After 
the reaction, the solvent was evaporated to dry. The residue was dissolved in acetone and 
the byproduct zinc Pc was removed by filtration. The crude product was purified by 
chromatography with alumina column eluted with methanol/DCM (5/95) to get the free 
base. MS (MALDI-TOF) m/z 954.90 [M] +, calcd. for C60H58N8O4  954.46. The free-base 
Pc was dissolved in 20 mL DMF and heated to 40 ºC for two days. Then the solvent was 
evaporated to dry. The crude product was purified by alumina column with MeOH/DCM 
(2/98) and the following alumina preparative TLC afforded the product as greenish blue 
product (10 mg, 6%). 1H NMR (d-DMF, 400 MHz): δ 9.61 (br, 2H, OH), 9.35 – 9.17 (m, 
6H, Ar-H), 8.95 (s, 2H, Ar-H), 8.23 – 8.13 (m, 6H, Ar-H), 7.32 (s, 2H, Ar-H), 7.28 (s, 
2H, Ar-H), 1.60 (s, 18H, C(CH3)3), 1.46 (s, 18H, C(CH3)3). 13C NMR (d-DMF, 100 
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MHz): δ 162.90, 154.10, 153.95, 153.87, 153.80, 153.20, 152.29, 147.88, 139.79, 139.11, 
139.03, 138.93, 135.30, 134.24, 123.15, 122.94, 122.80, 119.97, 116.15, 111.68 (Ar-C), 
29.77 (C(CH3)3, other carbon signals shielded by d-DMF). LR-MS (MALDI-TOF) m/z 
1016.25 [M] +, calcd. for C60H56N8O4Zn  1016.37.  
 2-[2-(2-Iodoethoxy)ethoxy]ethanol 4.14. 2-[2-(2-Chloroethoxy)ethoxy]ethanol 
(10 g, 59.2 mmol) and sodium iodide (55 g, 0.37 mol) were dissolved in acetone (100 
mL) and the refluxed for 24 h. The solution was filtered to remove the salt and the 
acetone was evaporated to dry. Water (15 mL) was added to dissolve the slurry. Ether 
(100 mL) was used to extract the product for three times. The combined organic solution 
was dried over sodium sulfate and the solvent was evaporated to dry. It was dried at 40 
ºC under vacuum for 24 h to afford the reddish yellow viscous liquid (14 g, 90%). 1H 
NMR (CDCl3, 400 MHz): δ 3.61 (t, J = 6.8 Hz, 2H, OCH2), 3.57 (t, J = 4.6 Hz, 2H, 
OCH2), 3.52 (s, 4H, CH2), 3.45 (t, J = 4.6 Hz, 2H, OCH2), 3.14 - 3.10 (m, 3H, OCH2, 
OH). 13C NMR (CDCl3, 100 MHz): δ 72.20, 71.43, 69.88, 69.74, 61.18, 2.67. HRMS-
ESI: m/z 260.9975 [M+H]+, 282.9796 [M+Na]+, calcd. for [C6H14O3I]+ 260.9982, 
[C6H13O3INa]+ 282.9807. 
            Phthalonitrile 4.15. Phthalonitrile 4.4 (0.2 g, 0.35 mmol) and potassium 
carbonate (0.24 g, 1.7 mmol) were dissolved in acetone (20 mL). The flask was charged 
with argon and the reaction solution was heated to 50 ºC. 2-[2-(2-
Chloroethoxy)ethoxy]ethanol (0.28 g, 1.1 mmol) was added into  the reaction solution by 
syringe. Another portion of 2-[2-(2-chloroethoxy)ethoxy]ethanol (0.14 g, 0.5 mmol) and 
potassium carbonate (0.12 g, 0.9 mmol) was added into the reaction solution. The 
reaction was followed by TLC and another two days later the reaction went to complete. 
The reaction solution was cooled down to room temperature and the inorganic salt was 
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removed by filtration under vacuum. The solution was concentrated and loaded on a 
silica column. The product was eluted with DCM/methanol (98/2) and dried to afford 
slight yellow viscous liquid (0.18 g, 59%). 1H NMR (d-acetone, 250 MHz): δ 7.32 (s, 2H, 
Ar-H), 7.06 (s, 2H, Ar-H), 6.91 (s, 2H, Ar-H), 4.23 (t, J = 4.4 Hz, 4H, OCH2), 3.92 (t, J = 
4.4 Hz, 4H, OCH2), 3.70 – 3.51 (m, 18H, OCH2, OH), 1.37 (s, 18H, C(CH3)3), 1.35 (s, 
18H, C(CH3)3). 13C NMR (d-acetone, 63 MHz ): δ 155.67, 153.54, 146.33, 140.36, 
138.51, 121.97, 120.61, 116.12, 112.72, 110.15 (Ar-C, CN), 73.45, 71.21, 71.14, 70.50, 
68.53, 61.89 (OCH2), 35.22, 35.14, 30.60, 29.94 (C(CH3)3). HRMS-ESI: m/z 833.4947 
[M+H]+, calcd. for [C48H69N2O10]+ 833.4946.   
            ZnPc 4.16. Phthalonitrile 4.4 (0.2 g, 0.24 mmol) and phthalonitrile (1.8 g, 14 
mmol) were dissolved in pentanol (20 mL). The flask was charged with argon. The 
reaction solution was heated to 140 ºC and DBU (0.1 mL, 0.66 mmol) was added. After 
three hours, zinc acetate (0.8 g, 4.4 mmol) was added to the reaction solution. The 
temperature was decreased to 100 ºC and kept for eight hours. After the reaction, the 
solution was cooled down to room temperature and filtered under vacuum. The solid was 
washed with acetone and methanol. The filtrate was evaporated to dry. The residue was 
loaded on a silica column and the crude product was eluted with ethyl acetate/methanol 
(98/2) to afford dark green solid (60 mg, 15%). HRMS-ESI: m/z 1283.5362 [M+H]+, 
calcd. for [C72H81N8O10Zn]+ 1283.5367.   
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CHAPTER 5 
 
 
SYNTHESES OF PHOSPHONATE-SUBSTITUTED PHTHALOCYANINES 
 
 
5.1       Background  
            Phosphonic acid containing dyes, for example porphyrins,1-3 Pcs,4-6 chlorins7 and 
small molecule dyes such as cyanine and squaraine dyes,8 have been synthesized and 
applied in biological and material sciences, such as fluorescent labels and as organic 
photovoltaic devices. Some examples of bisphosphates9, 10 were shown to have good 
activity in inhibiting the growth of human cell lines (MCF-7, NCI-H460, SF-268). 
            Only a few papers to date have reported the synthesis of Pcs bearing phosphonate 
substituents.4-6, 11 In this Chapter, one symmetric Pc containing eight phosphonate groups 
was synthesized.   
5.2       Synthesis of Octaphosphonate-Substituted Zinc Phthalocyanine 
            Two methods of phosphonation were investigated in our synthetic strategy. The 
Pd (0)–catalyzed carbon-phosphorus bond formation is a classical method to synthesize 
the aryl phosphonic acids. Dialkylarylphosphonates can be synthesized from aryl 
bromides or iodides with dialkyl phosphite in the presence of triethylamine and a 
catalytic amount of tetrakis(triphenylphosphine)palladium.12, 13 A precursor containing a 
phosphonate ester group was synthesized through the Pd (0)–catalyzed reaction in 41% 
yield (Scheme 5.1). 3-Iodophenol was coupled with diethylphosphite using 10% 
tetrakis(triphenylphosphine)-palladium as the catalyst, in the presence of freshly 
redistilled triethylamine without any solvent. The reaction proceeded in an inert gas 
environment for 5 hours to afford the product 5.1 as colorless viscous liquid in 41% 
yield. 4-Iodophenol was tried as the starting material in the Pd (0) coupling reaction, but  
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Scheme 5.1. Synthesis of phosphonate conjugated phthalonitrile. 
It was not successful. The reaction of 3-phosphonate-substituted phenol 5.1 and 4,5-
dichlorophthalonitrile led to diphosphonate-substituted phthalonitrile 5.2 in 15% yield. 
Therefore, the overall yield to synthesize the precursor of diphosphonate-substituted 
phthalonitrile is only 6%. We also investigated the Pd (0)-catalyzed phosphonation 
reaction on the octaiodo-substituted zinc Pc 5.4 (Figure 5.1), but this reaction was not 
successful either. 
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Figure 5.1. Structure of Octaiodo-substituted Pc 5.4. 
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            Since the yield of diphosphonate-substituted phthalonitrile 5.2 was not favorable, 
we decided to investigate another phosphonation method: the Michaelis-Arbuzov 
reaction. Aryl iodides or bromides reacted with trialkyl phosphites in the presence of a 
catalytic amount of anhydrous nickel dichloride.14, 15 The diiodo-substituted phthalonitrile 
5.3 was synthesized from 4-iodophenol and 4, 5-dichlorophthalonitrile in 94% yield as 
shown in Scheme 5.2. Figure 5.2 shows the single crystal structure of 5.3. The following 
phosphonation reaction took place from phthalonitrile 5.3 and tributylphosphite or 
triethylphosphite catalyzed by a small amount of nickel dichloride in mesitylene (Scheme 
5.2). These two reactions gave similar yields of 60% to afford the diphosphonate-
substituted phthalonitriles 5.5 and 5.6. The overall yield to synthesize the phosphonate-
substituted phthalonitrile 5.5 and 5.6 is 58-60%, which is much higher than that obtained 
from Pd (0)-catalyzed reaction.  
            The lithium method was applied in the macrocyclization reaction (Scheme 5.3). 
The first trial to use DBU as the catalyst didn’t lead to any desired product. The idea of 
using 5.5 as the precursor to synthesize a soluble octaphosphonate-substituted zinc Pc 
bearing sixteen butoxyl groups was not realistic, since some unexpected de-esterification 
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                                                                 5.3                                               5.5: R1 = C4H9 
                                                                                                                     5.6: R2 = C2H5 
Scheme 5.2. Synthesis of phosphonate conjugated phthalonitriles. 
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Figure 5.2.  X-ray crystal structure of phthalonitrile 5.3. 
was observed under the strong basic conditions. The de-esterification of the phosphonate 
groups from the crude intermediate was complete by reacting with 
bromotrimethylsilane16 at 100 ºC in a sealed tube for four days followed by 1H NMR. 
The octaphosphonic acid-substituted Pc was not soluble in most common solvents, while 
it is soluble under basic aqueous solution when it is in the partial or fully ionic forms.  
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   5.5: R1 = C4H9                                                                               5.7             
   5.6: R2 = C2H5 
 
Scheme 5.3. Synthesis of octaphosphonic acid-substituted Pc 5.7. 
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Figure 5.3. Absorption spectra of Pc 5.7 in 100 mM phosphate buffer at pH 11.0 
(magenta), pH 9.0 (cyan), pH 8.0 (blue), pH 5.0 (green), pH 3.0 (red), pH 2.0 (black) at 5 
µM.    
             Figure 5.3 shows the UV/Vis spectra of Pc 5.7 at pH 11.0, 9.0, 8.0, 5.0, 3.0 and 
2.0. The absorption spectra at higher pH values (~ 9.0-12.0) show a strong Q band at 681 
nm. With the decreasing pH values, the Q band has a blue shift to 644 nm, and the 
intensity of the peak at 681 nm decreases while the intensity of the peak at 644 nm 
increases to the highest until the pH value reaches to ~ 5.0. At lower pH values (~ 1.0-
3.0), broadening of the peak and decreasing intensity were observed due to the 
aggregation of the neutral form of the Pc 5.7.  
5.3       Synthesis of Precursors 
            Two phthalonitriles 5.8 and 5.9 containing Br groups were synthesized in good 
yields from 4,5-dichlorophthalonitrile as shown in Scheme 5.4. The reaction to synthesize 
substituted dibenzo-p-dioxine 5.8 took 15 min to be completed. After purification, the 
yield is 70%. Phthalonitrile 5.9 was synthesized in 68% yield. Figure 5.4 shows the single 
crystal structure of this precursor. Future work will involve the synthesis of phosphonate-
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substituted phthalonitriles 5.10-5.11 and macrocyclization of 5.8-5.11 to obtain the 
corresponding Pcs. 
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Scheme 5.4. Syntheses of phthalonitrile precursors. 
 
 
 
 
Figure 5.4. Single crystal X-ray structure of phthalonitrile 5.9. 
5.4       Conclusion 
            In this Chapter, one zinc Pc containing eight phosphonic acid groups was 
synthesized and characterized. The photophysical study of this Pc is currently underway. 
 130
Two phthalonitriles containing Br groups were also synthesized and can be further 
modified by phophonation reaction as precursors of phosphonate-substituted Pcs. 
5.5       Experimental 
            Phenol 5.1. 3-Iodophenol (0.41 g, 2 mmol) and tetrakis(triphenylphosphine)-
palladium (0.2 g, 0.2 mmol) were put in the Schlenk tube. It was degassed and refilled 
with argon for three times. Dry diethylphosphite (2.9 mL, 21.8 mmol) and triethylamine 
(3.1 mL, 22 mmol) which were deoxygenated were injected through plastic syringe. The 
reaction was heated at 100 ºC for 5 hours. After heating, the reaction residue was diluted 
with DCM and washed with 1 M hydrochloride solution for twice, and then washed with 
sodium bicarbonate solution and water twice respectively. The solution was dried over 
anhydrous sodium sulfate. The crude product was purified by chromatography with silica 
gel eluted by mixed solvents of DCM : methanol (95/5) to afford colorless viscous liquid 
(0.17 g, 42%). 1H NMR (CD2Cl2, 250 MHz ): δ 8.82 (br, 1H, OH), 7.69 – 7.63 (m, 1H, 
Ar-H), 7.37 - 7.31 (m, 1H, Ar-H), 7.26 - 7.18 (m, 1H, Ar-H), 7.13 – 7.09 (m, 1H, Ar-H), 
4.17 - 4.08 (m, 4H, OCH2CH3), 1.33 (t, J = 4.9 Hz, OCH2CH3, 6H). 13C-NMR (CD2Cl2, 
63 MHz): δ158.84 (d), 130.79 (d), 127.32, 122.63 (d), 121.06 (d), 119.69 (d, Ar-C), 
63.41 (d, OCH2CH3), 16.83 (d, OCH2CH3). 31P NMR (CD2Cl2, 101 MHz): δ 20.61. 
            Phthalonitrile 5.2. 4, 5 – Dichlorophthalonitrile (0.047 g, 0.24 mmol) and phenol 
5.1 (0.144 g, 0.63 mmol) were dissolved in 10 mL of anhydrous DMF. The flask was 
charged with argon and heated to 80 ºC. Potassium carbonate (0.2 g, 1.5 mmol) was 
added into the solution in three portions. The reaction solution was heated for three hours. 
After the reaction solution was cooled down to room temperature the solution was poured 
into 50 mL of cold water. DCM (100 mL × 2) was used to extract the product. The crude 
product was purified with silica column using solvent system of methanol/DCM (5/95) to 
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get the colorless viscous liquid (0.02 g, 15%). 1H NMR (CD3OD, 300 MHz): δ 7.61 (s, 
2H, Ar-H), 7.57 – 7.49 (m, 4H, Ar-H), 7.34 - 7.28 (m, 2H, Ar-H), 7.24-7.21 (m, 2H, Ar-
H), 4.06 - 4.00 (m, 8H, OCH2CH3), 1.23 (t, J = 7.1 Hz, 12H). 13C NMR (CD3OD, 75 
MHz): δ 156.76 (d), 152.24, 132.24 (d), 129.06 (d), 126.76, 123.99, 122.31 (d), 115.90, 
113.56 (Ar-C, CN), 64.14 (d), 16.62 (d). 31P NMR (CD2Cl2, 121 MHz): δ 24.58.  
            Phthalonitrile 5.3. 4, 5-Dichlorophthalonitrile (2g, 10.1 mmol) and 4-iodophenol 
(17.9 g, 81.2 mmol) were dissolved in 25 mL of DMSO. The reaction solution was 
heated at 80 ºC under argon. Potassium carbonate (4 g, × 7) was added every 5 minutes. 
After the addition of potassium carbonate, the reaction was proceeded for another 1.5 
hours. After the reaction solution was cooled down to room temperature, the reaction 
solution was poured into 400 mL of ice water. The solution was filtered under vacuum 
and yellow solid paste was obtained. The solid was dissolved in 100 mL of DCM and 
dried over anhydrous sodium sulfate. The crude product was purified by silica gel with 
the elution of hexane/ DCM (1/4) to afford white solid (5.4 g, 94 %). 1H NMR (CD2Cl2, 
250 MHz): δ 7.73 (d, J = 7.1 Hz, 4H, Ar-H), 7.24 (s, 2H, Ar-H), 6.79 (d, J = 7.1 Hz, 4H, 
Ar-H). 13C NMR (CD2Cl2, 63 MHz): δ 154.83, 151.79, 140.60, 126.57, 122.25, 115.55, 
111.35, 89.65 (Ar-C). 
            Pc 5.4. Phthalonitrile 5.3 (0.5 g, 0.9 mmol) and zinc acetate dihydrate (0.073 g, 
0.3 mmol) were dissolved in anhydrous n-pentanol (20 mL). The reaction solution was 
heated to 140 ºC and catalytic amount of DBU (0.5 mL) was added through syringe. The 
turbid solution was remained at 140 ºC overnight. After the reaction, the solution was 
cooled down to room temperature and filtered under vacuum. The green solid was 
purified by chromatography on silica gel with THF (0.2 g, 40%). 1H NMR (d-THF, 250 
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MHz): δ 9.02 (s, 8H, Ar-H), 7.72 (d, J = 8.7 Hz, 16H, Ar-H), 6.04 (d, J = 7.1 Hz, 16H, 
Ar-H). 
            Phthalonitrile 5.5. Phthalonitrile 5.3 (0.5 g, 0.9 mmol) and anhydrous nickel 
dichloride (27 mg, 0.2 mmol) were put in a 50 mL of two-neck round bottom flask. The 
flask was vacuum-refill with argon for three times and anhydrous mestylene (25 mL) was 
added through syringe and the solution was heated to 160 ºC. Tributyl phosphite (0.8 mL, 
2.9 mmol) in 10 mL mestylene was added into the reaction solution dropwise through 
additional funnel in 30 min. The reaction solution was heated for 16 hours. The green 
solution was dissolved in 20 mL DCM and filtered through vacuum to remove any 
inorganic salts and then fractionally distilled to remove any high boiling point reagent 
and byproduct. The residue was purified with alumna column eluted by methanol/DCM 
(5/95) to afford clear viscous liquid ( 0.36 g, 58%). 1H NMR (d-acetone, 400 MHz): δ 
7.90 (s, 2H, Ar-H), 7.82 – 7.77 (m, 4H, Ar-H), 7.26 – 7.23 (m, 4H, Ar-H), 4.05 – 3.95 
(m, 8H, O(CH2)3CH3), 1.65 – 1.58 (m, 8H, O(CH2)3CH3), 1.42 – 1.32 (m, 8H, 
O(CH2)3CH3), 0.88 (t, J = 7.4 Hz, 12H, O(CH2)3CH3). 13C NMR (d-acetone, 100 MHz): δ 
158.60 (d), 150.76, 134.06 (d), 126.35, 124.41, 118.20 (d), 114.80, 112.50 (Ar-C, CN), 
65.39 (d, O(CH2)3CH3), 32.28 (d, O(CH2)3CH3), 18.50 (O(CH2)3CH3), 12.92 
(O(CH2)3CH3). 31P NMR (d-acetone, 162 MHz): δ 17.03. HRMS-ESI: m/z 697.2802 
[M+H]+, calcd. for [C36H47N2O8P2]+ 697.2802. FTIR (solid): 2233.8 (CN), 1207.6 (C-O), 
1167.2 - 1104.2 (P=O) cm-1. 
            Phthalonitrile 5.6. Phthalonitrile 5.3 (1 g, 1.8 mmol) and anhydrous nickel 
dichloride (55 mg, 0.4 mmol) were put in a 50 mL of two-neck round bottom flask. The 
flask was vacuum-refill with argon for three times and anhydrous mestylene (35 mL) was 
added through syringe and the solution was heated to 160 ºC. Triethyl phosphite (0.9 mL, 
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5.2 mmol) in 10 mL mestylene was added into the reaction solution dropwise through 
additional funnel in 30 min. The reaction solution was heated for 16 hours. The green 
solution was fractionally distilled to remove any high boiling point reagent and 
byproduct. The residue was purified with alumna column eluted by methanol/DCM 
(2/98) to afford clear viscous liquid (0.6 g, 60%). 1H NMR (d-acetone, 400 MHz): δ 7.93 
(s, 2H, Ar-H), 7.82 – 7.76 (m, 4H, Ar-H), 7.26 – 7.23 (m, 4H, Ar-H), 4.10 – 3.99 (m, 8H, 
OCH2CH3), 1.25 (t, J = 7.1 Hz, 12H, OCH2CH3). 13C NMR (d-acetone, 100 MHz): δ 
159.36 (d), 151.46, 134.77 (d), 127.22, 125.08, 118.90 (d), 115.58, 113.23 (Ar-C, CN), 
62.53 (d, OCH2CH3), 16.52 (d, OCH2CH3). 31P NMR (d-acetone, 162 MHz): δ 17.05.  
HRMS-ESI: m/z 585.1550 [M+H]+, calcd. for [C28H31N2O8P2]+ 585.1550. FTIR (solid): 
2232.5 (CN), 1211.7 (C-O), 1163.1 (P=O), 957.0 (C-O-P) cm-1. 
            Pc 5.7. Phthalonitrile 5.6 (0.5 g, 0.86 mmol) was dissolved in anhydrous pentanol 
(15 mL). The flask was charged with argon and heated to 140 ºC. Lithium (0.05 g, 7.1 
mmol) was added in small pieces carefully. The reaction solution was heated for 48 
hours. After the temperature dropped to 120 ºC, anhydrous zinc acetate (0.4 g, 2.2 mmol) 
was added. The reaction solution was heated for ten hours. After the reaction solution 
cooled down to room temperature, the solution was filtered under vacuum and the solid 
was washed with DCM and acetone for three times. The solid was dissolved in 1N NaOH 
solution (10 mL) and 1N HCl solution was added to the green solution to get the 
precipitate out. Green solid was obtained after centrifugation. The solid was washed with 
water for two times and dried at 80 ºC under vacuum for 24 hours. The intermediate was 
put in a thick-wall tube. The tube was evacuated and refilled with argon repeatedly for 
three times and bromotrimethylsilane (3 mL, 22.7 mmoL) was added through plastic 
syringe. The sealed tube was heated to 100 ºC and remained at this temperature for four 
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days followed by H NMR. After the reaction, the reagent was evaporated out under 
vacuum. The solid was dissolved in 1N NaOH solution (10 mL) and 1N HCl solution was 
added to the green solution to get the precipitate out. The solid was washed with water, 
acetone/methanol (1/1) for two times. Then the solid was dissolve in 1N NaOH solution 
(2 mL) and filtered. The solution was added dropwise into the 1N HCl solution (10 mL) 
and ethanol (5 mL) was added. The mixed suspension was centrifuged and the product 
was dried under 80 ºC under vacuum for 24 hours to afford dark green shinning solid 
(0.06 g, 15%). 1H NMR (D2O, pH = 14, 400 MHz): δ 8.50 (s, 8H, Ar-H), 7.50 (t, 16H, 
Ar-H), 8.12 (d, J = 8.1 Hz, 16H, Ar-H). 31P NMR (D2O, pH = 14, 162 MHz): δ 12.04. 
            Phthalonitrile 5.8. 4, 5-Dichlorophthalonitrile (0.5 g, 2.5 mmol) and 4, 5-
dibromobenzene-1, 2-diol (0.7 g, 2.6 mmol) were dissolved in 10 mL DMSO. The 
reaction solution was heated at 90 ºC under argon. Potassium carbonate (5.5 g, 40 mmol) 
was added in 6 portions every 5 minutes. After the addition of potassium carbonate, the 
reaction was proceeded for another 0.5 hours. After the reaction solution was cooled 
down to room temperature, the reaction solution was poured into 100 mL ice water. The 
solution was filtered under vacuum and brown solid was obtained. The solid was 
dissolved in 100 mL DCM and dried over anhydrous sodium sulfate. The crude product 
was purified by silica gel with the elution of hexane/ DCM (1/4) to afford earth white 
solid (0.8 g, 70 %). 1H NMR (d-DMSO, 250 MHz): δ 7.85 (s, 2H, Ar-H), 7.52 (s, 2H, Ar-
H). 
            Phthalonitrile 5.9. 4, 5-Dichlorophthalonitrile (0.5 g, 2.5 mmol) and 4-bromo-2, 
6-dimethylphenol (1.5 g, 7.5 mmol) were dissolved in 25 mL DMSO. The reaction 
solution was heated at 80 ºC under argon. Potassium carbonate (1 g, × 7) was added 
every 5 minutes. After the addition of potassium carbonate, the reaction was proceeded 
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for another 3 hours. After the reaction solution was cooled down to room temperature, the 
reaction solution was poured into 500 mL of ice water. The solution was filtered under 
vacuum and yellow solid paste was obtained. The solid was dissolved in 100 mL of DCM 
and dried over anhydrous sodium sulfate. The crude product was purified by silica gel 
with the elution of hexane/ DCM (1/4) to afford white solid (0.9 g, 68%). 1H NMR 
(CD2Cl2, 300 MHz): δ 7.38 (s, 4H, Ar-H), 6.82 (s, 4H, Ar-H), 2.17 (s, 12H, Ar-H). 13C 
NMR (CD2Cl2, 75 MHz): δ 150.29, 149.24, 133.52, 133.04, 120.04, 118.47, 115.80, 
110.68 (Ar-C), 16.20 (CH3).  
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APPENDIX A:  CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 2 
    
        
   
Figure A.1.  1H NMR of Pc 2.6 in d-DMF (*denotes solvents). 
 
        
 
Figure A.2.  1H NMR of Pc 2.15 in d-DMF (*denotes solvents). 
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Figure A.3.  1H NMR of Pc 2.16 in d-DMF (*denotes solvents). 
 
           
 
Figure A.4.  1H NMR of Pc 2.17 in d-DMF (*denotes solvents). 
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Figure A.5.  1H NMR of Pc 2.18 in d-DMF (*denotes solvents). 
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APPENDIX B:  CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 3 
 
 
    
 
 
Figure B.1. 1H NMR spectrum of conjugated Pc 3.7 in d-DMF (*denotes solvents). 
 
 
 
 
 
Figure B.2. 1H NMR spectrum of conjugated Pc 3.8 in d-DMF (*denotes solvents). 
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Figure B.3. 1H NMR spectrum of conjugated Pc 3.9 in d-DMF (*denotes solvents). 
 
 
 
Figure B.4. 1H NMR spectrum of conjugated Pc 3.10 in d-DMF (*denotes solvents). 
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APPENDIX C:  CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 4 
 
 
Figure C.1. 1H NMR spectrum of Pc 4.2 in d-DCM (*denotes solvents). 
 
 
 
 
Figure C.2. 1H NMR spectrum of Pc 4.3 in d-DCM (*denotes solvents). 
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Figure C.3. 1H NMR spectrum of Pc 4.5 in d-acetone (*denotes solvents). 
 
 
 
Figure C.4. HRMS-ESI spectra of Pc 4.5.  
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Figure C.5. HRMS-ESI spectra of Pc 4.8.  
 
 
 
Figure C.6. 1H NMR spectrum of Pc 4.10 in d-DCM (*denotes solvents). 
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Figure C.7. 1H NMR spectrum of Pc 4.13 in d-DMF (*denotes solvents). 
 
 
 
 
 
 
 
Figure C.8. 1H NMR spectrum of phthalonitrile 4.15 in d-acetone (*denotes solvents). 
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Figure C.9. HRMS-ESI spectra of phthalonitrile 4.15. 
 
 
 
Figure C.10. HRMS-ESI spectra of Pc 4.16. 
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APPENDIX D:  CHARACTERIZATION DATA FOR COMPOUNDS IN 
CHAPTER 5 
 
 
 
Figure D.1. 1H NMR spectrum of phthalonitrile 5.3 in d-DCM (*denotes solvents). 
 
 
 
 
 
Figure D.2. 1H NMR spectrum of phthalonitrile 5.5 in d-acetone (*denotes solvents). 
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Figure D.3. 31P NMR spectrum of phthalonitrile 5.5 in d-acetone.  
 
 
 
 
 
 
Figure D.4. HRMS-ESI spectra of phthalonitrile 5.5. 
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Figure D.5. 1H NMR spectrum of phthalonitrile 5.6 in d-acetone (*denotes solvents). 
 
 
 
 
Figure D.6. HRMS-ESI spectra of phthalonitrile 5.6. 
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Figure D.7. 31P NMR spectrum of Pc 5.7 in D2O (pH=13).  
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